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The aims of this thesis were to establish the prevalence of erectile
impotence in male diabetics, investigate the aetiology and follow the natural
history in order to gain a fuller understanding of the condition. From a cohort of
541 diabetic men aged 20-59 years it was found that 190 (35%) were impotent.
Impotence was associated with age, retinopathy and symptomatic peripheral and
autonomic neuropathy. Subgroups of patients were investigated in more detail
using cardiovascular autonomic function tests and by the non-invasive evaluation
f » v
of bladder function. Impotent diabetic men had more abnormalities in bladder
function. The severity of bladder dysfunction correlated with the degree of
abnormality in cardiovascular autonomic function tests. Four hundred and sixty-
six of the original cohort were followed prospectively over a five year period.
Only 11 of those originally impotent had regained potency while 78 out of 275
who were originally potent became impotent. Apart from age, the most
important factors, present originally which increased the likelihood of developing
impotence were poor diabetic control, heavy alcohol intake and the presence of
retinopathy or intermittent claudication. Sixty-three patients died, but
impotence per se was not associated with increased mortality. The thesis
concludes by discussing the implications of these data for the prevention and
management of erectile impotence in diabetic men.
INTRODUCTION AND ACKNOWLEDGEMENTS
The concept of this thesis grew from the germ of an idea which I had
during my Final Year Elective Attachment to the Diabetic Department of the
Royal Infirmary, Edinburgh in the summer of 1976. At that time there was great
interest in the impact of autonomic neuropathy on diabetics, and erectile
impotence was considered to be one of the commoner manifestations of
autonomic neuropathy in men with diabetes. Two aspects of this clinical
problem stimulated my interest and prompted me to look at it in more detail.
Firstly, impotence seemed to be a major source of morbidity for many diabetic
men and yet the prospects for investigation and treatment were limited.
Secondly, while the more florid symptoms and signs of autonomic neuropathy
occurred in only a small number of longstanding diabetics with multiple
complications, impotence seemed very much commoner, affecting men at almost
all stages of their illness.
After discussing these issues with colleagues in the Diabetic Department, I
was encouraged to document the size of the problem by doing a large randomized
cross-sectional study. I am grateful for the help and advice I received from Drs
Basil Clarke and Ian Campbell of the Diabetic Outpatient Department and to Dr.
Robin J. Prescott of the Medical Computing and Statistics Unit.
This study generated a large representative cohort of impotent and potent
diabetic men who were relatively well characterized from a clinical point of
view. Several questions were subsequently posed by this study and I felt that
detailed analyses of subgroups of these men would shed further light on the
aetiology of erectile impotence among these men. Several other researchers in
Edinburgh expressed a great interest in becoming involved with such studies and
so a group of collaborators was set-up to look into this:
Dr. Christopher Fairburn of the Department of Psychiatry, Edinburgh
University and Dr. John Bancroft of the MRC Reproductive Biology
Unit, Chalmers Street, Edinburgh were interested in documenting the
clinical features associated with sexual dysfunction in diabetic men
as a detailed description was lacking in the literature. The results of
this study are shown as an appendix to this thesis.
Dr. Frederick C. Wu of the Departments of Endocrinology /Obstetrics
and Gynaecology was interested in carrying out comprehensive
endocrine testing among a group of these men. Unfortunately results
from this work are not yet available but should add some interesting
information on this complex area.
Dr. David Q. Borsey, from the Diabetic Department, Royal Infirmary,
Edinburgh and Dr. David J. Ewing from the Department of Medicine,
Royal Infirmary, Edinburgh, and myself as principal investigator were
interested in evaluating the technique of Uroflowmetry among
diabetic men to see whether this technique could be used as a simple
screening test to determine whether or not impotence in any
particular individual was associated with signs of bladder neuropathy.
Dr. F.C. Wu was also of considerable help in this study.
Drs John Bancroft and Christopher Bell, of the MRC Reproductive
Biology Unit, Chalmers Street, Edinburgh decided to look more
directly at the vascular mechanisms of erection and at the
psychophysiological response of potent and impotent men to visual
erotic stimuli. Some data from this work are included as an appendix
to this thesis.
Although I played some part in all of these studies, my major contribution
was in the studies of Uroflowmetry and cardiovascular DAN testing and so, only
these aspects are presented in the main body of the thesis.
Towards the end of 1980 it became clear that many features had changed
among the large cohort of men. Some who were previously potent had become
impotent, a few previously impotent had regained potency while several others
had developed other complications or had died. I felt that a much clearer
understanding of the clinical problem of impotence would be obtained if the
entire cohort were reviewed again to document the natural history of the
condition. I therefore reevaluated the group during 1981-82. I am very grateful
to Dr. Robert J. young of the Diabetic Department, Royal Infirmary, Edinburgh
for help with the data collection and analysis of this prospective study.
Throughout all this work I have found my collaboration with others
stimulating and educational. I am grateful for all that I have learned. I would
like to single out a few people for special thanks. Dr. Basil F. Clarke has been
an immense help to me throughout the entire study. Dr. Robin J. Prescott and
his Department carried out the complex computer based statistical analyses
associated with the cross-sectional and prospective epidemiological studies, it
has been refreshing to work with a statistician who can make this complex field
understandable to a clinician. I would like to thank Mrs. Sarah Dickson of the
Diabetic Department for the tireless effort she expended in the tedious tasks of
locating hospital notes without which the data collection in the large
epidemiological studies would have been incomplete. I am also grateful to Ms.
Jane Richards (in Nottingham) and Mr. Kris Jones (in Seattle) for their careful
typing of the manuscript.
Finally, I would like to express my thanks to my wife Ishbel, and to my
children, Lewis, Wendy and Roderick. They have had a lot to put up with from
me in the past few years during the preparation of this thesis. Without their
patience and understanding I might have given up long ago.
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EXPLANATION OF THE RATIONALE FOR THE STATISTICAL METHODOLOGY
USED IN THE EPIDEMIOLOGY STUDIES OF THIS THESIS.
The aetiology of erectile dysfunction among diabetic men is likely to be so
complex that several interrelated factors may well play a role in its
development. For this reason, when trying to derive which aetiological factors
are likely to be of most significance in the development of erectile impotence
the most appropriate statistical method to analyze these data is by use of
LINEAR LOGISTIC MODELS. To understand these one should first understand
the rationale for using MULTIPLE REGRESSION MODELS, which in turn are
understood best after looking at LINEAR REGRESSION. Linear and multiple
regression are well described by Armitage (1971) and linear logistic modelling by
Cox (1970).
LINEAR REGRESSION
Linear regression is useful if one is interested in knowing how variable y
(the DEPENDENT VARIABLE) is affected by changes in x (the INDEPENDENT
VARIABLE) in a population of subjects. If one assumes that y is a continuous
variable, that the distribution of y, for any given value of x is normal, and that
the expected (mean) value for y is a linear function of x, then we can plot the
data as shown in Figure 1. The relationship of x and y is represented by a
straight line such that we can predict Y. for any value of x (say Xj):
Y. = a + bx. where a is the intercept and b is the slope of the regression
line.
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FIGURE 1 Linear regression
This methodology might be used, for example, if we wanted to look at the
effect of carbohydrate intake at lunchtime on the postprandial blood glucose
level. For example,
Y = blood glucose 2 hours after lunch
x = carbohydrate intake at lunch
Since both x and y here are continuous variables, and since we could
measure values of x and y in a population of insulin dependent diabetics for
example, we could fit a simple linear relationship as described above, assuming
that the relationship is not of a more complicated form than linear.
However, in reality the postprandial blood glucose in insulin dependent
diabetics could be affected by many other variables e.g., insulin dose,
endogenous C-peptide level, total calorie intake, proportion of high fibre
carbohydrate etc. Here, not only is there an increase in the number of variables
affecting y, but, in addition, several of the independent variables x^, x2, etc. are
in fact interrelated (e.g., the more endogenous C-peptide a patient has, the
lower his insulin dose is likely to be). For these reasons multiple regression
analysis is necessary to make sense of the data.
MULTIPLE REGRESSION
The purpose of this is to study the effect on variable y (the dependent
variable, e.g., two hour postprandial blood glucose) of changes in several other
independent variables x^, x2, x^, etc. These independent variables are also
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called EXPLANATORY or PREDICTOR variables. The method also takes into
account the fact that changes in several of these predictor variables can affect
each other.
The data to be analyzed consist of observations on a set of n individuals,
each individual providing a value of the dependent variable y and a value for
each of the predictor variables x^, x2,...Xp where p is the number of predictor
variables. The number of predictor variables, p, should preferrably be
considerably less than the number of observations, n, and the same p predictor
variables must be available for each individual in any one analysis. Since the
complexity of the calculations increases rapidly with the value of p, it is
necessasry to employ a computer program for multiple regression analysis.
We can produce an equation, similar to the one shown for linear regression,
where for particular values of x^,x2,...x the observed value of y is specified by
the linear model:
y=a+ 3 1x1 + 6 2x2 + ...3pxp + e
where e is an error term and is supposed to be independently and normally
distributed with zero mean. The constants 3p B2, ... 3p are called partial
regression coefficients and a is the intercept. Thus the coefficient 3 ^ is the
amount by which y changes on average when x^ changes by "one unit" and when
all the other x's remain constant. Thus, in general 3 ^ will be different form the
ordinary regression coefficient b (as described above for linear regression)
because the latter represents the effect of changes in x^ on the average values
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of y with no attempt to keep the other variables constant. The coefficients
^2' '** ^p are idealized quantities measureable only from an infinite number of
observations. In practice we use an estimate of the coefficients (which is
acceptable, especially where n is large) and thus an estimated regression
equation can be made:
Y = a + b1x1 + b0x0 +...b x .11 2 2 p p
The next step is to find the partial regression coefficients (b^, b^, bg,...bp) which
is done using matrix algebra (Armitage, 1971, pgs. 305-310, Murphy, 1982, pgs.
200-229).
Analysis of Variance Test for deletion of variables.
Having derived values for b^, b2,...bp, the t-test for any one of these
partial regression coefficients (e.g., b^) tests whether the corresponding
predictor variable Xj can be dropped from the regression equation without any
significant effect on the variation of y. With a large number of interrelated
predictor variables it often becomes quite difficult to sort out the meaning of
the various partial regression coefficients. Obviously the predictor variables
themselves have to be chosen sensibly in the first place as being factors likely to
affect the dependent variable y. The procedures used to find which of the
variables are most significant in causing changes in y are either step-up
procedures or step-down procedures. With step-up procedures the computer is
asked to try each x in turn, choosing the one which provides the biggest effect on
the regression in terms of minimising the residual sum of squares. It retains this
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predictor variable and goes through the remainder to see which of those, when
added to the retained variable gives the largest improvement to the regression.
Having selected this second variable to be retained it repeats the process, adding
one more variable each time until the increments by which the residual sum of
squares is changed cease to be (in some sense) significant. With a step-down
procedure the computer first does the regression on all predictor variables. It
then does regression by dropping each variable in turn to derive a set of
regressions using p-1 variables. Whichever dropped variable caused least change
to the regression is eliminated as being non-significant. The process is then
repeated for all the possible regressions using p-2 variables. The process stops
when all the retained regression coefficients are (by some criteria) significant
such that, by dropping any one of these remaining variables, the change in
residual sum of squares is sizeable and thus for the best explanation of which
independent variables (x's) affect changes in y, aH must be retained. Both of
these procedures usually (though not necessarily) converge to the same model. In
the studies described in this thesis the step-up procedure was most commonly
used.
The interpretation of the results obtained from this process requires some
common sense. For example if we included "number of teeth" as a predictor
variable for impotence we might find that there was a highly significant negative
correlation between the number of teeth and the probability of impotence ('.)
whereas the true explanation is likely to be that advancing age is affecting both
x (number of teeth) and y (potency). However, theoretically the computer might
eliminate age and retain "loss of teeth" as being one of the best predictors of
potency. The techniques of multiple regression should sort out this type of
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problem, however, unless the relationship between the two variables is very
strong. Nevertheless, careful scrutiny of the predictor variables retained and
those eliminated is therefore an essential part of the data interpretation.
LINEAR LOGISTIC MODELLING
I have attempted, in the above description, to explain why multiple
regression is a more valid method of data analysis than the "one variable at a
time" approach when looking at the effect of a large number of interrelated
variables on the dependent variable y in which we are interested. The limitation
of multiple regression analysis, as described, is that it assumes that the
dependent variable y is a continuous variable which is normally distributed.
While this is appropriate for the example of postprandial blood glucose given
earlier, it is inappropriate where y is represented by an all-or-none, yes or no
type of response. Thus in our studies, we asked patients if they "had been
completely unable to achieve and maintain an erection sufficient for vaginal
intercourse on all occasions during the past 6 months." The response to this was
therefore yes or no. Linear logistic models were derived for this situation (Cox
1970). Thus if p denotes the probability that an individual is impotent, we fit the
equation:
log(p / (1-p)) = a + b1x1 + b2x2 +...1bnxn
where x^, x2,...xn represent the values of our "explanatory" variables.
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EXPLANATORY VARIABLES USED
Age - continuous variable, in years
Weight -<110% IBW
Marital status - married / other
Duration of diabetes - continuous variable, in years
Diabetic treatment - I, OHA, Diet
Alcohol intake - Grades I-IV
Retinopathy - I-IV
Nephropathy - I-IV
Peripheral neuropathy - Yes/No
Autonomic Neuropathy - Yes/No
Ischaemic heart disease - Yes/No
Intermittent claudication - Yes/No
Diabetic control - Poor/Fair/Good
The models used in our analysis were fitted using the computer package,
BMDP. As acknowledged previously I am grateful to R.J. Prescott and the
Department of Medical Computing and Statistics for their work in the computing
of these data. The interpretation of the results was carried out by consultation
between R.J. Prescott, D.K. McCulloch and I.W. Campbell during the prevalence
study and between R.J. Prescott, D.K. McCulloch and R.J. Young during the
natural history study.
In both the cross-sectional and prospective epidemiology papers in the
thesis tables are used to illustrate the data in visual detail. The p-values shown
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below each table are derived from the linear logistic model and are derived from
likelihood ratio tests, based on differences in log likelihoods when a term is
included and then excluded from the model. The p-values thus show the
significance which that variable has on impotence, taking into account not only
the data shown in the table but also incorporating the interrelationships of that
and all the other predictive variables used."
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REVIEW OF THE LITERATURE
INTRODUCTION
Erectile impotence is defined as the inability to achieve and maintain a
penile erection of sufficient rigidity for insertion and completion of the sexual
act. Its occurrence causes a great deal of misery, especially if it is unexpected,
permanent and occurring at an early age. Apart from the unhappiness brought
about by the loss of sexual satisfaction, impotence has more far reaching
effects, causing loss of self-esteem and confidence.
The first report in the literature suggesting that sexual dysfunction could
occur as a consequence of diabetes mellitus was made almost two centuries ago
by Dr. John Cleghorn, lecturer in chemistry and one of the physicians to the
Infirmary at Glasgow. His letter to Dr. John Rollo in May 1797 was published in
Rollo's book the following year (Rollo 1798). Cleghorn described succinctly the
plight of a 38 year old Glaswegian porter:
"He is the father of several children, but since he has been seized
with Diabetes - coitus nullus. Erigitum nunquam: ne quidem semel
rigescit."
Several other authors in the pre-insulin era commented on the frequency of
the problem (von Noorden, 1903; Naunyn, 1906). Naunyn regarded impotence as
one of the commonest symptoms in male diabetics, reporting its occurrence both
in patients debilitated by loss of sugar and in other patients relatively untroubled
by the disease. Following the introduction of insulin in 1922 very little mention
is made of impotence for thirty years. Simpson (1950) expressed the belief that
persistent impotence, complained of by the patient, was not common "in patients
who had always been controlled with a balanced diet and insulin." However,
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when patients were asked about sexual problems directly, in formal surveys to
assess the prevalence of impotence, the findings differed markedly from this
view.
PREVALENCE OF DIABETIC IMPOTENCE
Several authors in the past twenty five years have found a high prevalence
of impotence among diabetic men (Rubin and Babbott, 1958; Schoffling, 1960;
Montenero and Donatone, 1962; Prikhozhan, 1967; Ellenberg, 1971; Faerman et
al, 1972; Kolodny et al, 1974). The overall prevalence varies from 40 - 75% in
these studies, the differences being largely attributable to variations in the age
ranges of the subjects (Table 1) and to methods of case selection. This is much
higher than the overall prevalence of 2.8% quoted by Kinsey et al (1948) for the
general population.
All the studies quoted above show a marked rise in the prevalence of
impotence with increasing age. There is disagreement however about the
association of impotence with duration of diabetes. Schoffling et al (1960) found
that the mean duration of diabetes was 9.3 years in the group of men with
impotence compared with 4.3 years in a similar potent group. Other authors
(Rubin and Babbott, 1958; Ellenberg, 1971; Kolodny et al, 1974) have failed to
find such an association however.
Some authors have claimed that impotence bears no relationship to
diabetic control (Martin, 1953; Ellenberg, 1971; Kolodny et al, 1974) but since
none of these studies was prospective in nature and none used an adequate




Previous studies outlining the prevalence of impotence in diabetic men
AUTHOR (date) No. OF AGE RANGE PERCENTAGE
SUBJECTS (Yr) IMPOTENT (%)
Rubin and Babbott 198 16 - 92 55%
(1958)
Schoffling (1960) 314 16 - 65 51%
Montenero and Donatone 436 20 - 65 52%
(1962)
Prikhozhan (1967) 350 Not stated 75%
Ellenberg (1971) 200 Not stated 59%
Faerman et al (1972) 299 18 - 50 40%
Kolodny et al (1974) 175 18 - 81 49%
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CLINICAL FEATURES OF DIABETIC IMPOTENCE
With the increasing awareness of sexual dysfunction among diabetic men
brought about by these studies the clinical pattern of erectile impotence in these
patients has emerged. Two forms of erectile difficulty are described. In the
first, failure of erection occurs in the context of poor diabetic control. Rubin
and Babbott (1958) describe how erectile failure and loss of libido accompany the
general malaise and lethargy associated with hyperglycaemia and how all three
reverse once the patient's physical condition improves. Kolodny et at (1974)
describe how 8 out of 14 men who were impotent at the onset of diabetes
regained potency following the initiation of diabetic therapy. The second and
much more common form of diabetic impotence occurs gradually and insidiously
in the context of established diabetes. This latter condition is often referred to
as "organic impotence" which is then simplistically distinguished from
"psychogenic impotence" on the basis of five or six characteristics which are
believed by some to be powerful discriminating features (Cooper, 1972 - see
Table 2). The features of this "organic imotence" are contrasted vividly with the
features of "psychogenic impotence." In the former, impotence is said to occur
gradually in diabetic men with preservation of normal libido and in the absence
of psychological upset or marital dysharmony. Accompanying this erectile
failure are a loss of spontaneous and morning erections and a difficulty in
achieving erection during masturbation. In the latter, impotence is usually
sudden in onset, intermittent and selective in expression and associated with a
decrease in libido, and the presence of an obvious marital or psychological
precipitant. In this situation the ability to obtain an erection spontaneously,
during mastrubation, or on waking are said to be maintained. While these
stereotyped clinical features have been used by some authors in the differential
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diagnosis of impotence among diabetic men (Cooper, 1972; Ellenberg, 1980),
their validity has recently been challenged. Several patients may show
intermediate clinical features (Schiavi and Hogan, 1979) and there have been
recent reports of the successful use of sex therapy in the treatment of diabetic
impotence (Waxberg, 1978; Renshaw, 1979).
AETIOLOGY OF DIABETIC IMPOTENCE
Before reviewing the work which has been done to investigate the aetiology
of imotence in diabetics, I would like, first, to review what is known about the
mechanism by which erections are obtained and maintained in the normal human




























Unrelated to life events.






Mechanisms involved in normal male sexual function
(i) Neurological
At a fairly simplistic level, the neurological mechanisms involved in the
normal male sexual response can be stated in the following way. Penile erection
occurs as a reflex mediated by the parasympathetic nerve fibres from the
second, third and fourth sacral segments of the spinal cord (nervi erigentes).
Stimulation of these nerves results in dilation of the penile arteries, increase in
blood flow and tumescence of the corpora cavernosa and corpus spongiosum.
Detumescence results from vasoconstriction of the penile arteries with
subsequent decrease of arterial blood flow, diminution of pressure and release of
the compressed veins (Learmouth, 1931; Bors and Camarr, 1960). Ejaculation, on
the other hand, is mediated by sympathetic nerve fibres causing forceful
antegrade propulsion of fluid from the urethra to the outside, by contraction of
the bulbocavernosus muscle (Whitelaw and Smithwick, 1951) while affecting
closure of the internal vesical sphincter at the moment of ejaculation (Retief,
1950).
While all this is true, we are largely ignorant of the interneuronal
transmitters involved in these mechanisms. Although erection is believed to be
influenced by the cholinergic parasympathetic fibres described above, controlled
experiments have shown that atropine does not prevent erection in man or
monkey (Wagner and Brindley, 1980). More recently the neurotransmitter
vasoactive intestinal polypeptide (VIP) has been demonstrated in the penis (Polak
et al, 1981; Willis et al, 1981). In vitro studies of smooth muscle from the
cavernous bodies of rabbit, monkey and man have shown that VIP has a relaxing
effect on this tissue (Wagner, 1982). The significance of these findings is unclear
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but they highlight the deficiencies in our full understanding of the neural control
of erectile function.
(ii) Endocrine
An understanding of the influence of endocrine factors in the male sexual
response is hampered by several problems. Firstly there is very little uniformity
in the definitions of terms such as "potency" or "libido" in the published
literature. Thus the adequacy of these definitions and their comparability
between studies makes the interpretation of data tentative at best. Secondly it
is often difficult to unravel the cause and effect relationship between sexual
behaviour and hormone levels. Thirdly a considerable amount of published work
draws conclusions from studies which were not adequately controlled and so it is
not surprising that conflicting results are obtained by different authors.
Libido is described by Davidson, Kwan and Greenleaf (1982) as the "sum of
the affective - cognitive processes which result in the tendency to engage in
sexual behaviour." It comprises several elements. There is the desire for sexual
activity, expressed in increased sexual thoughts and fantasies. Related to these
are elements of enjoyment, pleasure or satisfaction derived from engaging in
such thoughts. Finally libido is influenced by the importance which an individual
attributes to his or her sexuality which is partly influenced by external pressures
from society and the media. Potency, on the other hand, can be defined as "the
capacity to respond to sexual stimuli (exogenous or endogenous) with
physiological genitopelvic responses: primarily (a) erection and associated
vasomotor activity, and (b) ejaculation and associated neuromuscular activity."
Both of these terms are fairly complex. In addition, although they are often
separated for purposes of clarity in data analyses they are interrelated
physiologically. It is hardly surprising that no simple relationships can be found
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between hormone levels and a process as complex as this.
Turning to the problem of "cause and effect," before looking at the
evidence for how endocrine factors may influence sexual behaviour it is worth
considering how sexual activity can influence hormone levels. There is evidence
that androgen levels become elevated after sexual activity (Fox et al, 1972;
Kraemer et al, 1976) and that increased plasma testosterone levels can be noted
as a response to watching a sexually stimulating film (Pirke, Kockott and
Dittmar, 1974). In addition, psychological stress such as that observed during
stressful training of military officers has been reported to be associated with
depressed testosterone levels (Kruez, Rose and Jennings, 1972). These effects
may partly explain why some studies of androgen function in cases of
"psychogenic impotence" have decreased testosterone in the urine (Ismail et al,
1970) and plasma (Legros et al, 1973; Raboch, Mellan and Starka, 1973).
However, when precise definitions of psychogenic impotence have been used and
where adequate control subjects are also studied the consensus of opinion
indicates that androgen deficiency does not contribute to the development of
psychogenic erectile impotence (Lawrence and Swyer, 1974; Ansari, 1975,
Comhaire and Vermeulen, 1975; Schwartz, Kolodny and Masters, 1980; Pirke and
Kockott, 1982).
This problem of "cause and effect" is also difficult to unravel when looking
at the influence of hormone levels on the well-known downward trend in sexual
function with advancing age shown both in the normal population (Kinsey et al,
1948) and in diabetics (see Table 1). Advancing age is associated with a decrease
in plasma testosterone, an increase in sex hormone binding globulin and an
increase in gonadotrophins (Vermeulen, Rubens and Verdonck, 1972; Baker et,
1976; Stearns et al, 1976). However, although a correlation can be shown
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between hormonal levels and behavioural variables such as libido and
performance, as assessed by questionnaires, the relationship is not strong and the
effect of androgen replacement in this situation is not impressive (Davidson,
Kwan and Greenleaf, 1982).
Studies of the sexuality of human castrates should shed some light on the
influence of androgen levels on sexual function. Unfortunately well designed
studies are lacking and thus only very broad conclusions can be drawn. Several
studies have shown that sexual behaviour is drastically reduced or completely
suppressed in a high percentage of castrates (Stone, 1932; Bremer, 1959;
Langeluddecke, 1963; Mitamura, 1970; Cornu, 1973; Heim and Hursch, 1979;
Heim, 1981). However it is of interest to note from these studies that a
proportion of castrated men retain a significant degree of sexual function and
that, in general, erectile potency is less affected by castration than sexual
interest and libido.
Similar distinctions have been made with regard to the effect of androgen
replacement on the sexual function of hypogonadal men. While several studies
show a significant relationship between changes in testosterone levels and
changes in several elements of sexuality, the effects on libido and the frequency
of sexual thoughts are much quicker while the improvement in erectile and
ejaculatory function follows afterwards. There is some evidence that decrease
in testosterone levels leads to a waning of sexual thoughts and fantasies and that
erectile and ejaculatory problems are largely secondary to this. It has been
noted in 8 hypogonadal males (including 2 castrates) that the erectile response to
visual erotic stimulation was no different when taking androgen replacement
than without, and indeed was not significantly different from normal controls
(Bancroft and Wu, 1982). However these men showed an impaired erectile
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response to fantasy when off replacement therapy which was restored after
treatment, suggesting that testosterone may have more effect on cognitive
aspects of sexual function and that erectile responses may be secondary to these.
Davidson, Kwan and Greenleaf (1982) claim that, not only is the erectile
response during erotic films normal in castrates and hypogonadal men but that
detumescence after the film has finished is slower. They conclude that the main
influence of testosterone is to stimulate cognitive acts involved in the
generation of sexual imagery or to facilitate the awareness of genital
stimulation.
In conclusion, there is strong evidence that endocrine factors have a major
modulating effect on the basic male sexual response. However, because of the
complexity of the interrelationships between the sexual activity and the
endocrine system, the diagnostic value of single measurements of plasma or
urinary hormone levels is limited.
(iii) Vascular
There is no doubt that an adequate arterial blood supply to the penis is
necessary for the development and maintenance of a normal erection. The first
clinical demonstration that arterial occlusion could result in erectile failure was
made by Leriche (1940) who described a syndrome characterized by ischaemia of
the lower limbs and erectile impotence following occlusion of the aorto-iliac
bifurcation. Further evidence came in 1958 when O'Connor reported a case of
Leriche syndrome where endarterectomy of the aortic bifurcation resulted in
restoration of sexual activity. Although several larger series have suggested
that improved potency occurs in only a small proportion of patients (Harris and
Jepson, 1965; May et al, 1969; Spiro and Cotton, 1970) the importance of an
adequate vascular supply for erectile function is indisputed. A rare, but
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dramatic piece of supporting evidence for this is the "pelvic steal syndrome"
(Michal et al, 1978; Metz and Mathiesen, 1979; Queral et al, 1979). In this
syndrome the patient is able to achieve and maintain an erection at rest but
immediately after commencing coital movements he develops pain in the gluteal
muscles and detumescence of the penis. Once again, restoration of potency has
been described after reconstructive vascular surgery in such cases (Michal et al,
1978).
Recently attempts have been made to quantify the extent of proximal
vascular insufficiency. The simplest of these methods is the measurement of
systolic blood pressure in the penile arteries measured in the flaccid state by
placing a small cuff round the base of the penis and detecting the return of
systolic pulsation using a Doppler ultrasound technique. The values obtained are
compared with the systolic pressure in the arm, and expressed as a ratio - the
penile - brachial pressure index (PBPI). When using this technique among
patients known to have proximal aorto-iliac occlusion and associated impotence,
a PBPI of less than 0.6 suggests an arterial cause for the impotence while ratios
greater than 0.75 make an arterial cause less likely (Gaskell, 1971; Engel et al,
1978; Queral et al, 1979). However, in conditions where more distal
atheromatous occlusion is likely (notably in diabetes) the interpretation of the
PBPI must be more cautious.
Michal et al (1976) have pioneered a more invasive technique in order to
obtain more detailed information about the haemodynamic changes surrounding
impotence. Phalloarteriography is a technique by which selective arteriography
of the hypogastric arteries is performed while, at the same time artificial
erection is induced by infusing heparinized saline directly into the cavernous
bodies. Apart from allowing good visualisation of the penile arterial bed, the
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technique also allows measurement of intracavernous pressue and penile
circumference during erection along with an estimate of the flow rate necessary
to maintain erection. Although this technique is indeed invasive, and requires
local or even general anaesthesia, Michal claims that it is well tolerated and may
even lead to an improvement in erectile capability lasting for several days, at
least, in about 20% of cases. This technique of selective arteriography, with or
without the addition of artificial erection has confirmed that distal arterial
occlusion is commonly associated with impotence (Ginestie and Romieu, 1976;
Michal, 1976) although this had been shown indirectly much earlier using
impedance plethysmography (Canning, 1963).
The intricate mechanisms by which arterial input and venous outflow from
the penis are co-ordinated to produce a normal erection have only been
unravelled to some extent in the past decade. Up until recently the dominating
theory was the "polster theory." This was initiated by the German anatomist von
Ebner (1900) who described specialised "pads" or "cushions" of smooth muscle
inside the vessels of the penis. Kiss (1921) agreed with von Ebner's findings as
did Conti (1952) who coined the term "polster." These observations were purely
anatomical however and the explanation of the physiological function of these
polsters in influencing blood flow in the penis was only theoretical. Several
investigators have challenged the theory that such polsters act as valves
regulating penile blood flow. (Newman and Morthup, 1981; McConnell et al,
1982; Wagner et al, 1982). It is thought that these "polsters" are either age-
related or pathological and that similar lesions may be found in other organs of
the body (Wagner, 1982). A more plausible theory is that there are large shunt-
vessels leading from the deep penile artery through the tunica albuginea into the
spongiose vessels which lead back to the venous system. These shunt vessels
21
have been demonstrated as vascular casts (Wagner et al, 1982) and are shown to
be muscular helicine arteries which are capable of dilation or constriction under
neural control. It is thought that these remain open when the penis is flaccid but
that they contract following erotic stimulation and thus prevent a run-off of
blood into the venous system. In this situation the arterial blood is diverted into
the cavernous bodies leading to penile erection.
(iv) Psychological
Although it is possible to describe the male sexual response purely in terms
of neurological and vascular mechanisms there is no doubt that voluntary or
involuntary cortical influences can have a profound modulating effect on these
basic reflexes. Thus "psychogenic impotence" can be considered to be the result
of cortical inhibition during the early excitement phase of the sexual response
(Kaplan, 1974). It has been estimated that up to 90% of cases of erectile
impotence in the general population are caused largely by psychological
inhibition of this sort (Wershub, 1959; Masters and Johnson, 1970; Kaplan, 1974;
Levine, 1977; McCary, 1978).
During the past fifteen years there has been more careful analyses of the
factors associated with psychogenic impotence leading to a clearer description
of the problem and allowing a more rational approach to treatment. Erectile
dysfunction can be classified as primary (where the man has never been able to
achieve or maintain an erection long enough to have intercourse) and secondary
(where the man has had at least one successful coital experience but is now
unable to have an erection). Primary erectile dysfunction is rarer, more difficult
to treat and has different psychological associations than secondary erectile
dysfunction. In the primary disorder there is frequently a history of strict
parental attitudes in childhood, religious stringency, traumatic childhood
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experiences, homosexual involvements or emotionally scarring first sexual
encounters (Masters and Johnson, 1970; McCary, 1978). Masters and Johnson
have consistently observed two characteristics in virtually all the cases of
primary erectile dysfunction: fear, and an unusual sensitivity to unknown
psychological factors that apparently would not affect other men in the same
way.
With secondary erectile dysfunction the commonest finding is of extreme
anxiety. This anxiety, in turn, is usually a manifestation of fear, guilt and anger.
The commonest fear is the fear of failing to give the partner sexual satisfaction
(sometimes called "performance anxiety") and often stems from the man having
inappropriate expectation based on cultural myths and sexual ignorance. Other
fears include the fear of injuring the partner, getting her pregnant, or being
discovered in the act. Anxiety stemming from guilt may be due to extramarital
affairs, shame and self-degradation about sexual experiences, and again,
religious orthodoxy. Anxiety can also result from anger about marital
arguments. The man's anger may reduce his interest in sex, or cause him to rush
through the sexual act, partly through lack of interest and partly to punish his
partner. She in turn may build up resentment and anger at being unsatisfied thus
creating a stage for a deteriorating relationship. In this situation it is thought
that erectile dysfunction may be an unconscious way of getting even with the
partner. At a conscious level, he cannot be blamed because erection is an
automatic response.
Levine (1976) identifies several other emotional or intrapsychic themes
that may be present in men with secondary erectile dysfunction. Some men
separate lust and affection, such that "sexual women" are derogated but exciting
while their wife is adored but not arousing. Also, the combination of a timid
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ineffectual man, lacking in self-esteem and self-assertion, and an insensitive and
dominant sexual partner may commonly lead to psychogenic impotence. Some
men may not be able to have erectons without unusual forms of sexual behaviour
or fantasies. Others may be inhibited by guilt and anxiety stemming from
previous pleasurable homosexual experiences.
Thus there are a wide variety of situations where erectile dysfunction may
develop. If there is a triggering event, such as intercurrent illness, undue fatigue
or excessive alcohol intake, such that a man notices, on one occasion that his
sexual performance has fallen below whatever standards he believes to be
normal, then his ability to accept this single episode of failure will depend on the
psychological background described above, and, above all, his partner's response
to his "sexual failure." If the man's anxiety is not alleviated by the time of his
next sexual attempt then he may become anxious due to an expectation of
failure and may concentrate his attention on evaluating his performance during
lovemaking rather than relaxing and participating in the sexual act. Masters and
Johnson (1970) refer to this as "taking the spectator role."
It is clear then that even in the absence of any organic damage to the
genitals many factors in the psychological makeup of a man may contribute to
the problem of erectile impotence. Appropriate treatment requires firstly a
clear understanding of the psychological background and an evaluation of the
attitudes of both sexual partners to it. The main goals of treatment are then to
decrease performance anxiety by trying to remove the man's fear of failure,
reorientate his emotions and sensations towards "participation" and away from
"spectatoring" and finally trying to remove the woman's fear of the man's
dysfunction. Although treatment can be attempted without the participation of
the female sexual partner, the outcomes are significantly better when the
woman is included (Cooper, 1971; Kaplan, 1974).
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SECTION B
Factors involved in sexual dysfunction among male diabetics
Varying amounts of attention have been focussed on the four main aspects
of sexual physiology described in Section A in studies to investigate the aetiology
of impotence among diabetic men.
(a) Neurological factors
Several studies have shown an association between impotence and the
presence of neuropathy in diabetics (Rundles, 1945; Martin, 1953; Ellenberg,
1971; Faerman et al, 1972; Kolodny et al, 1974; Jensen et al, 1979) although most
of the supporting evidence for these claims are indirect. Abnormalities in
bladder structure (Faerman et al, 1972) and function (Ellenberg, 1971) have been
demonstrated in impotent diabetics, and since the bladder is subserved by the
same sacral parasympathetic fibres which cause penile erection, damage to these
fibres has been suggested as the explanation for coincidental bladder and sexual
difficulty in these men. More direct evidence for autonomic nerve damge was
found by Faerman et al (1974) when they demonstrated histochemical
abnormalities in the autonomic fibres of the corpora cavernosa of five impotent
diabetic men whereas no abnormalities were present in five potent, non-diabetic
controls. Melman and Henry (1979) found lower noradrenaline concentrations in
the spongy erectile tissue of impotent diabetic men when compared with non-
diabetic controls. Unfortunately neither of these studies used potent diabetic
men as a control group. Despite these criticisms, however, there is compelling
evidence that pelvic autonomic nerve damage is a major contributing factor to
erectile impotence in some diabetics. One apparent anomaly is that impotence
is very much more common than any other features of autonomic neuropathy,
and a large number of patients present with impotence as an isolated feature.
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Ewing et al (1980) found that when some of these men were followed
prospectively, a substantial number developed symptoms of more widespread
autonomic neuropathy which can be verified by objective testing of autonomic
function. It has been shown in the cardiovascular system that the
parasympathetic fibres are damaged earliest and that sympathetic damage
occurs at a later stage (Ewing et al, 1981). It may be that the long
parasympathetic fibres to the pelvic organs are the most vulnerable fibres of all
and so erectile impotence is the most common early feature of neuropathic
damage in diabetics.
(b) Endocrine factors
Experimental studies with animal models have found a reduction in
androgen production, Leydig cell numbers and LH receptors, and this reduction is
not only proportional to the duration and severity of hyperglycaemia, but is also
reversed by insulin administration (Hunt and Bailey, 1961; Foglia et al, 1969;
Charreau et al, 1978; Paz et al, 1978).
Early clinical studies suggested that patients with diabetic impotence had a
reduced Leydig cell number and a diminished excretion of urinary metabolites of
testosterone (Schoffling et al, 1963). However, Faerman et al (1972) found no
abnormalities in Leydig cell number and morphology in the testicular biopsies of
seven impotent diabetic men. Furthermore, they found that in vitro testicular
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metabolism of H pregnenolone was no different between these patients and five
control subjects with varicocoeles. Several other workers have supported this
view by finding no difference in mean plasma testosterone concentrations
between impotent and potent diabetic men and normal controls (Kent, 1966;
Ellenberg, 1971; Kolodny et al, 1974; Wright et al, 1976 and Jensen et al, 1979).
Recent studies have indicated that the picture is more complicated than
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previously envisaged. Geisthovel et al (1976) found that impotent diabetic men
had a significantly lower free plasma testosterone and an impaired HCG response
compared with potent diabetic controls and Daubesser et al (1978) found
diminished total plasma testosterone in both diabetic and non-diabetic impotent
men compared with potent controls. On this basis the latter group suggested
that Leydig cell abnormalities might be secondary to the low coital frequency of
impotent subjects. However, other studies have found low plasma total and free
testosterone levels in diabetic men as compared with normal controls,
irrespective of whether or not there were sexual problems (Shalwan et al, 1978;
Gattucio et al, 1979; Ando et al, 1979). The latter studies suggest that
abnormalities in Leydig cell function may reflect the duration and severity of
metabolic disturbance and its treatment, while the association with erectile
impotence and other sexual problems might merely be coincidental.
Reports on the hypothalamic pituitary function of diabetic men have been
no less confusing. Again Schoffling's group provided the initial impetus by
demonstrating lowered total urinary gonadotrophin activity in some impotent
diabetic men. However, radio-immunoassay studies found normal basal levels
and an intact response to GRH stimulation both among impotent and potent
diabetic men (Rastogi et al, 1974; Daubesser et al, 1978; Jensen et al, 1979;
Gattucio et al, 1979). Distiller et al (1975) found an impaired LH response to
GRH stimulation despite normal basal gonadotrophin levels. This finding has
been subsequently confirmed by other investigators who have also reported a
similar decrease in the LH response of impotent and potent diabetic subjects
(Wright et al, 1976; Shalwan et al, 1978). However, Ando et al (1979) found high
basal LH levels and a prolonged response to GRH stimulation in young diabetic
men with good glycaemic control.
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Hyperprolactinaemia has been found to be associated with impotence in
some non-diabetic men (Thorner and Besser, 1977; Franks et al, 1978;
Nagulesparen et al, 1978). However, there have been conflicting reports of
prolactin levels in diabetic subjects. Hunter et al (1974) found high mean random
prolactin levels in 10 diabetic patients without retinopathy with normal levels in
four patients with retinopathy. Other groups, however, have found normal basal
prolactin concentrations in insulin-dependent diabetic men with or without
retinopathy (Harter et al, 1976; Froland et al, 1977; Champeyroux et al, 1978).
More recently, Lester et al (1981) found no significant difference between the
mean serum prolactin concentrations of 19 impotent diabetic men compared with
64 potent diabetics.
In view of the conflicting results obtained in all areas of endocrine
research in diabetic men it is difficult to evaluate the relevance of hormonal
factors to the sexual problems of diabetic men. Overall it seems that the
changes that have been demonstrated may not be of primary aetiological
importance since similar changes are encountered among potent diabetic
controls. However, the relationship between individual aspects of the male
sexual response (erection, ejaculation and sexual appetite) and these hormonal
changes has yet to be explored. Furthermore there has been a failure to take
account of variables such as the quality of metabolic control, the subject's age
and treatment, and cyclical variations in testosterone and gonadotrophin levels.
From a more practical point of view, however, the fruitless attempts to treat
diabetic impotence with hormone replacement therapy (Ellenberg, 1971; Cooper,
1972; Kolodny et al, 1974) would suggest that endocrine disturbance is not of
prime aetiological importance in this condition.
(c) Vascular factors
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The significance of structural vascular disease to the erectile problems of
diabetic men is difficult to assess. Since it is well known that atheroma is
commoner among diabetics, occurs at a younger age and extends into more distal
arteries than in the general population, it would be surprising if arteriopathy did
not play a major role in "diabetic impotence." Histological studies have
confirmed that diabetic males have more severe narrowing and occlusion of the
hypogastricocavernous inflow to the penis than do age matched non-diabetics
(Ruzbarsky and Michal, 1977). Unfortunately no study has compared the
histological appearances between impotent diabetics and potent diabetics,
matched for age and duration of diabetes. Without such a control group it is
almost impossible to say whether the changes seen reflect the diabetic process,
per se, with erectile impotence being an unrelated coincidental finding, or
whether the arteriological abnormalities seen do indeed have a causative
association with impotence. This same problem makes it difficult to interpret
much of the data obtained from clinical investigations. Penile blood pressure
studies have suggested that the penile blood supply is impaired in many cases of
diabetes (Gaskell, 1971; Abelson, 1974; Engel et al, 1978; Karacan, 1980) and
such findings can sometimes be confirmed by arteriography (Engel et al, 1978) or
phalloarteriography (Michal, 1982). The interpretation of these findings is
hampered not only by the lack of appropriate control subjects but also by the
fact that many of the impotent diabetic men who show the worst vascular
pathology also have severe peripheral and autonomic neuropathy (Michal, 1982).
Depending on the bias of the investigator /author these findings are interpreted
as either showing that arteriopathy is the major cause of diabetic impotence,
though some patients have coincidental neuropathy, or as showing quite the
reverse. It seems naive to look at "diabetic impotence" in this way. Both
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vascular and neuropathic factors may interrelate in that arterial input and
venous drainage from the penis are influenced by autonomic reflexes so that
damage at several points could lead to erectile dysfunction.
(d) Psychological factors
It is surprising how little attention has been paid to psychological factors in
the sexual difficulties in diabetic men. After all, diabetics are unlikely to be
immune from the complex problems, described already, which can promote or
aggravate sexual difficulty. In addition, diabetes, especially the insulin
dependent type is a stressful illness imposing social and financial handicaps. Not
surprisingly, several studies have shown that diabetes can have a profound
psychological effect, not only on the individual but on his inter-personal
relationships and family functioning (Treuting, 1962; Hauser and Pollets, 1979;
Anderson and Auslander, 1980, Tattersall and Jackson, 1982). While much of this
work has focussed on the problems of diabetic adolescents, in a study of 112
adults who had had diabetes for 25 to 48 years, Murawski et al (1970) using the
Minnesota multiphasic personality inventory found that the entire sample,
whether they had complications of diabetes or not, had a high depression score.
They also expressed pervasive feelings of pessimism, hopelessness and depression
in their test responses.
Until recently the assessment of whether or not a diabetic man had an
"organic" or "psychogenic" cause for his sexual dysfunction was based on a fairly
brief history, elucidating the distinguishing features outlined in Table 2. Since
1975, however, there have been several reports claiming that a more objective
method of distinguishing between the two is by the measurement of erections
during sleep (Fisher et al, 1975; Karacan et al 1975, 1977 and 1978; Fisher et al,
1979; Hosking et al, 1979). This work was initially based on some established
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observations, but the applications of this technique to the differential diagnoses
of diabetic impotence has required some quite sweeping assumptions. It has been
known for 40 years that erectile episodes lasting for about 25 minutes and
recurring about every 85 minutes are a normal occurrence in males (Ohlmeyer et
al, 1944). These were found to be related to episodes of rapid eye-movement
(REM) sleep and to exhibit a predictable pattern with increasing age. The
maximal increase in penile diameter, the frequency of erectile episodes and the
total amount of time where erections are present during the night (the total
tumescence time) all peak after puberty and in early adult life but decline
thereafter (Karacan, 1976). Despite this careful work and also some evidence
that anxiety may inhibit sleep-related erections (Fisher, 1966; Karacan, 1966)
one of the big assumptions which is made when using the measurement of
nocturnal erections to distinguish between psychogenic and organic impotence is
that in the former, REM associated erections will be normal (in marked
discrepancy with the patient's daytime performance) while in the latter, such
REM-associated erections will be markedly reduced in amplitude, frequency and
duration. Problems of interpretation have been discovered as this technique has
become more widely used. Some authors have based their findings on the
absolute change in penile diameter, regarding an increase of greater than 15-16
mm as being normal (Karacan et al, 1978; Hosking et al, 1979). One problem
with this is that the interindividual variation in penile size and in diameter
change associated with full rigidity is large and so interpretation based on
absolute changes may be misleading. It has been found that the discriminating
power of this test is increased if note is also taken of duration of maximum
erection, frequency of erectile episodes and total tumescence time (Fisher et al,
1979). In addition, both Fisher and Karacan suggest that the rigidity of the penis
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associated with a certain change in penile diameter shold be verified either
manually by an independent observer, or by measuring the "buckling pressure"
(Karacan, 1980)
Another problem with the technique of measuring nocturnal penile
erections has been the lack of validation of the methodology. Marshall, Surridge
and Delva (1981) carried out independent assessments on 27 impotent men, based
on medical and psychiatric history and placed them into one of four categories -
organic, psychogenic, mixed aetiology and uncertain. They then measured the
nocturnal erection pattern in these subjects and scored the results blindly. They
found that they could pick out psychogenic impotence in 80% of cases when using
maximum change in erection only, but that accuracy increased to 95% when they
also included data on the frequency of erectile episodes. In a recent review,
Schiavi and Fisher (1982) go further and suggest that interpretation is made most
accurate when there is concurrent EEG and psychophysiological measurements,
when measurements are done on 2 or 3 consecutive nights, when 2 strain gauges
are used (one at the base of the penis and one behind the glans) and when
verification of rigidity is carried out by an independent observer. All of these
suggestions will undoubtedly increase the discriminating power of this procedure.
Unfortunately they also argue against the use of this technique as a simple
discriminator which can be used in a general medical ward, or even at home
(Bohlen, 1981).
NATURAL HISTORY OF DIABETIC IMPOTENCE
For a full clinical description of diabetic impotence it is necessary, not
only to establish the prevalence and investigate the aetiology, but also to follow
the natural history of the condition. Ewing et al (1976) first pointed out that the
presence of damage to the autonomic system in diabetics, as judged by abnormal
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autonomic function tests, was a grave prognostic feature. More recently this
group have published a 5 year follow-up of 73 diabetics (Ewing et al, 1980(a)).
This included a group of 14 men with impotence as an isolated feature, all of
whom had normal cardiovascular autonomic function tests (Ewing et al, 1980(b)).
When followed for five years, 6 of these men still had impotence as their only
symptom and all 6 had normal autonomic function tests. Five of the remaining 8
had died during this period of whom 3 developed other symptoms of autonomic
neuropathy before death.
CONCLUSIONS
While much research has been carried out on various aspects of impotence
among diabetic men particularly during the past thirty years, there are several
areas where the clinical descriptions of the condition are unclear or disputed. A
large and unbiased epidemiological study to establish the prevalence of the
condition at the present time is needed. To plan the appropriate management of
these patients it is also necessary to clarify the relative importance of the
aetiological factors pertaining to particular patients. Finally, the untreated
natural history of a large group of impotent diabetic men remains to be
established and would allow a more appropriate selection of cases for treatment.
AIMS OF THIS THESIS
My first aim was to estimate the prevalence of erectile impotence among
the population of patients attending the Diabetic Department of the Royal
Infirmary, Edinburgh and to compare this with a local control population. Having
identified the size of the problem I wanted to investigate the likely aetiology of
erectile impotence in diabetic men, by looking at subgroups of patients in more
detail. As has been already stated, many of these investigations were
collaborative and so not all of the data derived from these studies are
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appropriate to be presented in this thesis. Finally I wanted to follow a large
group of diabetic men prospectively to determine the natural history of erectile
impotence and to identify factors associated with the development of impotence
de novo among potent diabetics.
Subsequent chapters of this thesis will outline the results of my studies in
these area&.
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THE PREVALENCE OF DIABETIC IMPOTENCE
INTRODUCTION
The aim of this study was to establish the prevalence of erectile impotence
in the large clinic population attending the Diabetic Clinic of the Royal
Infirmary, Edinburgh. As discussed before, many of the previous studies have
produced widely differing estimates (Table 1). These occur because of
differences in definition of impotence, methods of case selection and age range
of patients studied. For these reasons I planned to use a strict definition of
impotence and to interview a large and randomly selected group of patients
within a limited age range.
PATIENT SELECTION
During the 9 month period from June 1976 to March 1977, 563 males
attending the Diabetic Out-Patient Department were interviewed. A total of
132 clinics were covered and at each clinic every male aged between 20-59
years was included. After three months an initial group of 319 men (Group 1)
had been interviewed. Since this group comprised unselected consecutive
attenders at the clinic it was decided to interview a random group of
approximately 100 men to exclude the possibility of bias in the original group.
The total clinic male population aged 20 - 59 years was 887 and from the
remaining 568 patients who had not yet been interviewed a random sample of 101
men (Group 2) was drawn who were subsequently interviewed over a six month
period. Over this latter period a second non-random group of 121 men (Group 3)
who were attending the clinic and not included in the random sample were also
interviewed.
The total number of men included for study was thus 541, representing 61%
of the male clinic population aged between 20-59 years. A further 22 who were
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unable to give staisfactory interviews were omitted: in the two non-random
groups (Group 1 and 3), 9 were mentally defective, 2 had cerebrovascular
accidents with dysphasia and 2 were unable to speak English; in the random group
(Group 2) 5 had recently left the area, 1 was hospitalized elsewhere, 2 were
mentally defective and 1 had a cerebrovascular accident.
METHODS
Each subject was interviewed on his own in a counsulting room within the
normal diabetic clinic. The interview was semi-structured and the data
collection sheet is shown in Appendix A.
Details were obtained about the patient's age, age at onset of diabetes,
height, weight and standard wt. (Metropolitan Life Insurance Tables, 1959).
Diabetic Treatment
The precise doses and names of oral hypoglycaemic drugs and insulin were
noted. However, for subsequent analysis treatment was categorised as insulin,
oral hypoglycaemic agents (O.H.A.) or diet alone.
Other Drug Therapy
A note was taken of all other drugs which the patient was taking. Each of
these was given a code number with a view to incorporating certain drugs or drug
groups in the subsequent multivariate analysis. However it was found that so
few of the patients were taking other drugs that such analysis would be
meaningless. This information was valuable, however, in pointing out alternative
causes of sexual dysfunction in some individual cases (e.g., patient no. 2, Table
22).
Other Illnesses
Enquiry was made as to whether the patient had ever suffered from angina,
myocardial infarction, cardiac failure, intermittent claudication thyroid disease
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or had previously had a sympathectomy. In each case an explanation was given,
in simple terms of what was meant by the term "angina" etc. If the patient said
that he had suffered from any of these conditions then details were taken of
where, when and how severe the illness was. Verification was made from
hospital records where possible. Apart from these specific conditions each
patient was asked in general about any other serious illnesses or operations. For
the purposes of multivariate analyses, a clinical decision was later made on the
information available as to whether significant ischaemic heart disease was
absent or present.
Alcohol Intake
Each man was asked to estimate honestly, and as accurately as possible
how much beer, wine, spirits or other alcoholic beverage he consumed in an
average week. He was also asked if the weekly consumption had changed
recently and if he had ever received treatment for an alcohol related condition.
From the raw data each patient was placed in one of four grades of alcohol
consumption.
GRADE 1 ("non-drinkers") - men who took less than six alcoholic drinks
throughout the year, usually limited to special occasions.
GRADE 2 ("social drinkers") - men who consumed up to 10 alcoholic drinks
per week, usually on two or three nights plus occasional wine with meals.
GRADE 3 ("heavy drinkers") - men taking 3 or more drinks almost every
night and often more at weekends.
GRADE 4 ("alcoholics") - men whose drinking habits were frankly outside
the social norm, and those attending, previously or at present, the alcoholic
treatment centre in the city. Many of these patients drank half a bottle of
spirits or more per day.
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Subsequently, however, for purposes of multivariate analysis grades 1 and 2
were lumped together as "MILD" drinkers and grades 3 and 4 as "HEAVY"
drinkers.
Diabetic Control
Since the assay for glycosylated haemoglobin was not available in the
laboratory during the early part of the study, diabetic control was assessed using
clinic blood glucose results. These were mid-morning post-prandial blood
samples analysed on a single-channel Beckman autoanalyzer. An average was
taken from the previous 6 clinic visits and the patient was then placed in one of
three categories for diabetic control:
GOOD - < 9 mmol/1
FAIR - 9.1 - 13.9 mmol/1
BAD - 14.0 mmol/1.
Retinopathy
All patients had a retinal examination in a dark cubicle with both pupils
dilated. Any abnormalities, or new findings which differed from previous
recordings in the diabetic clinic notes were verified by Dr. I.W. Campbell or Dr.
B.F. Clarke. Retinopathy status was recorded as:
None
- no abnormalities seen.
Background
- microaneurysms and/or dot/blot haemorrhages
Exudative
- hard exudates present and/or signs of macular aedema and/or soft
exudates present in addition to background changes.
Proliferative
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- new vessels present on the disc or in the periphery. Patients were also
included in this category if they had severe venous changes, (distended and
tortuous veins with variation in calibre) or if they had evidence of previous
proliferative retinopathy (scars from photocoagulation, vitreous
haemorrhage, etc).
Nephropathy
All patients attending the Diabetic Department of the Royal Infirmary,
Edinburgh have urinalysis at each clinic visit using "Albustix" (Ames). All
previous records from each patient were scrutinized and he was then placed in
one of four categories:
None
- proteinuria never detected.
Intermittent
- occasional traces of proteinuria noted in the past which were not simply
associated with urinary tract infection.
Moderate
- proteinuria present at a level of ++ for 12 months at least.
Heavy
- persistent proteinuria of +++ or more.
Peripheral Neuropathy
Careful enquiry was made of any symptoms suggestive of peripheral
neuropathy. Each symptom was explained in simple terms and patients were
asked specifically about numbness, paraesthesiae, burning pains and muscle
weakness in arms, legs or elsewhere. Where a patient said "Yes" to any of these
symptoms then details were ascertained and the patient asked to grade this
symptom as "mild", "moderate" or "severe." If a patient had one or more
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positive responses then a neurological examination was carried out looking
specifically for evidence of sensory loss, muscle wasting, absence of deep tendon
reflexes, evidence of recent or old neuropathic ulceration. The decision as to
whether or not a patient had symptomatic peripheral neuropathy was based on
the clinical evidence. The criteria employed were the presence of one or more
"severe" or two or more "mild / moderate" symptoms along with objective
evidence that these symptoms were due to neuropathy. If a patient had no
symptoms at all, then neurological examination was not carried out.
Autonomic Neuropathy
Careful enquiry was made of any symptoms suggestive of autonomic
neuropathy. In each case the meaning of the symptom was explained, and, where
a patient gave a positive response, further details were obtained to try to decide
whether his symptom was likely to be due to autonomic neuropathy or not.
Patients were asked specifically about whether, either at the present time or in
the recent past, they had experienced postural hypotension, dysphagia, epigastric
fullness, constipation, intermittent diarrhoea, hypoglycaemic unawareness,
diminished sweating in the legs, gustatory sweating, bladder dysfunction
(dribbling, poor stream, frequency, incontinence). For any positive responses the
patient was asked to grade this symptom as "mild", "moderate" or "severe." If
the patient had three or more "mild / moderate" symptoms then cardiovascular
autonomic function tests were carried out using the methods described by Ewing
et al (1978). These tests were carried out in the Department of Medicine at the
Royal Infirmary, Edinburgh. More details of the tests used and the criteria for
abnormality are given in the next chapter (pages 60 to 62). The criteria for the
presence of symptomatic autonomic neuropathy were two or more "severe" or
three or more "mild / moderate" symptoms along with at least one abnormal
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cardiovascular autonomic function test.
Impotence
All the questions relating to sexual dysfunction were left till the end of the
interview and until rapport was achieved with each man. The subject was first
approached in a general way by asking if, since the onset of diabetes, he had ever
experienced any difficulty with sex. Subsequent questions probed further until a
clear picture was obtained. The criteria used for the presence or absence of
erectile impotence were:
". . . complete inability to achieve and maintain an erection of sufficient
rigidity and duration to allow vaginal penetration on all occasions of
attempted intercourse during the past 6 months."
As this is a very strict set of criteria, one might expect that many men
would fall into a category of "partial erectile dysfunction" which was
intermediate between normality and the criteria set out above. It was found,
however that there were so few men who fitted this category that, for the
purposes of multivariate analyses they were included with the potent group.
For any man who did complain of erectile impotence, details were taken of
the duration of impotence, the life circumstances which were present at the
onset of erectile dysfunction, the presence or absence of spontaneous morning
erections, whether the symptoms began suddenly or gradually, and whether it had
been episodic or steadily progressive.
If impotence was absent then enquiry was made about whether the man had
ever experienced temporary impotence in the past. If so, details were taken.
Libido
Each man was asked to say how he rated his interest in sex at the present
time, compared with what he would consider should be normal. This was
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recorded as normal, increased or decreased.
Ejaculation
Patients were asked if they were able to ejaculate in any circumstances
and if so they were asked whether they considered their ejaculation to be normal
or abnormal. If abnormal, then details were taken. This information was not
used in the multivariate anlyses.
DATA HANDLING
Some of the data obtained from these semi-structured interviews were
handled manually or were used for broad descriptive purposes only. In order to
investigate which of these clinical features were independently associated with
the presence of erectile impotence the technique of linear logistic modelling was
employed. The rationale and methodology of this statistical technique has been
described already (pages 1 to 8). The information from the semi-structured
interview data sheets was firstly coded, then transferred to punch cards. Using
the Edinburgh Regional Computing Centre's facilities the computer package
BMDP was employed. Patient groups 1, 2 and 3 were compared using chi-squared
tests or a one-way analysis of variance depending upon whether the variable
concerned was qualitative or quantitative.
RESULTS
Comparison of the non-randomised groups (1 and 3) and the randomised
group (2) were made. The differences between the groups are outlined below.
There were few significant differences and they were such that the
amalgamation of the grouped data would give valid results on diabetic
impotence. The ages of the three groups were comparable with mean ± S.E.M. of
groups 1, 2 and 3 being 43.4 ± 0.6 years, 46.1 ± 1.1 years and 43.7 ± 1.1 years
respectively. The overall prevalence of impotence was 35%, 39% and 31%
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respectively in the three groups. The only variables demonstrating significant
differences between the groups (at the 5% level) were retinopathy with
prevalences of 34%, 22% and 26% respectively and symptomatic peripheral
neuropathy with prevalences of 23%, 13% and 14% in the three groups. All
subsequent analyses were performed with the combined data from all three
groups.
Of the 541 men interviewed, 190 (35%) were impotent (Table 3). The
increasing prevalence of impotence with age is whown in Figure 2 and over the
age range studied this relationship can be described adequately by a logistic
curve. The prevalence is clearly greater among the diabetic men than among
normal subjects.
Because age has such an obvious influence on the prevalence of impotence
it is necessary to look at the effect of other variables on impotence within
comparable age groups. Thus in Tables 4-10 three age groups were chosen to
give adequate numbers in each group: 20-34 years; 35-49 years; 50-59 years.
The effect of duration of diabetes on the prevalence of impotence in
insulin-dependent and noninsulin-dependent diabetics is shown in Tables 4 and 5.
There was an increasing prevalence of impotence with increasing duration of
diabetes in all age groups but no difference in prevalence was seen between the
insulin-dependent and noninsulin-dependent groups. However, when analysed
using the linear logistic regression model the effect of duration was found to be
indirect. Duration of diabetes is associated with an increasing prevalence of
many other aetiological factors such as microangiopathy and neuropathy and so
its individual importance is not considered to be significant in the context of the
analysis using the linear logistic model.
Using the linear logistic model five variables showed a significant
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Relationship of impotence to age in diabetic and
normal male subjects. The normal male data are
derived from Kinsey et al (1948)
association with impotence: age (p< 0.001), treatment of diabetes with insulin or
oral hypoglycaemic agent but not diet alone (p < 0.001), retinopathy (p < 0.001),
symptomatic peripheral neuropathy (p < 0.001) and symptomatic autonomic
neuropathy (p< 0.005).
In Table 6 it is seen that impotence is 2-3 times commoner among patients
taking insulin or oral hypoglycaemic agents than among those on dietary
restriction only. The reason for this difference is unclear but is apparently
independent of age, duration of diabetes and level of diabetic control.
The effect of retinopathy on the prevalence of impotence is striking (Table
7). At all ages the prevalence of impotence rises sharply with increasing
severity of retinopathy such that all men over the age of 50, with proliferative
retinopathy were impotent.
The association of peripheral neuropathy and the presence of impotence is
most marked among younger patients (Table 8). Thus only 7% of those under 35
years of age were impotent, if they had no evidence of symptomatic peripheral
neuropathy. However, among those who did have evidence of peripheral
neuropathy the prevalence rose to 44%.
The association between symptomatic autonomic neuropathy and erectile
impotence is even closer (Table 9). Overall, 24/25 (96%) of men with other
symptoms and signs of autonomic neuropathy were impotent.
Table 10 shows the relationship of nephropathy to impotence among
diabetic men within these age groups. It can be seen that the prevalence of
impotence rises sharply at all ages with increasing evidence of nephropathy.
Thus, among men aged 35-49 years, for example, the prevalence of impotence
among men with no clinical evidence of nephropathy is 28%. This rises to 100%
in those men who show persistent heavy proteinuria. Because the trends in this
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Table are so clear, it is surprising that the overall significance of nephropathy to
the presence of impotence is so small (p < 0.1). The reason for this is that, as
discussed before (pages 2 to 6) it is inappropriate to take a variable like
"nephropathy" in isolation and then derive a "p-value" based on the data
contained in Table 10. Patients with severe nephropathy have usually got
evidence of severe retinopathy, peripheral neuropathy and autonomic
neuropathy. Thus, when all these variables are used in the regression analysis it
is found that nephropathy, per se, can be dropped from the analysis without
affecting the regression.
The relationship between ischaemic heart disease and the prevalence of
impotence is shown in Table 11. Although there is a suggestion, at least among
men over 50 years of age that the presence of ischaemic heart disease is
associated with impotence, the relationship is not strong.
Previous Episodes Of Transient Impotence
Transient impotence had occurred in 24 of the potent subjects, 8 during
poor control, 4 during anxiety and 12 at times such as at diagnosis of diabetes (3
subjects), following excess alcohol (2 subjects) and during intercurrent unrelated
illness such as myocardial infarction (7 subjects).
DISCUSSION
This study has confirmed that erectile impotence is considerably more
prevalent among diabetics than in the general population, in all age groups. The
overall prevalence (35%) is lower than any previous reports (Table 1). There may
be several explanations for this. Firstly, no one over the age of 59 years was
interviewed whereas most previous studies have included a significant number of
subjects over the age of 60. Since the prevalence of impotence is higher among
the elderly the overall prevalence will be increased by their inclusion. In fact,
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the prevalence of impotence is so markedly affected by age that it is almost
meaningless to quote or compare the overall prevalence rates between studies
without taking the age distribution of the populations sampled into account.
Another reason for differences in the results seen in this study and previous
reports is methods of case selections. A large number of patients were
interviewed in this study. They were unselected as regards treatment, duration
of diabetes or complications. The study was conducted over a nine month period
to include less frequent clinic attenders. In addition a group of randomly
selected patients was included. All of these aspects were employed so that the
results obtained would be from a truly representative sample of patients.
A further difference between studies is with the definition of impotence
used. In this study a rather strict definition of impotence was employed (see
page 41). Since it is quite conceivable for a man to have significant sexual
dysfunction and yet be "potent" by this definition, it is fair to assume that this
study has not uncovered the whole spectrum of sexual dysfunction among this
group of men. However, since one of the main purposes of the study was to
identify which clinical features were associated with erectile impotence, it was
felt that a strict and unambiguous definition was preferable.
The study has confirmed the view of Schoffling (1963) that impotence
becomes more prevalent with increasing duration of diabetes. However the use
of multivariate analysis would suggest that the effect of duration is indirect.
The longer a patient has had diabetes the more likely he is to develop
neuropathic and vascular complications which, in turn, show a close correlation
with erectile impotence.
The significant association of impotence with diabetics on insulin or oral
hypoglycaemic agents rather than diet alone is hard to explain, and differs from
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two previous studies where impotence occurred equally in patients on all forms
of therapy (Schoffling, 1960, Montenero and Donatone, 1962).
The results also suggest a strong association between impotence and the
severity of microangiopathy. Although diabetics with severe retinopathy are
more likely to have peripheral and autonomic neuropathy, in addition, the use of
multiple regression analysis indicates that retinopathy has a significant
association with impotence which is independent of neuropathy and other clinical
factors. This is a new finding and was not seen in previous studies by Rubin and
Babbott (1958) and Kolodny et al (1974) where retinopathy occurred with equal
frequency in both potent and impotent diabetics.
It was not possible in this study to get an accurate assessment of previous
glycaemic control and therefore one cannot make any confident statement about
the effect of metabolic control on the development of impotence among diabetic
men. However, since the development of retinopathy is regarded by many as
being related to poor metabolic control (Tchobroutsky, 1978) this study provides
indirect support for the notion that poor diabetic control may be associated with
impotence.
Previous studies have shown that impotence is found in a high percentage
of patients with peripheral neuropathy (Rundles, 1945; Martin, 1953) and with
autonomic neuropathy (Ellenberg, 1971; Faerman et al, 1971). While these
general trends have been confirmed in this study, it is pertinent to note that
127/436 (29%) of those without symptomatic peripheral neuropathy and 169/520
(33%) of those without symptomatic autonomic neuropathy were also impotent.
This is still a much higher prevalence than would be expected in the non-diabetic
population. The implication from these findings may be that impotence is the
earliest manifestation of neuropathy and therefore antedates the clinical
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expression of more overt neuropathic symptoms. Alternatively, the aetiology of
impotence may be multifactorial with differing aetiologies among subgroups of
impotent patients.
The independent effect of retinopathy on the prevalence of impotence
suggests that, for some patients at least, microangiopathy may be the major
"cause" for their impotence. Since any therapy for erectile impotence should be
geared towards specific aetiological factors it is important to examine and
investigate individual patients in more depth to elucidate the predominant
causative factors in their case.
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TABLE 3
Relationship of age to impotence in diabetic males
AGE RANGE TOTAL NO. NO. DIABETICS % DIABETICS
(years) DIABETICS IMPOTENT IMPOTENT
20 - 24 53 3 5.7
25- 29 35 5 14.3
30 - 34 44 7 15.9
35- 39 43 13 30.2
40 - 44 52 15 28.8
45 - 49 91 33 36.3
50 - 54 99 49 49.5
55 - 59 124 65 52.4
TOTALS 541 190 35.1
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TABLE 4
Relationship of duration of diabetes to impotence in insulin-dependent diabetic























Relationship of duration of diabetes to impotence in noninsulin-dependent
diabetic men within three age groups
Age (years)
DURATION 20-34 35-49 50-59
0-4 0/6 9/58 (16%) 26/75 (35%)
5-14 0/1 9/17 (53%) 28/56 (50%)
15 - 29 — 0/2 5/8 (63%)
30+
TABLE 6





caemic agents 0/3 (0%)











* See text for explanation.
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TABLE 7
























* See text for explanation.
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TABLE 8
Relationship of peripheral neuropathy to impotence in diabetic men within three
age groups
PERIPHERAL




35 - 49 50 - 59
44/151 (27%) 75/169 (44%)
20/35 (57%) 39/54 (72%)
p< 0.001 *
* See text for explanation.
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TABLE 9

















* See text for explanation.
55
TABLE 10
Relationship of nephropathy to impotence in diabetic men within three age
groups
NEPHROPATHY 20 - 34
None (0) 8/109 (7%)
Intermittent
(0/+) 2/11 (18%)
Moderate (++) 4/10 (40%)
Heavy (+++) 1/2 (50%)
Age (years)
35 - 49 50 - 59








* See text for explanation.
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TABLE 11







20 - 34 35 - 49
54/166 (33%) 83/174 (48%)
7/20 (35%) 31/49 (63%)
p< 0.1 *
* See text for explanation.
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EVALUATION OF A SIMPLE URINARY FLOW RECORDING FOR THE ASSESS¬
MENT OF DIABETIC IMPOTENCE
INTRODUCTION
As already discussed, the association of diabetic impotence with the
presence of somatic and autonomic neuropathy is strong, although most of the
evidence is indirect. In an attempt to look more directly at the nerves involved
in penile erection some authors have evaluated bladder function in impotent
diabetic men (Ellenberg, 1971; Faerman et al, 1972). Ellenberg used the
technique of cystometry and found that 37 of 45 impotent diabetics had
neurogenic bladder abnormalities compared with 3 of 30 potent diabetics.
However, 38 of the impotent diabetics in Ellenberg's study had clinical evidence
of neuropathy and are therefore not representative of a random sample of
impotent diabetics. In my own study only 105 of 541 men had evidence of
peripheral neuropathy, of whom 66 (35%) had clinical evidence of peripheral or
autonomic neuropathy.
Investigation of urinary bladder dysfunction has been facilitated during the
past decade by increasingly sophisticated techniques for bladder evaluation.
Bradley et al (1975) have developed cystometry using gas as a filling medium and
using detrusor reflex activating procedures. The commonest abnormalities seen
with this technique are of detrusor areflexia and impaired sensation of bladder
filling although occasionally detrusor hyper-reflexia has been found in patients
with evidence of spinovascular disease. Sphincter electromyography (Bradley,
1976), urethral pressure profiles (Bradley et al, 1975) and electroencephalography
(Bradley, 1977) have all been employed and show that the earliest abnormalities
are impairment of peripheral visceral afferent pathways, followed later by
detrusor reflex compensation.
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Unfortunately all the above techniques are invasive and are therefore not
applicable to large numbers of patients including asymptomatic and control
subjects. The development of UROFLOWMETRY as an entirely non-invasive and
simple procedure (Shoukry et al, 1975) has provided a potentially useful tool for
examining bladder function in large numbers of subjects. In this procedure, the
quantified measurement of urine flow (uroflowmetry) is done by having the
patient void into a flowmeter. The flowmeter is a load cell mounted in the wall
of a commode whose output is an instantaneous differential of the weight of the
flow column and is therefore a measurement of urinary flow rate. A
diagrammatic representation of the recording obtained in this procedure is shown
in Figure 3. As shown the three main variables which can be measured are peak
flow rate (P), total flow time (F) and volume of urine passed (V). From these it
is possible to derive various indices of urinary function such as F/P, V/F, V/P and
F/PxV. In diabetic patients the most common type of urine flow pattern
observed is a low peak flow rate with a prolonged duration of flow (Bradley,
1980). Thus, the most useful measures would be P, F or F/P. However, since
severe neurogenic bladder dysfunction is also associated with a reduced volume
of micturition and a large residual volume (Ellenberg, 1971; Bradley, 1980) and
since peak flow rate and flow time are at least partly related to the volume of
urine passed, it might be more appropriate to derive an index of urinary flow
which takes this into account (e.g. F/PxV).
The aims of this study were to assess the value of the technique of
uroflowmetry in the assessment of erectile dysfunction among diabetic men.
Firstly, it was hoped that the indices derived from uroflowmetry would help to
pick out those diabetic men who had neuropathy as a main factor in their
impotence. Secondly, we were interested to see how closely the indices derived
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Flow Time (F)
Volume (V) = the
area under the
Possible measurements derived from mictiograph (see text)
(1) P - peak flow rate in ml per second
(2) F = flow time in seconds)






FIGURE 3 Normal urinary flow mictiograph.
from uroflowmetry would correlate with cardiovascular autonomic function
tests.
PATIENTS AND METHODS
Fifty-one diabetic men whose potency had been determined in the
epidemiological study were compared with 18 non-diabetic potent subjects who
were staff members at the Royal Infirmary, Edinburgh. It was also hoped to
compare the results of non-diabetic impotent men attending the sexual problems
clinic at the Royal Infirmary but unfortunately only 4 of these subjects were
obtained who were willing to take part and their data have not been included in
the statistical analyses. The three comparison groups were therefore:
(A) 18 potent non-diabetics (mean age 42.3 years, range 24-60 years)
(B) 16 potent diabetics (mean age 38.9 years, range 24-53 years)
(C) 35 impotent diabetics (mean age 43.3 years, range 23-54 years)
ASSESSMENT OF CARDIOVASCULAR AUTONOMIC FUNCTION
In the past fifteen years a variety of simple non-invasive procedures have
been developed to test cardiovascular reflex function. Much of the pioneering
work in this field was carried out by Dr. David J. Ewing and co-workers in the
University Department of Medicine at the Royal Infirmary in Edinburgh. The
techniques employed and the criteria for normality are those described by Ewing
and Clarke, 1982. Four tests were used on each diabetic subject. The first two
(the Valsalva manoeuvre and the lying-to-standing heart rate response) assess
cardiac parasympathetic function; the other two (measurement of postural
hypotension and the blood pressure response to sustained handgrip) only show




During the strain of performing the Valsalva manoeuvre (forced expiration
against resistance) there is normally tachycardia and peripheral vasoconstriction.
After stopping the manoeuvre there is an overshoot rise in blood pressure and
bradycardia. Heart rate changes give a reliable guide to the associated
haemodynamic events (Ewing, 1978). The technique employed in this study
involves the subject's blowing into a mouthpiece connected to a manometer held
at 40 mm Hg pressure for fifteen seconds while a continuous ECG is recorded.
The "Valsalva Ratio" is calculated by taking the longest R-R interval after the
manoeuvre (reflecting the overshoot bradycardia) and dividing this by the
shortest R-R interval (reflecting the tachycardia during strain). A Valsalva
Ratio of 1.21 or greater is considered normal, 1.11 - 1.20 is borderline and 1.10
or less abnormal (Ewing et al, 1973).
(ii) Heart rate response to standing
The normal response to standing up quickly includes a rapid increase in
heart rate, maximal at about the 15th beat after standing, with a subsequent
relative bradycardia maximal at about the 30th beat. It has been shown that this
reflex is mediated via the vagus nerve (Ewing et al, 1978) and that it can be
quantified with a continuous ECG monitor by measuring the R-R interval at beat
30 and dividing this by the R-R interval at beat 15. The resulting "30/15 ratio" is
normally greater than 1.03, while values of 1.01 - 1.03 are considered borderline
while values less than 1.00 are abnormal (Ewing et al, 1978).
(iii) Blood pressure response to standing
Standing up quickly leads to pooling of blood in the legs, with a fall in blood
pressure. However, this is normally corrected by vasoconstriction and
tachycardia. Postural hypotension can be measured using a cuff
sphygmomanometer, and a fall in systolic blood pressure of 30 mm Hg or more is
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arbitrarily defined as abnormal (Clarke et al, 1979), 11-29 mm Hg as borderline
and< 10 mm Hg as normal.
(iv) Blood pressure response to sustained handgrip
Sustained (isometric) muscular exercise normally causes an increase in
systemic blood pressure (Ewing, 1978). A simple test, based on this reflex uses a
handgrip dynamometer, standardised at 30% of the maximum voluntary
contraction, with measurement of the blood pressure during handgrip (Ewing et
al, 1974). A rise in diastolic blood pressure of 16 mm Hg or more is defined as
normal, 11 to 15 mm Hg as borderline and 10 mm Hg or less as abnormal.
The results of these cardiovascular tests in the 51 diabetic men are shown
in Tables 12 and 13.
ASSESSMENT OF URINARY FLOW PATTERNS
Urinary flow recordings were carried out in the Urological Day Bed Area of
the Royal Infirmary, Edinburgh, using the Mictiograph machine. Each subject
was tested on one occasion only. He was given water to drink until he felt a
distinct desire to pass urine. Micturition was carried out in a private cubicle in
the standing position.
The measurement of urinary flow time (F), peak flow rate (P), volume of
_3
urine passed (V) and the indices F/P and F/PxVxlO are shown for potent non-
diabetics in Table 14 and for the 51 diabetic men in Tables 15 and 16.
STATISTICAL ANALYSES
As will be seen from Figures 4-8, the data derived in this study are not
normally distributed. Analyses were therefore performed using the following
non-parametric tests. In Figures 4-7 the Mann-Whitney U test was applied to
test significance levels between any two subgroups. In Figure 8 the Kendall
Rank Correlation Coefficient was applied to test the association of the index
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F/PxV against age. In Figure 9 the Kruskal-Wallis One-Way Analysis of Variance
was applied to test whether there was a significant trend for the index F/PxV to
rise with increasing cardiovascular autonomic dysfunction, irrespective of
potency.
RESULTS
The results of the Cardiovascular autonomic function tests are shown in
Tables 12 and 13. Any results which are borderline are marked with an asterisk
(*) while those which are abnormal are marked thus (+). It can be seen that
11/16 (69%) potent diabetics have normal results in all four tests (Table 12)
compared with only 7/35 (20%) impotent diabetics (Table 13). However there is
a large range of abnormality among these 51 patients. In order to grade the
overall severity of autonomic dysfunction the following system has been
employed. For each test the subject gets a score of "0" for a normal result,
for a borderline result and "1" for an abnormal result. The score for all 4 tests is
added up and this is presented in the extreme right hand column of Tables 12 and
13 as the OVERALL A.N. SCORE (where A.N. stands for Autonomic
Neuropathy). Thus the range of severity is from "0", where all 4 tests are normal
to "4" where all tests are abnormal.
The results which follow will firstly analyse the uroflowmetry data with
respect to potency/impotency (Figures 4-8). Following this I will examine the
correlation between the indices derived from uroflowmetry and the severity of
autonomic dysfunction, irrespective of potency (Figure 9).
(A) Results of Uroflowmetry in Groups A to C
Peak urinary flow (P) rates were higher among potent subjects (Figure 4).
The means were 32.4 mis/sec in Group A, 36.5 mis/sec in Group B and 22.2
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FIGURE 4 Distribution of peak urinary flow rate (P)





























FIGURE 5 Distribution of urinary flow time (F) among
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FIGURE 6 Distribution of the index: urinary flow time/
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FIGURE 7 Distribution of the index: urinary flow time/
peak urinary flow rate X volume of urine passed
(F/PXV) among potent non—diabetics and potent
and impotent diabetic subjects.
•(49.0)



































Kendall Rank Correlation Coefficient r - 0.11 (p >0.1)
FIGURE 8 Correlation between the index F/PXV and age
among diabetic and non-diabetic men.
groups A and B, but both of these groups had significantly higher peak flow rates
than group C (p < 0.001). When looking at urinary flow time (Figure 5) although
these seemed to be longer for the diabetic patients as a whole, none of the
differences achieved statistical significance. However when urinary flow times
were divided by peak flow rates for each individual (Figure 6) then the difference
between potent men (groups A and B) and the impotent men becomes more
obvious (p < 0.007). In order to try to separate the groups further, the index
F/PxV was derived for each subject (Figure 7). Although this index did provide
an even more confident separaton (p < 0.00003) the trends are essentially the
same as those seen in Figure 6.
Although groups A, B and C had been matched closely for age, it is sensible
to check that any differences in urinary flow measurements do not simply arise
due to the effects of ageing (and consequent prostatic enlargement). Figure 8
shows the relationship of the index F/PxV to age in groups A, B and C. The
correlation is very weak (Kendall Rank Correlation Coefficient r = 0.11, p> 0.1)
and so the changes seen in Figures 4, 6 and 7 are more likely to be due to some
other effect, independent of ageing.
(B) Correlation between indices derived from uroflowmetry and measurements
of cardiovascular autonomic reflex function
There are several problems associated with categorising patients simply on
the basis of being "potent" or "impotent." Firstly, this classification is
subjective, and relies not only on the subject's honesty but also on his concept of
normality. Secondly, by the definition employed, a man is either potent or
impotent, there is no in between. In order to assess the role of autonomic nerve
dysfunction in this situation it might be useful to compare the results of the
established cardiovascular autonomic function tests with the indices derived
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from uroflowmetry, since both of these are objective measurements which can
be ranked from normality to abnormality. In Figure 9 the 51 diabetic patients
have been regrouped (irrespective of potency) on the basis of their
overall A.N, score. There were 18 patients whose tests were completely normal.
A further 17 men had minimal abnormality with one or two borderline tests or
one abnormal result (overall A.N. score \ - 1). The remaining patients were
divided into those with an overall A.N. score of li - 2 (9 patients) and those with
an overall A.N. score of 2\ - 4 (7 patients). These four groups therefore exhibit
increasingly severe cardiovascular autonomic dysfunction. From the first part of
the analysis it was clear that the most discriminating index from uroflowmetry
_3
was F/PxVxlO (Figure 7). Figure 9 shows the distribution of this index among
these 4 groups of diabetic men. Although there is considerable scatter of the
points, there is a trend for F/PxV to be lower in those patients showing little or
no evidence of cardiovascular autonomic dysfunction and for this index to rise
with increasingly severe autonomic neuropathy (Kruskal-Wallis One Way Analysis
of Variance, H = 8.45; p< 0.05).
DISCUSSION
This study has confirmed that abnormalities of bladder function may occur
among diabetic men. The most significant single measurement was the peak
urinary flow rate (P) which was reduced in the impotent diabetic men. The
evidence for a prolonged urinary flow time (F) was less convincing as a single
measurement (Figure 5) but the index derived from flow time divided by peak
flow (F/P) confirmed that both these features of bladder function are impaired in
some diabetics, as suggested by Bradley (1980).
The fact that age matched potent diabetic men produced urinary flow
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FIGURE 9 Distribution of the index F/PxV among
diabetic men with differing degrees of
cardiovascular autonomic dysfunction
abnormalities of bladder function are not caused by diabetes per se but rather by
an associated autonomic neuropathy which occurs in some diabetics. In the
absence of prostatic or urethral obstruction the abnormalities seen among the
impotent diabetics of reduced flow rate and prolonged urinary flow time suggest
motor denervation of the detrusor muscle of the bladder.
The index which best reflects these abnormalities of bladder function is
F/PxV. The correlation between this index and abnormalities in cardiovascular
A.N. tests (Figure 9) strengthens the idea that the changes seen in bladder
function are partly due to autonomic neuropathy. This study therefore lends
further support for the role of autonomic neuropathy in some cases of "diabetic
impotence."
Although this study has shown that, as a group, impotent diabetic men have
abnormal urinary flow patterns, the technique of uroflowmetry, as used here, is
not precise enough to allow one to draw firm conclusions on individual patients.
It is of interest however that of the 7 impotent diabetic men who had completely
normal cardiovascular A.N. results, 4 (patients 21, 32, 34 and 40, Table 12) had
abnormal urinary flow patterns. It may be that impotence is a very early
symptom of autonomic neuropathy, in some cases, and that associated bladder
abnormalities occur along with this, even before the cardiovascular autonomic
nerves have been affected by neuropathy. Thus, although single urinary
recordings among groups of patients in this cross-sectional study have not shown
clear distinctions between the groups, it remains to be seen whether sequential
urinary flow recordings in individual patients over a period of years would help to
identify patients with developing pelvic autonomic neuropathy. Apart from the
shortcomings of the technique of uroflowmetry used in this study one further
explanation of the wide scatter of results could be that this is reflecting the
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heterogeneity in the aetiology of impotence in diabetic men. Once again,
sequential uroflowmetry data might help to distinguish those patients who have a




Results of Cardiovascular Autonomic Function Tests among 16 Potent Diabetic Men
(Group B)
No Patient Age Parasympathetic Sympathetic Overall A.N.Score
Function Function
Valsalva 30/15 Postural Handgrip
Ratio Ratio change in response
systolic change in
B.P. diastolic
(mm Hg) B.P. (mm Hg)
1 DW 24 2.28 1.33 +15 +40 0
2 PE 26 1.28 1.22 -8 +42 0
3 VK 30 2.53 1.07 +8 +42 0
•f *
4 IT 31 1.21 0.96 -26 +20 li
5 GP 31 1.33 1.15 +5 +35 0
6 WW 33 1.65 1.13 0 +35 0





8 MD 40 1.76 1.22 0 +20 0
9 SB 41 1.05+ 1.10 0 +18 1
10 DC 43 2.54 1.58 +6 +12 0
11 RB 43 2.27 1.28 +10 +35 0
12 JF 44 1.40 1.13 -10 +24 0
13 DH 46 1.45 1.18 -10 +40 0
14 JM 50 1.44 1.00+ 0 +15 1
15 JMcD 51 1.43 1.07 0 +20 0
■f * *
16 CMcL 53 1.02 1.03 -15 +25 2
* = borderline; + = abnormal; = see text for explanation
68
Table 13
Results of Cardiovascular Autonomic Function Tests among 35 Impotent Diabetic Men
(Group C)
No Patient Age Parasympathetic Sympathetic Overall A.N.Score
Function Function
Valsalva 30/15 Postural Handgrip
Ratio Ratio change in response
systolic change in
B.P. diastolic
(mm Hg) B.P. (mm Hg)
+ *
2i17 RG 23 1.24 1.00 -30 +11
18 NC 25 1.70 1.00+ -5 +35 1
19 AB 27 1.33 1.00+ -10 +28 1
20 SW 28 1.43 1.00+ -56+ +22 2
21 DMcK 29 1.31 1.07 0 +25 0
22 DA 32 1.58 0.89+ 0 +42 1
23 EL 35 1.00+ 1.00+ -35+ +5+ 4
-f- # *
24 DA 36 1.25 0.92 -15 +11 2
25 KMcF 38 1.46 0.97+ -45+ +35 2
26 AS 38 - 1.00+ 0 +45 1
27 JS 41 1.02+ 1.00+ 0 +20 2
28 AG 43 - 0.97+ -32+ +00+ 3
29 OE 43 2.13 1.08 +25 +57 0
30 GG 44 1.95 1.07 -32+ +23 1





32 JL 45 1.78 1.14 -10 +40 0
33 AT 45 1.19* 0.97+ *-25 +20 2
34 MS 46 1.44 1.12 0 +60 0
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Table 13 (cont.)
Results of Cardiovascular Autonomic Function Tests among 35 Impotent Diabetic Men
(Group C)
No Patient Age Parasympathetic Sympathetic Overall A.N.Score
Function Function
Valsalva 30/15 Postural Handgrip
Ratio Ratio change in response
systolic change in
B.P. diastolic
(mm Hg) B.P. (mm Hg)





36 FR 47 1.00+ 1.00+ -5 +10+ 3
* *4* 4* ■4"
37 JMcL 48 1.18 0.93 -40 +10 3 "2
* *4" *
38 DH 48 1.14 0.97 -28 +17 2
39 LL 48 1.51 1.07 +10 +10 1
40 JG 49 1.55 1.06 0 +17 0





-f- *4" * 4"
42 JM 50 1.08 1.00 -15 +10 3i
4* *
+2043 WP 50 1.04 1.06 -15 1 i
* *
44 AB 50 1.12 1.03 -10 +22 i
45 EB 51 1.06+ 1.09 -5 +27 i
46 WG 51 1.24 0.92+ -10 +20 i





48 EH 52 1.52 1.07 +10 +30 0
49 WL 53 1.00+ 1.00+ +5 0+ 3
50 RW 54
*
1.14 1.11 -5 +18
1
2
51 RMcK 54 2.06 1.06 +5 +23 0
* = borderline; + = abnormal; = see text for explanation
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Table 14
Results of Uroflowmetry among 18 Potent Non-diabetic Men (Group A)
Subject Age Flow Time Peak Flow Volume F/P F/PxV(10
(F)(sec) (P)ml/sec (V)(ml)
SB 24 21 47 450 0.4 1.0
JC 27 25 60 390 0.4 1.1
IS 27 22 27 285 0.8 2.9
DB 29 16 18 250 0.9 3.6
BF 31 20 56 450 0.4 0.8
FW 32 60 19 900 3.2 3.5
RC 35 13 49 425 0.3 0.6
DE 39 25 13 250 1.9 3.6
JB 44 36 11 325 3.3 10.1
PG 48 31 17 350 1.8 5.2
IJ 50 45 38 800 1.2 1.5
BW 51 20 44 225 0.5 2.0
DD 51 28 22 356 1.3 3.6
EE 52 56 28 600 2.0 3.3
AM 52 24 35 425 0.7 1.6
DC 52 25 55 700 0.5 0.7
LD 58 25 14 225 1.8 7.9
RP 60 20 22 250 0.9 3.6
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Table 15
Results of Uroflowmetry among 16 Potent Diabetic Men (Group B)













































































































Results of Uroflowmetry among 35 Impotent Diabetic Men (Group C)
No. Subject Age Flow Time Peak Flow Volume F/P F/PxV(10
(F)(see) (P)ml/sec (V)(ml)
17 RG 23 30 21 350 1.4 4.1
18 NC 25 48 17 400 2.8 7.1
19 AB 27 35 18 450 1.9 4.3
20 SW 28 21 32 675 0.7 1.0
21 DMcK 29 25 25 225 1.0 4.4
22 DA 32 40 28 400 1.4 3.6
23 EL 35 22 15 150 1.5 9.8
24 DA 36 69 21 450 3.3 7.3
25 KMcF 38 26 20 400 1.3 3.3
26 AS 38 21 22 300 1.0 3.2
27 JS 41 53 30 860 1.8 2.1
28 AG 43 105 20 825 5.3 6.4
29 OE 43 28 37 425 0.8 1.8
30 GG 44 54 20 750 2.7 3.6
31 JM 44 22 8 150 2.8 18.3
32 JL 45 90 22 800 4.1 5.1
33 AT 45 35 24 450 1.5 3.2
34 MS 46 19 18 250 1.1 4.2
35 BG 47 67 11 400 6.1 15.2
36 FR 47 51 26.5 450 1.9 4.3
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Table 16 (cont.)
Results of Uroflowmetry among 35 Impotent Diabetic Men (Group C)
No. Subject Age Flow Time Peak Flow Volume F/P F/PxV(10
(F)(sec) (P)ml/sec (V)(ml)
37 JMcL 48 34 23
38 DH 48 120 7
39 LL 48 35 29
40 JG 49 36 15
41 WS 49 55 23
42 JM 50 30 29
43 WP 50 69 12
44 AB 50 20 27
45 EB 51 17 11
46 WG 51 25 43
47 JM 52 57 22
48 EH 52 20 23
49 WL 53 48 11
50 RW 54 25 27

















THE NATURAL HISTORY OF DIABETIC IMPOTENCE
INTRODUCTION
Very little is known about the factors leading to the development of
erectile impotence in diabetes. Similarly, the prognosis for established
impotence has not been clearly documented. Ellenberg (1971) suggested that it
was an irreversible and progressive disorder with a poor prognosis in the vast
majority of cases, although he produced no figures to back up this claim. In a
prospective study over a five year period, Ewing et al (1980) examined the course
of a small group of patients with symptoms of autonomic neuropathy. They
found that deterioration and early death was common in those subjects with
abnormal cardiovascular autonomic function tests, but that men with impotence
as an isolated symptom and with normal autonomic function tests fared better
than the rest.
The aim of the present study was to follow the progress of the large cohort
of patients described previously (pages 35 to 57) in order to examine three areas.
Firstly, what clinical festures among potent diabetic men are associated with the
development of impotence? Secondly, what is the untreated natural history of
diabetic impotence in terms of sexual dysfunction and the development of other
diabetic complications? Finally, what factors affect the mortality in this group
of patients?
PATIENTS AND METHODS
Of the original 541 men interviewed, 22 were untraceable while 36 had
moved from the Edinburgh area. Six patients refused to be reinterviewed and a
further 11 were considered unsuitable (5 for psychiatric reasons, 3 had cerebro¬
vascular disease, 1 had sustained traumatic brain damage and 2 patients were no
longer considered to have diabetes). This left 466 patients of whom 63 had died.
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The remaining 403 men were re-interviewed. The mean time interval between
first and second interview was 4 years 8 months (range 3 years 8 months to 6
years 2 months).
The questionnaire employed and the methods used were exactly the same
as those described before (pages 36 to 42). Once again analysis of the data
obtained was carried out using the facilities of the Regional Computing Centre.
Statistical methods employed were mainly multivariate analyses involving the
use of linear logistic models (Cox, 1970) fitted using the computer package
Genstat.
RESULTS
The results will be presented in three parts: (i) Factors associated with the
development of impotence. (ii) Progress of patients who were impotent
originally and (iii) An analysis of deaths.
(i) Factors associated with the development of impotence
Of the 275 men who were potent at the original interview and were still
available for study, 78 (28%) had become impotent. Using multivariate analysis,
the factors present originally which were most strongly correlated with the
development of impotence were age (p < 0.0001, Table 17, alcohol intake (p <
0.0001, Table 18), diabetic control (p < 0.03, Table 19), retinopathy (p < 0.04,
Table 20) and intermittent claudication (p< 0.05, Table 21).
Examining these data in more detail it can be seen that the development of
impotence was more than twice as common in men over 35 years of age than in
those under 35 (Table 17). The effect of alcohol intake is even more striking
(Table 18). While 22% of men who had mild alcohol intake (Grades 1 and 2)
became impotent, this rose to over 50% in men who were heavy drinkers (Grades
3 and 4). The presence of poor diabetic control (Table 19) increased the
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frequency of developing impotence from 22% to 33%. The association of
retinopathy on the development of impotence was most marked in those men who
had proliferative retinopathy at the original interview, where 60% have now
become impotent (Table 20). Finally, although the numbers were smaller for
intermittent claudication, it can be seen from Table 21 that the presence of
intermittent claudication five years ago was associated with the development of
impotence in 78% of cases.
(ii) Progress of patients who were impotent originally
Of the 128 men who were impotent at the original interview and were still
available for study, only 11 (8.6%) have regained potency. Using multivariate
analysis the factors present originally which were most strongly correlated with
regained potency were young age (p < 0.007) and short duration of diabetes (p <
0.01). In addition, there were features present in several of these patients at the
original interview which might have suggested a psychological cause, or other
precipitating factors which were potentially reversible (Table 22). It is also
worth noting that only 2 of these men had any other complications of diabetes.
One man (patient 1) had background retinopathy and mild peripheral neuropathy,
while another (patient 6) had mild peripheral neuropathy only.
The presence of impotence at the original interview was associated with
the development of two other diabetic complications, of the 87 men who had
impotence as an isolated diabetic complication, 14 have now developed
symptomatic peripheral neuropathy, 5 have developed symptomatic autonomic
neuropathy and a further 5 have developed both. In addition, of the 33 men who
were impotent and had additional symptoms of peripheral neuropathy at the
original interview, 6 have now developed symptomatic autonomic neuropathy in
addition. Multivariate analysis has confirmed that the development of peripheral
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neuropathy was associated with impotence (p< 0.003) and also with heavy alcohol
intake (p < 0.01). Similarly, the factors present originally which were associated
with the development of symptomatic autonomic neuropathy were poor diabetic
control (p < 0.004), impotence (p < 0.07), duration of diabetes (p < 0.04) and
peripheral neuropathy (p< 0.07).
(iii) Analysis of deaths
The mean age at death was 52.3 ± 9.0 years while the mean duration of
diabetes was 16.7 ± 9.6 years.
The causes of death were ascertained in all 63 cases and are shown in Table
23. These were myocardial infarction (24 cases), sudden unexplained death (8
cases), chronic renal failure (6 cases), cardiac failure (6 cases), cerebro-vascular
accident (5 cases), pneumonia (3 cases), pulmonary embolism (2 cases) and one
case each of carcinoma of stomach, carcinoma of bronchus, hepatoma, cerebral
tumour, carcinomatosis (from an unidentified primary tumour), septicaemia
following amputation for gangrene, cirrhosis of the liver, ketoacidosis and
hypoglycaemic coma.
Although 41 (65%) of the deaths were in men who had originally been
impotent, impotence per se was not significantly associated with mortality when
tested by multivariate analysis. Instead the most significant factors, present
originally, which correlated with death during the subsequent five years were age
(p< 0.0001), nephropathy (p< 0.0001), previous myocardial infarction (p< 0.0001),
autonomic neuropathy (p < 0.01) and retinopathy (p < 0.05). Thus of the 41
impotent men who had died, only 6 (nos. 23 - 28, Table 23) had had impotence as
an isolated complication of diabetes at the original interview. The remaining 35
impotent patients (nos. 29 - 63, Table 23) had had at least one other major
complication of diabetes, when first interviewed.
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This point is further illustrated by Table 24 which shows the distribution of
causes of death in potent subjects (n = 22), those with impotence alone (n = 6)
and those with impotence and other complications of diabetes (n = 35). It can be
seen that the distribution is similar among potent men and those with impotence
alone. The causes of death were somewhat different however among the
impotent diabetics who had other diabetic complications. Five of the cases of
chronic renal failure occurred in men who were known to have retinopathy and
nephropathy. Also, 7 of the 8 cases of sudden death occurred in men who, along
with impotence, had shown features of severe peripheral or autonomic
neuropathy when first interviewed.
DISCUSSION
This study has defined, for the first time, the natural history of impotence
in diabetic men. Of the 190 originally impotent patients, 41 had died during 5
years, 21 were unavailable or unsuitable and 128 were re-interviewed. Only 11
(9%) of those had regained potency. Even among those with "isolated" impotence
at the outset (i.e. no micro/macro vascular disease or symptomatic neuropathy)
only seven (16%) regained potency. Those recovering erectile function were
significantly younger, had shorter duration of diabetes and often some
psychological or organic factor had been present at initial interview which in
retrospect was sufficient to account for temporary impotence. In the majority
of cases, therefore, impotence developing in diabetic men is persistent.
Impotence per se was also found to be significantly associated with the
subsequent development of retinopathy and symptomatic peripheral and
autonomic neuropathy but it did not confer an increased risk of mortality.
The original cross-sectional study demonstrated that established impotence
was significantly associated with age, retinopathy and symptomatic peripheral
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and autonomic neuropathy. Prospective studies, unlike cross-sectional data, can
identify predictive as well as coexistent features with respect to a dependent
variable such as impotence. They can not, however, determine whether such
associations are causal. Nevertheless, on the basis of current pathological
understanding it is reasonable to speculate that some of these significant
associations might have aetiological roles in the development of impotence.
Age, retinopathy, peripheral vascular disease, glycaemic control and alcohol
intake at first interview were all associated with the development of impotence
within 5 years. The association of advancing age and the development of
impotence is not surprising and has been shown both in diabetics (Rubin and
Babbott, 1958; Schoffling, 1960; Montenero and Donatone, 1962; Ellenberg, 1971;
Faerman et al, 1972; Kolodny et al, 1974) and non-diabetics (Kinsey et al, 1948).
The other findings are, however, new.
The relationships between retinopathy, peripheral vascular disease and
impotence support the proposition that vascular as well as neuropathic features
may play an important aetiological role in the pathogenesis of impotence, as
suggested by others (Gaskell, 1971; Abelson, 1975; Ruzbarsky and Michal, 1977;
Karacan et al, 1978, Michal, 1982). By contrast it may seem surprising that
symptoms of peripheral and autonomic neuropathy were not predictive of the
development of impotence since there is a well established association in cross-
sectional studies. The probable explanation is that the majority of those with
symptoms of peripheral neuropathy (63%) or autonomic neuropathy (95%) at
review were already impotent at the original interview. This conclusion is also
supported by the observed tendency for neuropathy and impotence to develop
concurrently during the follow-up period. Thus impotence tends to come first.
This study would therefore support a mixed vascular (micro and macro) and
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neuropathic aetiology for impotence in diabetic men.
The associations which perhaps have the greatest interest with respect to
potential management are the relations with glycaemia and alcohol. It is
reasonable to imagine that the effect of poor glyeaemic control on the
development of impotence might be exerted through acceleration of diabetic
complications. The association is relatively weak, however, although this may be
due to the imprecise method of documenting glycaemic control. A strong link
has been found with drinking, however, even though the documentation of alcohol
consumption is notoriously inaccurate. In this study alcohol appears to have a
uniform effect in increasing the prevalence of impotence irrespective of the
preceding or parallel development of other diabetic complications. It remains to
be seen whether close attention to diabetic control and alcohol abstinence will
have a beneficial effect in established cases of impotence in diabetics.
This study has also clarified the prognosis of established diabetic
impotence. It is worth re-emphasizing that almost 70% of patients who had
impotence as an isolated complication of diabetes have remained with impotence
alone, or, in a few cases, have regained potency during five years of follow-up.
Relatively few of these patients have progressed to show other features of
neuropathic or microvascular damage or have died. This should be contrasted
with the very gloomy outlook for impotent diabetics who have evidence of
retinopathy, nephropathy or autonomic neuropathy. Very few of these subjects
regained potency spontaneously during five years of follow-up and almost half
died. Care should be taken, therefore, in selecting suitable patients for
treatment. It seems likely that the chances of success will be higher in patients
who have impotence as an isolated complication of diabetes.
The aetiological factors which were found to be correlated with mortality
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in this study were age, retinopathy, nephropathy and autonomic neuropathy.
Deckert et al (1967) showed that retinopathy carries a poor prognosis in diabetes
while Watkins et al (1972) described proteinuria as carrying a poor outlook. The
observations in the present study regarding autonomic neuropathy confirm the
findings of Ewing et al (1980). Impotence alone is not associated with an
excessmortality although when associated with other features of autonomic
neuropathy, the outlook is very poor. The fact that episodes of unexplained
"sudden death" were common among these subjects provided further speculation.
Ewing et al (1976) have postulated that these deaths may be directly attributable
to abnormal cardiovascular reflexes and others (Page and Watkins, 1978) have
supported this idea by demonstrating episodes of cardio-respiratory arrests in
such subjects.
Overall this study suggests that the term "diabetic impotence" describes a
group of conditions which may have quite different aetiologies and natural
histories. The prognosis with regard to continuing sexual dysfunction,
progression of other diabetic complications and mortality are determined largely
by other related factors which can be easily determined by taking a careful
history and examination, supplemented by a few simple tests.
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TABLE 17
Relation of AGE to the development of impotence among 275 diabetic men,
potent at first interview.
Age Still potent Now impotent
(years) No (%) No (%)
< 35 76 (86%) 12 (14%)
35-49 64 (63%) 37 (37%)
50 - 59 57 (66%) 29 (34%)




Relation of ALCOHOL INTAKE to the development of impotence among 275
diabetic men, potent at first interview.
Alcohol Intake Still potent Now impotent
No (%) No (%)
Mild
(Grades 1 and 2)
Heavy











Relation of DIABETIC CONTROL to the development of impotence among 275
diabetic men, potent at first interview.
Diabetic control Still potent Now impotent
Good 80 (78%) 22 (22%)
Fair 78 (68%) 37 (32%)
Bad 39 (67%) 19 (33%)




Relation of RETINOPATHY to the development of impotence among 275
diabetic men, potent at first interview.
Retinopathy Still potent Now impotent
No (%) No (%)
None 163 (73%) 60 (27%)
Background 26 (67%) 13 (33%)
Exudative 6 (75%) 2 (25%)
Proliferative 2 (40%) 3 (60%)




Relation of INTERMITTENT CLAUDICATION to the development of impotence
among 275 diabetic men, potent at first interview.
Intermittent Still potent Now impotent
claudication No (%) No (%)
Absent 195 (73%) 71 (27%)
Present 2 (22%) 7 (78%)




Details of 11 patients who regained erectile potency during five years follow-up.
Patient Age Duration of Unusual features at original
(years) Diabetes interview
1 45 12 years
2 49 4 years
3 25 6 months
4 43 18 years
5 24 7 years
6 50 2 months
7 48 2 months
8 30 8 years
9 37 15 years
Marital problems.
Taking phenoxybenzamine.
Partial impotence for less than 1
month. Anxiety at diagnosis of
diabetes.
Partial impotence for 10 months.
Found to be hypogonadal and
responded to testosterone.
Partial impotence following the
death of his wife.
Sudden deterioration in metabolic
control prior to initial inter¬
view. Potency recovered after
conversion to insulin.
Psychological features marked.
Claimed to have become completely
impotent since the diagnosis of
diabetes at the age of 22.
Problems with his second marriage.




Details of 11 patients who regained erectile potency during five years follow-up.
Patient Age Duration of Unusual features at original
(years) Diabetes interview
10 58 1 year
11 49 5 months
His main complaint was of a reduced
facility in obtaining an erection.
The main problem was of ill-
sustained erections and premature
ejaculations.
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Distribution of causes of death among men who were originally potent (n = 22),
had impotence alone (n = 6) and had impotence plus complications (n = 35).
CAUSE OF DEATH Potent Impotence Impotence plus Totals
(n=22) alone (n=6) complications
(n=35)
Myocardial Infarction 9 4 11 24
"Sudden death" 1 0 7 8
Chronic renal failure 1 0 5 6
Cardiac failure 4 0 2 6
Cerebrovascular 2 0 3 5
Accident
Other causes 5 2 7 14
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CONCLUSIONS
"Diabetic impotence" is a complex condition which has received scant
attention from physicians in the past partly because of embarrassment and
ignorance and a belief that it is progressive and untreatable. In trying to unravel
the complexities and reach a clearer understanding of the condition I have
attempted with the help of collaborating colleagues to follow a logical natural
progression. In the cross-sectional epidemiology, I have described the size of the
problem. Almost a quarter of diabetic men under the age of 50 years have
erectile impotence and this figure rises to over 50% in men over 50 years of age.
Given that the problem is large, then it is important to elicit exactly what it is
that these men are complaining of. Patients often find it difficult to describe
sexual dysfunction, due partly to embarrassment and partly to a lack of precise
vocabulary. The term "impotence" is commonly used by these patients but as
shown by the work of Fairburn et al (Appendix C), when time and privacy allow a
more detailed interview one can uncover a much wider clinical spectrum of
sexual dysfunction which makes the understanding and management of individual
cases much easier. There is ample evidence from the literature and from the
results of my own studies in this thesis that such detailed clinical histories from
impotent diabetic men are rarely obtained. Much of the misery for the patient
and his sexual partner, stems from ignorance. Whatever else one can achieve in
the management of diabetic impotence it should certainly be possible to improve
this aspect of their care.
In trying to understand the aetiology of diabetic impotence, this thesis has
provided evidence, both from epidemiological studies and from clinical
investigation that a variety of factors are involved in different cases. The
evidence that neuropathic damage plays a major role in some impotent diabetic
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men is convincing. Both symptomatic peripheral and autonomic neuropathy were
strongly correlated with the presence of impotence in the cross-sectional study.
It is interesting that neither of these factors were shown to be associated with
the development of impotence de novo among potent diabetic men followed
prospectively. I think that the likely explanation of this apparent anomaly is
that the nerve supply to the genitals is probably more vulnerable to damage than
other peripheral and autonomic fibres. Thus, by the time these men show
evidence of symptomatic peripheral or autonomic neuropathy, many will already
have developed impotence. The data on associated bladder function described in
pages 58 to 74 certainly support the idea that pelvic autonomic nerve damage
plays a major role in some cases of diabetic impotence.
The role of vascular pathology in diabetic impotence has been largely
ignored until recently. Both of the epidemiological studies in this thesis have
suggested that microvascular disease (indicated by the presence of retinopathy)
and maerovascular disease (indicated by the presence of ischaemic heart disease
and intermittent claudication) play a major role in the development of diabetic
impotence. The importance of an adequate vascular supply was also shown by
investigations by Bancroft et al (Appendix B) which also demonstrated how
delicate and vulnerable are the neuroregulatory controls on this vascular supply.
Psychological factors have often been played down in diabetic impotence
which has been regarded by many as a good example of purely organic
impotence. From the detailed clinical descriptions outlined by Fairburn et al, it
is clear that this is not the case. Psychological factors are certainly the
precipitating cause of impotence in some cases, as exemplified by some of the
cases in Table 22. In addition the morbidity associated with diabetic impotence
is largely determined by the psychological reactions of the patient and his sexual
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partner.
With improved understanding of the size of the problem and of the
aetiological factors which may lead to its development it should be possible to
design more appropriate treatment programmes for these patients. These should
also, however, take into account a knowledge of the natural history of the
untreated condition. I have shown that the chances of spontaneously regaining
potency are low and are related to the presence of psychological factors or
reversible organic disorders which will respond to treatment (see Table 22). The
outlook is also poor for men who have developed impotence in association with
other major diabetic complications. However, this still leaves a large number of
patients who have impotence as an isolated complication of diabetes. Almost
80% of this group remain in status quo during five years of follow-up. I would
suggest that this is a group of impotent diabetics where attempts at treatment
could be most usefully directed.
Although I have not attempted any therapeutic intervention in the studies
outlined in this thesis it should be possible to design more appropriate treatment
programmes for individual cases using the understanding which has been gained.
When a diabetic patient complains of "impotence" it is essential to take a
detailed history to determine exactly what he means by this. The history should
separate aspects of libido, erectile function and ejaculatory disturbance. The
speed of onset and the presence of precipitating factors should be determined.
These include changes in life circumstances such as worries regarding finance,
employment or marital stress as well as the influence of pharmacological
precipitants such as drugs (notably phenothiazines and antidepressant agents) and
alcohol. Enquiry must be made regarding the reaction of the patient and his
partner to the condition and their expectations of treatment. A knowledge of
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the past sexual history is also helpful in understanding how the present sexual
difficulty has developed.
Details of the patient's diabetic control should be obtained along with an
assessment of the severity of other diabetic complications.
Investigations should be kept to a minimum and should be undertaken early
in the course of management. The tendency to over investigate and to prolong
this aspect may have a deleterious effect on the patient's response to treatment.
It should be made clear to him that one is unlikely to stumble on a simple
physical cause for his impotence which can be easily remedied and that these
investigations merely form one aspect of his overall assessment. Despite these
reservations I believe that some investigations will prove helpful in deciding
appropriate treatment. Although endocrine distrubances play a very minor role
in most cases of diabetic impotence it is probably worth excluding hypogonadism
(by measuring gonadotrophins and testosterone), hypothyroidism (by measuring
thyroid function tests) and hyperprolactinaemia (by measuring prolactin). These
investigations are simple to perform in most centres and may occasionally
provide an easy form of treatment (for example patient no. 5, Table 22). Other
useful investigations include cardiovascular autonomic function tests (as
described by Ewing et al, 1976). While the normality of these tests does not
refute an organic component to the impotence, when these tests are shown to be
abnormal this has serious implications for the likely prognosis of the condition.
More specific investigations might include those described by Bancroft et
al (Appendix B). While these are sophisticated and could not be carried out in
every medical centre they remain a useful investigation which may well help to
distinguish between the importance of psychological and organic factors in
individual cases of impotence.
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Because of the heterogeneity of the aetiology of diabetic impotence
described above it is difficult to speculate on what course of management should
be employed following the results of all these findings. The management must
be determined by what has been found in an individual case. Some points remain
clear, however. In all cases it sould be possible to relieve some of the anxiety
and misery associated with diabetic impotence by explaining both to the patient
and his partner what the cause of the impotence is, in his case, and what the
likely prognosis will be. Although isolated reports of the beneficial effects of
more formal psycho-sexual counselling have been made (Renshaw, 1975) there is
a need for a large controlled clinical trial of this form of treatment. Similarly
with more physical approaches to treatment such as reconstructive vascular
surgery and prosthetic penile implantation, there is a need for more critical
assessment and more stringent inclusion criteria and post-operative follow-up.
Inevitably with a study of this magnitude there remain several areas where
one's understanding is still incomplete and where further investigations need to
be carried out. In particular I feel that there is still no satisfactory and simple
way of determining which patients may respond best to any particular form of
treatment. However, the studies which I have described in this thesis have
certainly clarified my own understanding of erectile impotence in diabetic men.
I am currently continuing my studies of this disorder by looking at the effect of
various forms of treatment. It is my sincere hope that this thesis, and other
published work derived from these data, will stimulate others to look into this
distressing clinical condition with more understanding so that the dismal outlook
for these men may be improved in years to come.
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APPENDIX A
Data collection sheets for semi-structured interviews used in cross-sectional
and prospective epidemiological studies of diabetic impotence




HEIGHT WEIGHT STANDARD WT.
AGE years AGE AT ONSET OF DIABETES years.
MARITAL STATUS Married / Single / Divorced / Separated / Widowed / Other





Angina YES / NO
Myocardial
Infarction YES / NO
Cardiac
Failure YES / NO
Intermittent
Claudication YES / NO
Thyroid
Disease YES / NO




Sympathectomy YES / NO
Other illnesses /
operations YES / NO
ALCOHOLIC INTAKE (in an average week)
DIABETIC CONTROL
Good (< 9 mmol/1)
Fair (9.1 - 13.9 mmol/1)
Bad (14.0 mmol/1 or more)
RETINOPATHY None / Background / Exudative / Proliferative
NEPHROPATHY None / Intermittent / ++ / +++
PERIPHERAL NEUROPATHY
Numbness YES / NO
Paraesthesiae YES / NO
Burning Pains YES / NO
Muscle Weak¬
ness YES / NO
If "YES"
Mild / Moderate / Severe
Mild / Moderate / Severe
Mild / Moderate / Severe
Mild / Moderate / Severe
Findings on examination:
Symptomatic Peripheral Neuropathy PRESENT / ABSENT
AUTONOMIC NEUROPATHY
If "YES"
Postural hypotension YES / NO Mild / Moderate /Severe
Dysphagia YES / NO Mild / Moderate / Severe
Epigastric Fullness YES / NO Mild / Moderate / Severe
Constipation YES / NO Mild / Moderate / Severe
Intermittent diarrhoea YES / NO Mild / Moderate / Severe
Hypoglycaemic unawareness YES / NO Mild / Moderate / Severe
Diminished sweating in legs YES / NO Mild / Moderate / Severe
Gustatory sweating YES / NO Mild / Moderate / Severe
Bladder dysfunction YES / NO Mild / Moderate / Severe
Cardiovascular A.N. tests NORMAL / ABNORMAL
Symptomatic Autonomic Neuropathy PRESENT /ABSENT
IMPOTENCE PRESENT / ABSENT
If "PRESENT", Durations months.
If "PRESENT", Details
If "ABSENT", Temporary impotence in the past YES / NO
Details if "YES"
LIBIDO NORMAL / INCREASED / DECREASED




Collaborative studies with the MRC Reproductive Biology Unit
The following article has been submitted for publication. The studies were
carried out by Drs. John Bancroft and Christopher Bell. Apart from supplying
patients with known potency/impotency, clinical characteristics and
cardiovascular autonomic tests and apart from acting as a normal control
subject, my only contribution to this work was in the "blind evaluation" of the
tracings used to place each erection in a certain "type."
These data are included because this study formed part of the overall
concept of this thesis and because the collective knowledge obtained from these
data influenced the thinking of all the collaborators. The "message" from this
study has implications for the evaluation and approach to management of many
men with "diabetic impotence."
PSYCHOPHYSIOLOGICAL ASSESSMENT OF PENILE ERECTION
A NEW APPROACH
I METHODOLOGY AND RESULTS IN NORMAL SUBJECTS
by
John Bancroft and Christopher Bell
1
INTRODUCTION
In recent years there has been increasing recognition that many cases
of erectile dysfunction are due, at least in part, to physical factors.
This has led to a renewed interest in the physiological mechanisms cf normal
erection and the search for methods of investigating erectile function that
may have diagnostic value.
The traditional view that erection is produced by arteriolar
vasodilation under the control of the parasympathetic outflow and mediated
cholinergically has been recently challenged (Bancroft, 1970; Wagner, 1982).
There is now evidence that in addition to increased arterial flow, the
reduction of venous drainage is involved (Brindley, 1983) and the closure of
arterio-venous shunts may also be important (Wagner et _al_, 1982).
Most methods of investigating erectile dysfunction now in use are
concerned with the physiological state of the non-erect penis (e.g.
measurement of penile blood pressure, Abelson 1975; Velcek et _al_> 1980) or
involve invasive procedures (e.g. arteriography and 'artificial erection',
Michal, 1982), "xenon washout", (Wagner & Uhrenholdt, 1982) or measure
erections during sleep, the relevance of which to erotic response and normal
sexual activity is not yet clear (Schiavi & Fisher, 1982).
In the first part of this paper we describe a method of investigating
erectile responses to erotic stimuli in the laboratory, which allows not
only measurement of penile diameter change but also penile blood flow.
Comparison of these two variables may throw light on the relative importance
of the different components of erection and the factors that influence them.
The use of the method in comparing men with and without erectile failure of
different kinds is reported in the second part.
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Methods
In addition to penile diameter, the following cardiovascular parameters
were monitored: penile and ear blood flow (recorded photometrically),
systolic and diastolic blood pressure. All parameters were recorded on a
Grass model 7D polygraph. Details of the techniques used are as follows:-
Penile Diameter
A standard mercury-in-rubber strain gauge with platinum electrodes was
used and connected to the 7PIE D.C. preamplifier via a Wheatstone Bridge
(Karacan, 1969). The strain gauge was calibrated prior to each test using
two perspex discs of diameters 25 and 26 mm. (the relationship between
diameter and deflection is linear beyond the range used).
Arterial pulse photometry
For measurement of penile pulse, we used a reflectance photometer
incorporating an R.S. 586-447 light emitting diode and a Clarex 904L
photoelectric cell (Fig. 1). The device was coupled to a Grass wide band
AC EEG preamplifier 7P5B, via the circuit shown in Fig. 2. A Grass
transmittance photometer (PTTI) was applied to one ear lobe to provide a
measure of peripheral arterial flow, and a record of heart rate so that the
penile pulse could be confirmed as being due to arterial pulsation. The
PTTI was coupled to a Grass 7P4 preamplifier. In some subjects a PTTI was
used in addition to record digital pulse.
The principle underlying photelectric pulse detection is that light of
appropriate wavelength, directed through the skin, is absorbed by the
underlying tissue in proportion to the amount of blood in the local
vasculature: pulsatile fluctuations off blood movement associated with
cardiac ejection can be recorded using a photoelectric detector to measure
either the light reflected from the tissue or that transmitted through it
(Hertzmann, 1937; Rawson, 1959). Although it is not possible to calibrate
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the signals obtained in terms of absolute flow units, there is substantial
in vitro evidence that the amplitude of the pulse recorded is proportional
to pulsatile flow though volume pulsation of blood vessels may also
contribute to the signal (Jennings et jfL 1980).
In the case of the penis, circulatory changes during sexual arousal
could conceivably lead to artefactual changes in penile arterial pulse
through several mechanisms.
1. Penile engorgement might alter the amount of light reflectance by
changing the distance between transducer and blood vessels or by compressing
the vessels against the transducer. We examined these possibilities by
using the penile reflectance photometer applied to the fingers of two
subjects while interposing perspex spacers (lmm-20mm) between transducer and
skin, and while inflating a pediatric blood pressure cuff around finger and
transducer to different pressures. We found that, provided incidental light
was excluded, variations in distance between detector and skin had
negligible effects unless more than about 10mm and that increasing pressure
had no effect unless sufficient for arterial compression (i.e. 80 mm Hg or
more).
-> >
2. Alterations in resistance to flow caused by erectile engorgement might
modify the signal. We therefore examined digital pulses during inflation of
a forearm cuff to 60 mm Hg in order to increase venous pressure (2 subjects)
and during application of a tight rubber band around the finger distal to
the pulse detector (5 subjects). Neither manoeuvre altered pulse amplitude.
By contrast, local increase in arterial flow induced by immersion of the
finger in water at 44°C caused substantial increase in pulse amplitude (4
subjects), while generalised increase in peripheral resistance induced by a
30 second period of immersion of one foot in water at 5°C caused reduction
of pulse amplitude in 8 of 9 subjects. We therefore felt justified in
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concluding that the penile pulse signals recorded are an appropriate index
of penile arterial flow and are not likely to be seriously distorted by
other events occurring during erection.
The penile photometer used in this study and its position of attachment
are shown in Figure 1. After much experimentation we devised a method of
attachment using a piece of adhesive chiropodist's felt of a size which,
when fixed to the stretched skin of the penis, will pass no more than
halfway round the circumference and keep the photocell in good contact with
the skin (Figure I).
In order to obtain a signal from the dorsal arteries the photocell was
positioned at the dorsal midline. It is necessary to avoid placing the
photocell directly over a vein. Care in attachment is important and often
an unsatisfactory signal can be improved with re-attachment and slight
re-positioning*. The photocell is sensitive to body movement, hence the
positioning of the lead is also important; clothing should be kept well
clear.
Blood Pressure
A standard sphygmomanometer cuff containing a microphone (Sharpe MB
200) was coupled to a Grass 7P8C sphygmomanometer preamplifier and inflated
automatically every 30 seconds with controlled deflation. This allowed
measurement of systolic and diastolic (Phase IV) pressures.
Since completing this study, we have been able to use a Doppler probe to
identify the position of the dorsal artery. This improves the quality of
the signal obtained. It has also shown that other sites more laterally can
be used by careful Doppler searching and these presumably reflect signals
from the deep penile arteries.
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Procedure
As sexual responses in the laboratory setting are obviously susceptible
to psychological factors, much care was taken to optimise conditions and to
keep them as constant as possible. The procedure used was as follows. The
subject was in a small room, kept at a temperature of approximately 70°F,
containing an easy chair and a television set, and joined by a door to a
laboratory containing the Grass polygraph, automatic cuff inflating machine
and video cassette recorder. The subject was asked to remove or lower his
trousers well clear of his penis. A towel was provided to place over his
lap. He was then asked to fit both devices whilst left alone in the room.
Afterwards, their position was checked by visual inspection and once a
satisfactory signal was obtained from them the ear photometer and blood
pressure cuff were fitted by the experimenter. The subject was then asked
to remain seated, comfortably but avoiding unnecessary movement and to watch
the television screen (i.e. a normal non-erotic programme) for a baseline
period of approximately 10 minutes during which all parameters were
recorded.
The testing procedure lasted approximately one hour, and was carried
out in identical fashion on two separate occasions. The average interval
between occasions was 33 days (range 13-53 days).
Erotic Stimuli
Two types of erotic stimuli were used, fantasy and film. For fantasy,
the subject was asked to produce as exciting an image as possible and to
maintain it until asked to stop. He was told that he would not be asked
details of the fantasy. The film extracts were each 2 to 3 minutes long,
showing explicit sexual activity (sexual intercourse and oral-genital
contact). One extract involved two women and one man, the remainder
involved one couple only. Five film extracts were used, one on both testing
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occasions, the others being used only once.
The order of presentation of stimuli in each session was as follows:
First fantasy (3 minutes), 3 film sequences, and second fantasy (3 minutes).
A minimum of 3 minutes was left between each stimulus, or longer if
necessary to allow the penile diameter to return to baseline.
Subjects
Normal volunteers were recruited from hospital and Research Unit staff.
The initial approach was tentative so that it was easy for the individual to
decline without embarrassment. If there was apparent willingness, a more
definite request was made. Each subject was told that we required men with
no obvious erectile problems as a comparison group for impotent men.
Twenty-two volunteers were tested, mean age 38.2 years (S.D. 10.3,
range 24-53). Three subjects were unable or unwilling to return for the
second testing session (mean age 34).
-Interpretation of physiological data
A typical "normal response" is shown in Figure 3. The following
parameters were measured in each response, and are shown in Figure 3.
1. Maximum penile diameter change.
2. Latency of erectile response to 2.5mm, 5mm and 10nm increase in
diameter.
3. Baseline penile pulse amplitude. The AC signal was samples for a 10
second period, at least 30 seconds prior to the onset of each erotic
stimulus. The "cleanest" sample closest to that time point was taken. The
mean amplitude in uVolts was calculated.
4. Penile pulse amplitude increase during erotic stimulation (a) the
"increase" from preceding baseline to maximum and (b) the "difference"
between maximum and minimum during erotic stimulation.
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5. The mean systolic and diastolic blood pressure was taken from the three
measurements preceding each erotic stimulus. The highest systolic and
diastolic levels during the stimulus presentation were then measured and the
difference between these and the baseline means taken as the blood pressure
response to erotic stimulation.
Temporal relationship between penile probe amplitude and penile diameter
change
It was evident that whilst both penile P.A. and diameter tend to change
in response to erotic stimuli, they often do so at different times. Most
typically, the penile P.A. starts to increase later than the onset of
diameter change. Often there is considerable delay and in some instances
the P.A. increase becomes much more noticeable after the erotic stimulus has
ended and when the erection has started to decline. It is also common for
there to be a decline in P.A., usually transient, in the early stages pf
the erection, followed by a more substantial increase (See Figure 4). (This
accounts for the pulse amplitude "difference" being greater than the pulse
amplitude "increase").
The temporal relationship between changes in pulse amplitude and penile
diameter was looked at in the first 12 subjects tested, by taking the
largest erectile response in each case. Five second samples of penile
diameter, penile pulse amplitude and pulse amplitude in the ear were taken
every 20 seconds starting during the baseline period and continuing through
until the erection was declining. Penile pulse amplitude was then
correlated with penile diameter and ear pulse amplitude, based on change
scores (i.e the differences between consecutive five second sample
intervals.
8
To investigate these various temporal relationships further we
described 6 patterns or types of response (Types I to IV are shown
diagramatically in Figure 6 and examples of each are shown in Figures 7 to
10). Types V and VI involved increase in diameter with no increase in P.A.
and vice versa. The operational definitions of each type are given in the
appendix.
Responses were categorised by two independent observers. There was
initial agreement for 75% of responses. Disagreements were then negotiated
and resolved by applying the operational criteria more rigorously. It
should be emphasised that this method of categorisation is a crude attempt
to distinguish between temporal relationships which vary in a continuous
rather than discrete fashion.
Interpretation of response latencies has proved to be complex as
latency to 2.5mm and 5mm are not independent of the final degree of erection




For none of the variables was there a significant difference between
the first and second sessions. The results will therefore be presented as
means for all 22 subjects (i.e including those tested only once) (See Table
1). The percentage of subjects showing at least one response and the
percentage of all possible responses reaching the criteria of 2.5, 5 and
10mm increase in diameter are also shown in Table 1.
Penile diameter changes in response to films were significantly greater
than those to fantasy (t=5.4, d.f.20, p = 0.001), though two subjects
responded more strongly to fantasy than to film. It should be emphasised,
however, that this experiment was not designed to compare the relative
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efficacy of these two types of stimuli.
Age was negatively correlated with mean penile diameter increase to
fantasy (r = -0.45, d.f.20, p= 0.05) but not to film (r = -0.06).
Penile Pulse
Measureable pulse amplitude (P.A.) was recorded in all but two
sessions. The main difficulty in interpreting the signal during erotic
stimulation resulted from rhythmic increases in penile diameter, assumed to
result from contractions of the perineal muscles, which produce marked
interference with the photometric signal. In one session these artefacts
were so frequent that the photometric signal was uninterpretable. In 17
other sessions, these contractions occurred, but the P.A. could be measured
between them. Subjects showing these contractions were significantly older
than those who did not (mean age 44.6 +_ 8.1, n=9; 33.5 +_ 9.1, n=13: t =
2.95, p = .01), but these two groups did not differ significantly in the
■degree of erection obtained.
Mean P.A. measurements during baseline periods and erotic stimulation
are shown in Table 1. For all statistical procedures, log transformations
of the microvolt values were used.
There was no significant correlation between pulse amplitude (either
baseline or change) and age. Mean change in pulse amplitude (P.A.),
however, did correlate with the degree of erection (for PA "increase"
r=0.44, d.f.17, p= 0.05, one-tailed; PA "difference" r=0.7, d.f.17, p=
0.001).
Temporal relationship between penile pulse amplitude and diameter
In the first 12 subjects the correlations between penile pulse
amplitude and diameter were extremely variable. Only three were
significant, two were negative and one positive. The distribution of
responses into the 6 categories is shown in Table 2 for the 18 men with
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two categorisable sessions each. The distribution was significantly
different in session 2, which showed more Type I and fewer Type II, III, IV
and V responses (X2 = 12.64, d.f.=6, p= 0.05). Percentages of each type
of erection which were in response to fantasy were as follows: type I, 28%;
II, 16%; III, 30%; IV, 38%; V 47% and VI, 89% (X? = 23.6, d.f.5, p=
0.001). Thus Type VI responses were particularly likely to occur with
fantasy stimulation. More data will be required before the functional
significance of these different types can be properly assessed. Types I and
II erections, however, tended to be larger and more rapid than Types IV and
V.
Blood Pressure
The baseline levels and changes in blood pressure during erotic
stimulation are shown in Table 1.
Mean blood pressure responses to erotic films were significantly
.greater than those to fantasy (systolic, t=4.11, d.f.17, p= 0.001;
diastolic, t=2.65, d.f.17, p= 0.05). The basis of the blood pressure rise
was examined further in some subjects by comparing finger P.A. during erotic
stimulation and during the cold pressor test (30 second period of emersion
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of one foot into water at 5°C). Both stimuli produced comparable increases
in blood pressure ( Chris Bell to complete
).
However while the cold pressor test was associated with a reduction in
digital P.A. by 20-90% in 8 out of 9 subjects tested, during erotic
stimulation the increased blood pressure was accompanied by a reduction of
digital P.A. in only 3 of 10 subjects tested, and in 4 there was a
substantial increase in amplitude (by 40-60%). Lack of reduction in digital
P.A. during erotic responses therefore indicates no increase in peripheral




This study has demonstrated an effective method of eliciting erections
in normal subjects in response to visual stimulation. Eighteen out of 22
subjects (82%) responded with more than 10mm increase in penile diameter on
at least one occasion; only one subject failed to respond with an increase
of more than 5mm. Responses to fantasy were less strong and less frequent,
but 7 subjects (32%) produced erections greater than 10mm diameter increase,
and in two subjecs their responses to fantasy were greater than those to
f i lm.
Only in response to fantasy did we find a correlation between erection
and age. This may be because the film stimulus was strong enough to obscure
the age effect. Alternatively, mechanisms involved in fantasy response may
be more susceptible to ageing. It is of possible relevance that in a study
of hypogonadal men, androgen withdrawal and replacement had an effect on
their erectile responses to fantasy but not to film, which remained within
the normal range even during androgen withdrawal (Bancroft & Wu, 1983).
In addition to erection there was a predictable increase in systolic
end diastolic blood pressure in response to erotic stimulation, more marked
for film than with fantasy. It was of some interest that this pressor
response was not associated with any evidence of decreased peripheral blood
flow, in contrast to the response to the cold pressor test, and the room
temperature was insufficient to cause thermoregulatory vasodilation of an
extreme degree. We therefore conclude that the pressor response to erotic
stimuli was due primarily to increased cardiac output rather than increased
peripheral resistance.
We have shown that measurement of pulse amplitude photoelectrically
from the dorsal surface of the penis is a practical and effective
non-invasive procedure providing that sufficient care is taken with
placement and method of fixing the photocell to the skin. Use of a Doppler
probe to locate the artery should enhance the efficacy of this method.
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Although we hope to obtain more direct physiological validation of this
photometric signal, we believe it justified to assume that it monitors
penile arterial flow, mainly through the dorsal penile arteries but, with
appropriate placement, from the deep arteries also. Whereas an increase of
pulse amplitude during the development of erection was usual, it was by no
means invariable and was usually later in onset than the increase in penile
diameter. A recent study of temperature change during erection in normal
subjects reported comparable findings (Webster & Hammer, 1983). One out of
eight normal subjects showed an increase in penile skin temperature,
presumably reflecting arterial flow, which occurred after the erectile
response was declining, suggesting a temporal pattern similar to our type IV
response.
Despite the evidence detailed under Methods to indicate that the
photometric records we obtained did represent pulsatile changes in penile
arterial flow, certain other explanations for the variations in pulse
amplitude seen must be considered:
(a) Pressure effects. Reduction in pulse amplitude during erection could be
due to increasing pressure on the photocell. Apart from the unlikelihood of
this, given the method of fixing the photocell used, this explanation could
not account for the fact that pulse amplitude frequently decreased and then
returned whilst erection continued to develop. Also reduction of pulse
amplitude sometimes occurred after the onset of the erotic stimulus and
before any erection had developed (e.g. Fig.9). Similarly, increase in
pulse amplitude occurred after cessation of the erotic stimulus and in the
absence of any penile diameter change. Pressure effects are not a
sufficient explanation for these phenomena.
(b) Positional effects. The temporal relationship of pulse amplitude and
diameter change may vary according to the position of the photocell on the
penis. However, variations of this relationship not only occurred between
individuals and between sessions, but also within sessions when the
photocell position was constant.
(c) Anatomical factors. The relative lateness of pulse amplitude change in
the dorsal artery, compared with diameter increase of the shaft may be
because the dorsal artery principally supplies the glans rather than the
corpora cavernosa. Apart from the variability of this temporal relationship
within the same subject, and the improbability of differential timing of
blood flow in the dorsal and deep penile arteries, we also found that in 2
subjects that were investigated, tumescence of the glans had no closer
temporal relationship with pulse amplitude change than shaft tumescence.
(d) Straightening of penile arteries. Michal (1982) reported that during
the induction of artificial erection by means of saline infusion into the
corpora cavernosa, there is a "selective dilation" of the penile arteries,
as shown on arteriograms, which is at least in part due to the straightening
of the otherwise tortuous vessels. Such straightening could result in
increased flow in those vessels. During normal erection, lengthening of the
penis in the early stages would also lead to straightening and hence
increased arterial flow. This process could account for the relative delay
in pulse amplitude increase that we have observed but not the decrease in
pulse amplitude during erection or the increase that occurs once the
erection starts to decline.
It is therefore likely that our recordings of pulse amplitude do
represent changes in arterial inflow to the penis, and our results indicate
that increased arterial flow is associated with erection in the majority of
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normal individuals. It appears, however, that arterial changes are
typically not essential for the early stages of erection, which presumably
depend on venous mechanisms or the regulation of intrapenile shunts (Wagner
et aj_, 1982). Nevertheless, it is possible that where arterial inflow
increases early, erection is more efficient and such arterial changes may be
necessary for the development of sufficient rigidity for vaginal entry.
This relative independence of arterial and other mechanisms implies
different control mechanisms, which may be differentially affected by
arteriopathic, neuropathic, pharmacological or psychological factors. It
may be that change in arterial flow is part of a more generalised sexual
arousal response, whereas the other erectile erectile mechanisms are part of
a more stimulus-controlled genital response. This would account for the
tendency for pulse amplitude increase to persist after the penile diameter
has returned to baseline.
The delay or dissociation of the arterial component may be due to
psychological inhibition. This is consistent with our finding that such
delay was less likely to occur in the second session when presumably
psychological inhibition was less marked.
The possibility that measurement of penile pulse amplitude and its
temporal relationship with penile circumference change, may reflect
abnormalities of penile blood vessels, their neurological control or
psychological inhibition will be explored further in the second paper when
responses in clinical subjects will be reported.
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1. The determining characteristic is the temporal relationship between
pulse amplitude (P.A.) change and volume change. A normal (type I) erection
shows a parallel increase in these two variables. A delayed (type II)
pattern shows P.A. increase starting later than volume increase. A
transient P.A. response shows P.A. increasing during the early stages of
volume increase but not continuing into the later stages (type III). A
dissociated response (type IV) shows P.A. tending to increase when volume is
going down and vice versa. P.A. increase without volume change is called
type VI and volume change without P.A. increase is called type V.
2. (a) For pulse amplitude (P.A.) increase to occur, it should have doubled
its previous lowest levels for at least 10 seconds.
(b) For volume increase to occur, the penile diameter should "increase
by 1 mm or more.
3. For type I, P.A. increase should be maintained (i.e. above criterion
level) up to the point of maximum volume and should have reached criterion
level before the 50% diameter increase is reached. (A transient decrease
below criterion level may occur during diameter increase. Providing that it
does not remain below the criterion level for longer than 20 seconds, it can
be ignored).
For type II, P.A. increase should be maintained up to maximum volume,
but it reaches criterion after the 50% volume increase is reached.
For type III, P.A. increase is not maintained up to maximum volume (i.e
has decreased below criterion before maximum volume is reached or when the
maximum P.A. is prior to 50% volume increase and then shows a substantial
dec! ine).
For type V, P.A. increase does not reach the criterion, but volume
increase does.
For type VI P.A. increase reaches criterion no later than 10 seconds
after end of erotic stimulus but volume increase does not.
Type IV erections have 3 sub-types
IV (a) - P.A. increase reaches criterion but only after the diameter has
started to decline (i.e. by at least 25% of the maximum). Or if it
continues to increase (i.e. reaches maximum) beyond the point of 25%
diameter reduction.
IV (b) - P.A. increase reaches maximum in 10 seconds or longer after the end
of the erotic stimulus but within 90 seconds regardless of what happened
before.
V (c) - P.A. shows predominantly a decrease (below 75% baseline level) for
duration of the stimulus or the duration of the diameter increase. Include
under V (c) those responses where there is a P.A. increase only before the
volume starts to increase, when the P.A. then shows a decline.
Chiropodist's adhesive












Penile photometer and method of fixing. The piece of adhesive felt
measures 55 mm x 30 mm. The diameter of the photocell is 10 mm.
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RESPONSE LATENCY TO 2-5 5 10mm
IGURE 3
typical normal response showing the variables measured in each case.
. Maximum penile diameter change. 2. Latency of erectile response to
.5 mm, 5 mm and 10 mm (in this case 21, 30 and 45 seconds respectively).
. (a) Baseline pulse amplitude during a 10 second period. (This would
ormally be sampled at least 30 seconds prior to the onset of the
timulus. (b) the minimum mean pulse amplitude during a 5 second period
nd (c) the maximum mean pulse amplitude during a 10 second period,
ulse amplitude 'increase' is c-a, 'difference' is c-b.
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epical example of transient
svelopment of an erection.
3% of erectile responses.
decline of pulse amplitude during the















Diagramatic representation of the different 'types
of erectile response showing different temporal






Type I erection showing pulse amplitude increase startin








rype II erection. The pulse amplitude increase.occurs late when the
iiameter change is already close to maximum. This is from the same
subject as in Figure 7, but came from the first session, whereas the
type I response was from the 2nd session. Note how the type II erection
is slower to develop.
E PULSE







rpe III erection showing a large but transient pulse amplitude change











DelV erection. This tracing shows the first and last part of the
sponse. In this intervening period there was a slow, gradual increase in
lile diameter whilst the pulse amplitude remained very small. Note how
2 pulr.o amplitude reduces as soon as the erotic stimulus is switched on
i finally returns with increased amplitude after the end of the stimulus
2n the erection is just beginning to decline.
TABLE 1
CHANGES IN PENILE D3AMETER, PENILE PULSE AMPLITUDE IN
22 NORMAL MEN IN RESPONSE TO EROTIC FANTASY AND FILM.
Mean Response Response
Baseline to Fantasy to film
Penile diameter Mean 26.7mm +4.6mm +9. lmro
S.D. 2.7 4.3 3.0
Increase in penile
diameter greater than:-
2.5mm % subjects 73% 100%
% responses 44% 95%
5mm % subjects 55% 95% •
% responses 35% 81%
10 mm % subjects 32% 82%
% responses 21% 42%
Fenile pulse Mean 659
amplitude (P.A.) S.D. ±508
liV
Increase Mean + 750 + 1209
S.D. ±1150 ±1159
Difference Mean 1194 1643
S.D. ±1270 ±1385
Blood Pressure mm Hg
Systolic Mean 119.1 + 16.4 + 24 .6
S.D. ±13.8 ±7.8 ±11.1
Diastolic Mean 75.4 + 14.9 + 16.6
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PSYCHOPHYSIOLOGICAL ASSESSMENT OF PENILE ERECTION
A NEW APPROACH
i
ASSESSMENT OF ERECTILE FUNCTION IN DIABETIC AND NON-OIARETIC IMPOTENCE
John Bancroft, Christopher Bell, Basil Clarke,
David Ewing, David McCulloch and Pamela Warner
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INTRODUCTION
Although measurement of erectile response to erotic stimuli in the
laboratory has been used for many years to assess sexual preferences and
outcome of modification of deviant sexual behaviour (Bancroft, 1974), little
attention has been paid to its use in the diagnosis of erectile dysfunction.
One exception is a study by Kockott et al_ (1980).
In this paper, we report the use of non-invasive psychophysiological
testing of erectile and other responses to erotic stimuli, in the comparison
of three groups of men, normal subjects, and non-diabetic and diabetic men
with erectile dysfunction. The results from a small group of diabetic men
without erectile problems will also be reported.
Methods
The method of testing and the physiological variables measured are
described in full in Part 1. In this paper we will be reporting erectile
responses (i.e. increase in penile diameter), penile blood flow (pulse
amplitude change) and systolic and diastolic blood pressure change to both
erotic films and fantasies. As described in Part 1, a variable temporal
relationship between degree of erection and pulse amplitude change has been
observed, leading to a typology of erections. Types I and II are considered
to be "normal" responses which tend to be larger and more rapid than types
IV and V. In type VI responses, only pulse amplitude change occurs.
Subjects
Twenty-two normal subjects (Group N) were described in Part 1. Their
ages ranged from 24 to 53 (mean 38 years).
Twenty-five non-diabetic men with erectile problems (Group NI) were
studied. Their ages ranged from 25 to 58 (mean 40). Included in this group
was one case of traumatic paraplegia, impotence following colonic resection
(one case), transverse myelitis (one case), Peyronies disease (one case),
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ischaemic heart disease (one case) and hypertension (three cases).
Twenty-six diabetic men with erectile problems (Group DI) were studied,
and had ages ranging from 25 to 53 (mean 42). The mean duration of their
diabetes was 15 years (range 5-31 years). Twenty-two were insulin dependent
and four were taking oral hypoglycaemic agents. The incidence of autonomic
neuropathy was established by means of cardio-vascular reflex tests (Ewing &
Clarke, 1982). The subjects were thus categorised into those with normal
cardio-vascular reflexes (Group 1, n=6), those with parasympathetic damage
only (Group PS, n=13) and those with parasympathetic and sympathetic damage
(Group PS plus S, n=7). Following systematic recording of the state of the
retina, subjects were categorised as (1) no retinopathy (n=8), (2)
background retinopathy (n=9) and (3) exudative or proliferative retinopathy
(n=8). Four diabetic men with no erectile problems were also studied (ON
group). Their age ranged from 24 to 53 (mean 39).
Each subject in the two groups with sexual dysfunction (Groups NI and
DI) was categorised, on the basis of history and physical examination, to
indicate the likelihood of psychogenic causation. Three categories were
used: (1) psychogenic causes not apparent, (2) present and possibly
contributory and (3) present and probably the main causative factor.
Performance anxiety was not considered as sufficient explanation for
erectile problems as it is usually secondary to either psychogenic or
organic factors.
The non-diabetic dysfunctional group were also categorised in a similar
way to indicate the likelihood of organic aetiology. Transient physical
episodes (e.g. painful circumcision, genital herpes) were regarded as
contributory (organic category 2) but not sufficient causes.
Method of Analysis
Two types of analysis will be reported.
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(a) Between Group Comparison
Three equal sized age-matched groups were taken from the original
groups, first excluding those with only one session of testing or those in
the NI group who had unequivocal (i.e. category 3) organic aetiology. This
resulted in three groups of 19 each, ages (mean +_ S.D.), N=31.9 _+ 10.1,
NI=39.2 +_ 11.3 and DI=40.1 _+ 7.9. The results will be presented as means of
the two testing sessions combined.
(b) Within Group Comparison
Each of the original dysfunctional groups are also divided according to
(1) the presence of psychogenic or organic factors and (2) in the case of
the diabetic group, the presence or absence of (a) autonomic neuropathy and
(b) retinopathy. Where more than one group was being compared, analysis of
variance was used, together with Scheffe test for comparison between pairs
of groups. Where only two groups were being compared, Students t-test was
used. Logarithmic transformation of penile pulse amplitude scores was used
in all cases.
RESULTS
Results for the degree of erection, penile pulse amplitude and systemic
blood pressure changes for the three matched groups are shown in Table 1.
The DI group produced significantly less erections in response to film than
both the N and NI groups and significantly less response to fantasy than the
N group. The N and NI groups were not significantly different in either
case. A comparable pattern was found for the pulse amplitude difference .
There were no significant differences in baseline systemic blood pressure or
blood pressure change during erotic stimulation.
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The distributions of the six types of erections in the three groups
are shown in Figure 1 as percentages of all responses (i.e. types I-VI).
Types I and II had very similar distributions within each subject group and
are therefore shown combined. A significant Chi square was found for
responses to both film and fantasy. This was mainly due, in the case of
responses to film, to a disproportionately high number of types I and II in
the N group, of type IV in the NI group and of type VI in the DI group.
For fantasy responses, there was a disproportionately high number of
type I in the normal group and of type VI in the diabetic group. Thus types
IV and VI may be of particular relevance in distinguishing between diabetic
and non-diabetic (?psychogenic) impotence.
Non-Diabetic Men with Erectile Dysfunction •
The 25 patients in this group were divided into two sub-groups
according to the categorisation of psychogenic and organic factors:
(1) those in whom psychogenic factors were considered to be of greater
importance than organic factors ("psychogenic" group, n=17) and (2) those in
whom organic factors were considered to be of either equal or greater
importance than psychogenic factors (n=8). The principal results are shown
in Table 2. The psychogenic group had significantly greater erectile
responses to film but there was no difference in the response to fantasy.
The "psychogenic" and "organic" sub-groups did not differ in their
pulse amplitude difference during erotic stimulation. There was also no
marked difference in the distribution of the types of erection between the
two groups although type VI erections (pulse amplitude increase only) tended
to occur more often in the organic group.
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The Diabetic Group
The 26 diabetic men with erectile failure were first divided into those
with (n=9) and without (n=17) evidence of psychogenic factors that could
account for or contribute to their erectile dysfunction. The principal
results in these two groups are shown in Table 3 together with the results
from the four potent diabetic men (Group ON).
The "psychogenic" group, who were slightly younger, showed a greater
erectile response to fantasy, but not to film. The pulse amplitude
difference during responses to film was however greater in the psychogenic
group who also showed a smaller rise in systemic blood pressure to erotic
stimulation.
Autonomic Neuropathy
The comparison of the groups with and without evidence of autonomic
neuropathy is shown in Table 4. There were no differences between the
groups in response to fantasy. In erectile response to film, group 1 was
significantly more responsive than group PS & S but did not differ from
group PS. Although both groups with autonomic damage (groups PS and PS & S)
showed smaller pulse amplitude changes than the non-neuropathic group
(groupl), the differences were not significant. There was no difference
between the 3 groups in terms of systemic blood pressure response.
There was a tendency for type VI responses to be more frequent amongst
those with autonomic neuropathy.
Retinopathy
Comparison of the three groups with differing degrees of diabetic
retinopathy is shown in Table 5. Although presence of retinopathy was
associated with smaller erectile responses to film, the differences between
the three groups were not significant. Penile pulse amplitude differences,
however, were significantly smaller in those with severe retinopathy
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(i.e. exudative or proliferative) than those without retinopathy. There
were no significant differences in systemic blood pressure response.
The three groups did not differ in their response to fantasy and there
was no obvious association between degree of retinopathy and type of
erectile response.
DISCUSSION
These results indicate that our method of assessing sexual
responsiveness has diagnostic value as well as being of psychophysiological
interest. Measurement of erections to film stimuli distinguished between
organic and psychogenic aetiologies as shown in the comparison of the three
matched groups (N, NI, DI) and the within group comparison of the
non-diabetic impotent men. Fantasy response was less effective in
distinguishing between diagnostic groups.
Kockott et _al_ (1980) have reported the only other comparable data in
the literature so far. Our findings support theirs in that our diabetic
impotent subjects showed smaller erectile responses than our normal
controls.
The measurement of change in penile pulse amplitude has been of most
relevance to the diabetic group. It did not distinguish between the
non-diabetic impotent men and the normal controls, nor, within the impotent
group, between those with predominantly psychogenic and organic aetiologies.
However, not only was the diabetic group different from the other two in its
pulse amplitude response, there were also interesting differences between
sub-groups of diabetic men. The diabetic men with obvious psychogenic
factors showed more normal pulse amplitude change than those with only the
diabetes to account for their problem, even though they didn't differ
significantly in the amount of erection produced. The relationship with
7
diabetic complications was also of interest. Penile pulse amplitude change
was significantly smaller in those with severe retinopathy, whereas the
differences between those with and without autonomic neuropathy was shown
most clearly (and significantly) in the degree of erection. These two
complications usually co-existed, so their effects may have confounded one
another. Our results suggest, however, that retinopathy was, as one would
expect, most associated with impairment of arterial inflow (as shown by
pulse amplitude change). Autonomic neuropathy, on the other hand, was more
associated with the degree of erection, and hence may be exerting its main
effects on the neural control of venous outflow or arterio-venous shunt
mechanisms. This effect on erection was only significant in the group with
both parasympathetic and sympathetic damage. Whether this is due to the
added effects of the sympathetic damage or to the generally more severe
degree of autonomic damage in this group is not yet clear. The possibility
that the parasympathetic and sympathetic damage may produce differential
effects on arterial inflow to the penis is worthy of consideration.
Parasympathetic damage alone might be expected to result in
unopposedvasoconstrictor tone and hence smaller pulse amplitude. With added
sympathetic damage, the vasoconstrictor tone would also be reduced, leading,
in the presence of normal vessels, to larger but less responsive pulse
amplitude. It is therefore of interest that in those three men with both
parsympathetic and sympathetic damage but without severe retinopathy, there
were relatively large increases in pulse amplitude for the small degree of
erection produced. Obviously more evidence will be required before this
interesting possibility can be assessed. If, in the presence of
parasympathetic damage, unopposed vasoconstrictor tone does occur and
adversely affects erection, then it may be amenable to pharmacological
treatment. It is noteworthy that those diabetic impotent men with neither
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retinopathy nor autonomic neuropathy all gave evidence of psychogenic
causation.
The typology of erections, based on the temporal relationship between
penile pulse amplitude and diameter change, remains of uncertain diagnostic
significance, but there are some interesting possibilities that deserve
further study. The type VI response, pulse amplitude change without
diameter change, may be relevant to specific types of pathology as it was
more frequent amongst the diabetics, especially those with autonomic
neuropathy. This is consistent with our suggestion that neuropathy
principally affects the non-arterial components of erection. Type IV
responses may also prove to be of considerable interest when we have more
information. They were certainly more frequent amongst the non-diabetic
impotent group, but did occur in some normal and diabetic subjects. As
suggested in the first paper, the temporal dissociation between pulsatile
flow and penile diameter change that characterises this type of response,
suggests some active inhibition or restriction of the arterial component
during response to an erotic stimulus. This may be a manifestation of
performance anxiety, in which case we should expect to find it occurring not
only in those with psychogenic impotence but also in some normal subjects as
well as some with organic aetiologies. If so, it would be of considerable
theoretical interest as well as diagnostic significance. Our method of
assessing this temporal relationship has so far been crude, but we believe
that these preliminary findings justify a further investigation of this
phenomenon with more sophisticated methods of data analysis.
The diagnostic value of our method of assessment needs to be compared
with other methods to establish its proper place in clinical practice. A
comparison of erectile responses assessed by this method with those recorded
during sleep will be reported in a further paper (Shapiro, O'Carroll &
Bancroft).
Our results suggest that small vessel disease, autonomic neuropathy and
psychogenic factors may all contribute to the erectile problems of diabetic
men, possibly by affecting different components of the erectile process.














































































































































































































































































































































































































































































































































































































































X2 = 4 5-0 2
p < 0* 0 0 5
1 ri
X2 = 2 7-1 0
p<0-005
i+n m
□ NORMAL MPOTENT E3 DIABETIC IMPOTENT
FIGURE 1. Distribution of six types of erectile response to erotic
film and fantasy in the three groups of subjects. (For
definition of types, see text and Paper 1.) Percentages
shown are of all responses within each group.
APPENDIX C
Published articles derived from these research studies.
Diabetologia 18, 279-283 (1980) Diabetologia
© by Springer-Verlag 1980
The Prevalence of Diabetic Impotence
D. K. McCulloch, I. W. Campbell, F. C. Wu, R. J. Prescott, and B. F. Clarke
Diabetic and Dietetic Department, Royal Infirmary, and Medical Computing and Statistics Unit, Edinburgh University,
Edinburgh, Scotland
Summary. In a survey of 541 diabetic males, aged
20-59 years, 190 (35%) had erectile impotence.
Using linear logistic regression models for analysis
the five most significant associations with impotence
were age (p < 0.001), treatment with either insulin
or oral hypoglycaemic agents (p < 0.001),
retinopathy (p < 0.001), symptomatic peripheral
neuropathy (p < 0.001) and symptomatic autonomic
neuropathy (p < 0.005). The greatest correlations
were found in patients with severe microangiopathy,
as demonstrated by proliferative retinopathy and
symptomatic autonomic neuropathy. In addition the
duration of diabetes and the presence of ischaemic
heart disease, nephropathy and poor diabetic control
may also be associated with diabetic impotence. It is
concluded that diabetic impotence is still a common
problem and may have a multifactorial aetiology.
Key words: Diabetic impotence, prevalence, aeti-
ological factors.
The increased frequency of impotence in the diabetic
male has long been recognised [7], Despite improve¬
ment in the treatment of diabetes since the early
insulin era there has been no decrease in recent
reports of the frequency of diabetic impotence [7, 10,
14], Thus the prevalence of impotence with increas¬
ing age in diabetic men aged between 20-60 years is
still approximately 18-71% [19] and considerably
greater than 0.1-18.4% for the corresponding nor¬
mal male population [13].
There has been no previous extensive survey of
the prevalence of diabetic impotence in the United
Kingdom. The aim of the present study was therefore
to ascertain the prevalence in males attending a large
U. K. diabetic clinic. An assessment was also made of
possible contributing factors involved in the aetiology
of diabetic impotence.
Materials and Methods
During a nine month period 563 males attending the Diabetic
Out-Patient Department were interviewed. A total of 132 clinics
were covered and at each clinic every male aged between 20-59
years was included. After three months an initial non-randomised
group of 319 men (Group 1) had been interviewed. At this time it
was decided to interview a random group of approximately 100
men to exclude the possibility of bias in the original group. The
total clinic male population aged 20-59 years was 887 and from
the remaining 568, a random sample of 101 men (Group 2) was
drawn who were subsequently interviewed over a six month
period. Over this latter period a second non-random group of 121
men (Group 3) who were attending the clinic and not included in
the random sample were also interviewed.
The total number of men included for study was thus 541,
representing 61% of the male clinic population aged between
20-59 years. A further 22 who were unable to give satisfactory
interviews were omitted: in the two non-random groups (Groups 1
and 3) 9 were mentally defective, 2 had cerebrovascular accidents
with dysphasia and 2 were unable to speak English; in the random
group (Group 2) 5 had recently left the area, 1 was hospitalised
elsewhere, 2 were mentally defective and 1 had a cerebrovascular
accident.
A detailed questionnaire was completed and included the
patient's age, weight and standard weight (Metropolitan Life
Insurance Company Tables, 1959), age at onset of diabetes and
marital status. Diabetic treatment was recorded as diet alone, oral
hypoglycaemic agents or insulin. Enquiry was made of other drug
therapy, angina pectoris, previous myocardial infarction or cardiac
failure, intermittent claudication, thyroid dysfunction, previous
sympathectomy or other abnormality that might predispose to
organic impotence such as neurological disease or previous injury.
A note was taken of the average weekly quantity of alcohol con¬
sumed by each patient.
All patients had a retinal examination at least yearly with both
pupils dilated and retinopathy status was recorded as none, back¬
ground, exudative (or maculopathy) or proliferative, many of the
latter having had or were awaiting photocoagulation treatment.
The presence of nephropathy was indicated from several urinal-
0012-186X/80/0018/0279/$01.00
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yses over the previous 12 months using "Albustix" and the pro¬
teinuria recorded as none (0), intermittent (0/ + ), moderate
(+ +) or heavy (+ + +).
Careful enquiry was made of symptoms suggestive of
peripheral neuropathy (numbness, parasthesiae, burning pains and
limb weakness).
These individual features were graded as "mild/moderate" or
"severe". Objectively, those with mild/moderate complaints usu¬
ally had documented in their case records absent ankle jerks,
absent vibration sense at the ankle, diminished sensation in the
feet and/or muscle wasting. Those with severe symptoms generally
had more extensive sensory loss in the lower limbs, absent knee
jerks and often had evidence of recent or old neuropathic ulcera¬
tion. The criteria for the presence of symptomatic peripheral
neuropathy were one or more severe or two or more mild/moder¬
ate symptoms along with objective evidence (as outlined above)
that these symptoms were due to neuropathy.
Enquiry was also made of symptoms of autonomic neuropathy
(postural hypotension, intermittent diarrhoea especially noctur-
nally, epigastric fullness, bladder dysfunction, diminished sweating
in the legs, gustatory sweating and hypoglycaemic unawareness).
The criteria for the presence of symptomatic autonomic
neuropathy were two or more severe or three or more mild/mod -
Table 1. Relationship of age to impotence in diabetic males
Age range Total no. No. %
(years) diabetics impotent impotent
20-24 53 3 5.7
25-29 35 5 14.3
30-34 44 7 15.9
35-39 43 13 30.2
40-44 52 15 28.8
t, 45-49 91 33 36.3
50-54 99 49 49.5
55-59 124 65 52.4
Total 541 190 35.1%
erate features. All such patients had well defined objective evi¬
dence of autonomic neuropathy from previous studies [8, 2],
Diabetic control was assessed by taking the average of the last six
2 h post prandial glucose estimations at previous clinic visits or all
the 2 h post prandial glucose values excluding the initial reading if
the patient had only been attending for a short time. Three groups
of diabetic control were arbitrarily designated:
Good - mean blood glucose level less than 9 mmol/1;
Fair - 9.1-13.9 mmol/1;
Bad - 14.0 mmol/1 or greater.
The patient was also asked if he was able to obtain a normal
penile erection and impotence was regarded as present if there had
been partial or complete failure to obtain an erection for at least
six months. The duration of impotence was recorded in months. If
the patient was potent at the time of interview, enquiry was made
if transient impotence had ever been present in the past, e. g.
during anxiety or poor control. Such patients were entered in the
study as being potent. Any decrease in libido was noted and
enquiry was made for features suggestive of a psychological cause
for the impotence [4],
The information was recorded on a questionnaire form, coded
and transferred to punch cards. Using the Edinburgh Regional
Computing Centre's facilities the computer p kage SPSS was
used for the production of the tables. In the tabulations which
follow three age groups were chosen to give adequate numbers in
each group - 20-34 years, 35-49 years, 50-59 years. Patient
Groups 1, 2 and 3 were compared using Chi-squared tests or a
one-way analysis or variance dependent upon whether the variable
concerned was qualitative or quantitative.
Investigation of the association of various clinical features with
impotence involved the use of linear logistic models which were
fitted using a second computer package, Genstat. The use of such
models is well described by Cox [5], They allow the probability of
impotence to be related to a set of clinical variables simultane¬
ously. In this way the interrelationship of the variables can be
taken into account and the relative importance of the variables in
producing impotence can be assessed. The method has consider¬
able similarities to methods of multiple regression, which are well
described by Armitage [1].
60"
Fig. 1. Relationship of impotence to age in diabetic
and normal male subjects. The normal male data
are derived from Kinsey et al. [13].
• • Normal, ♦—-—♦ Diabetics
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Comparison of the non-randomised groups (1 and 3)
and the randomised group (2) were made. The differ¬
ences between the groups are outlined below. There
were few significant differences and they were such
that the amalgamation of the grouped data would
give valid results on diabetic impotence. The ages of
the three groups were comparable with mean ±
S. E. M. of group 1, 2 and 3 being 43.4 ± 0.6,46.1 ±
1.1 and 43.7 ± 1.1 respectively. The overall preva¬
lence of impotence was 35%, 39% and 31% respec¬
tively in the three groups. The only variables demon¬
strating significant differences between the groups at
the 5% level were retinopathy with prevalences of
34%, 22% and 26% respectively and symptomatic
peripheral neuropathy with prevalences of 23%,
13% and 14% in the three groups. All subsequent
analyses were therefore performed with the com¬
bined data from all three groups, treating this as if it
were a random sample from the clinic population.
Of the 541 men interviewed, 190 (35%) were
impotent (Table 1). The increasing prevalence of
impotence with age is shown in the figure and over
the age range studied this relationship can be
described adequately by a logistic curve.
The effect of duration of diabetes on the preva¬
lence of impotence within the three age groups is
shown in Table 2. There was an increasing preva¬
lence of impotence with increasing duration of dia¬
betes in all age groups but no difference in preva¬
lence was seen between the insulin dependent and
insulin independent groups.
Two hundred and eighty (80%) of the potent and
173 (91%) of the impotent subjects were married.
Libido was diminished in 29 (8.3%) of the potent
diabetics and in 53 (28%) of the impotent diabetics.
In the latter none had features suggestive of
psychogenic impotence and it may be that the
diminished libido was secondary to the impotence.
Transient impotence had occurred in 24 of the potent
subjects, 8 during poor control, 4 during anxiety and
12 at other times such as at diagnosis of diabetes (3
Table 3. Relationship of diabetic treatment, retinopathy,
peripheral and autonomic neuropathy to impotence within three
age groups
Age (years)
Variable 20-34 35—49 50-59
Treatment
Insulin 12% (15/125) 39% (43/109) 65% (55/84)
Oral agents2 0% (0/3) 35% (13/37) 56% (43/77)
Diet 0% (0/4) 13% (5/40) 26% (16/62)
Retinopathy
None 5% (5/96) 24% (29/120) 39% (63/162)
Background 10% (2/20) 34% (12/35) 74% (26/35)
Exudative 0% (0/4) 46% (6/13) 94% (16/17)
Proliferative 67% (8/12) 78% (14/18) 100% (9/9)
Peripheral neuropathy
Absent 7% (8/116) 27% (44/151) 44% (75/169)
Present 44% (7/16) 57% (20/35) 72% (39/54)
Autonomic neuropathy
Absent 9% (11/127) 30% (54/179) 49% (104/213)
Present 80% (4/5) 100% (7/7) 100% (10/10)
a Within the group of patients on oral hypoglycaemic agents there
was no difference in impotence in each age group in those taking
sulphonylureas or biguanides (metformin)
subjects), following excessive alcohol (2 subjects)
and during intercurrent unrelated illnesses such as
myocardial infarction.
Using the linear logistic model five variables
showed a significant association with impotence: age
(p < 0.001), treatment of diabetes with insulin or
oral hypoglycaemic agent but not diet alone (p <
0.001), retinopathy (p < 0.001), symptomatic
peripheral neuropathy (p < 0.001) and symptomatic
autonomic neuropathy (p < 0.005). A summary of
the effects of these latter four variables is shown in
Table 3 within the three age groups. Impotence was
seen in all patients aged 50 years or more with pro¬
liferative retinopathy and in those aged 35 or more
with autonomic neuropathy.
The presence of ischaemic heart disease, ne¬
phropathy and poor diabetic control may also be
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Table 4. Relationship of nephropathy, control of diabetes and
ischaemic heart disease to impotence within three age groups
Age (years)
Variable 20-34 35-49 50-59
Nephropathy"
None (0) 7% (8/109) 28% (43/155) 47% (93/196)
Intermittent
(0/+ ) 18% (2/11) 44% (8/18) 68% (13/19)
Moderate
(++) 40% (4/10) 63% (5/8) 100% (4/4)
Heavy
(+ + +) 50% (1/2) 100% (5/5) 100% (4/4)
Control''
Good 7% (2/29) 21% (13/61) 34% (25/74)
Fair 9% (5/53) 28% (21/75) 54% (53/98)
Poor 16% (8/50) 54% (27/50) 71% (36/51)
Ischaemic heart disease
Absent 11% (15/132) 33% (54/166) 48% (83/174)
Present - 35% (7/20) 63% (31/49)
a Nephropathy and control are defined in the patients and
methods section
Table 5. A review of studies outlining the prevalence of impotence
in diabetic men










Present study 541 35
associated with diabetic impotence (Table 4). How¬
ever, these latter variables are closely associated with
the other risk factors and so statistical significance is
only achieved at the 10% level. Likewise, duration of
diabetes was not found to have a statistically signifi¬
cant association with the prevalence of impotence
when analysed using the linear logistic regression
model. This occurs despite its obvious aetiological
importance, because its effect on the model is indi¬
rect. Duration of diabetes is associated with an
increasing prevalence of many other aetiological fac¬
tors such as microangiopathy and neuropathy and so
its individual importance is not considered to be sig¬
nificant in the context of the analysis using the linear
logistic model.
Discussion
In our study the prevalence of impotence (35%) is
the lowest so far reported compared with other
recent surveys from USA, Europe and South
America (Table 5). We have studied the largest
number of patients, aged 20-59 years, but otherwise
unselected as regards treatment, duration or compli¬
cations. In addition the study was conducted over a
nine month period to include less frequent attenders
at the clinic. Our method of selection thus ruled out
some of the bias in selection present in previous
studies. Although impotence as in non-diabetics
increases with age, in our survey 76 (24%) of those
less than 50 years were impotent.
In the survey impotence was defined as the inabil¬
ity to initiate and sustain a satisfactory penile erec¬
tion. Penile erection occurs as a reflex mediated by
the parasympathetic nerve fibres from the spinal cord
segments sacral 2-4 (nervierigentes). It is generally
assumed that diabetic impotence is due solely to au¬
tonomic neuropathy affecting these nerves. This is
mainly based on indirect evidence that impotence is
associated with both anatomical [9] and physiological
abnormalities [6] of the bladder in some of these
diabetics. There has been one unconfirmed study
showing alterations in the autonomic nerve fibres in
the corpora cavernosa in impotent diabetics [11],
again suggesting that a neurological lesion could
cause the impotence.
However, in our previous studies of autonomic
neuropathy we have shown that impotence can fre¬
quently occur alone without any of the other symp¬
tom-complexes of autonomic neuropathy and in such
patients cardiovascular reflexes such as the Valsalva
manoeuvre and the blood pressure response to sus¬
tained handgrip are normal [8] as is the plasma renin
response to standing [3] as well as the preservation of
normal testicular sensation [2]. There is now agree¬
ment that there is no obvious endocrine abnormality
causing diabetic impotence and normal gonado-
trophin levels [10], normal testosterone concentra¬
tions [14] and a normal gonadotropin response to
LH-RH stimulation [25] have been reported. It has
become clear to those dealing with diabetic impo¬
tence that in some cases there would appear to be
many disease processes such as psychogenic,
neurological and vascular disorders involved in the
aetiology of impotence, an idea suggested in 1950 by
Simpson [24], Although psychogenic factors are the
commonest cause of non-diabetic impotence, we
have been impressed by how infrequently any of the
diabetic males had features to suggest psychogenic
cause [4],
That impotence in normal males [13] and in
diabetics [21] increases with age is well recognised.
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The significant association of impotence with dia¬
betics on oral agents and insulin rather than diet
alone differs from previous studies where impotence
occurred equally in patients on all forms of therapy
[23, 17]. Our results suggest that impotence may be
associated with an increased tendency to microan¬
giopathy. The strong correlation with the presence
and severity of retinopathy has not been shown by
others. In the smaller study of Rubin and Babbott
[21] retinopathy occurred with equal frequency in
both potent and impotent diabetics. The association
of impotence with neuropathic symptoms is not
unexpected. There are many previous studies to show
that impotence is found in a high percentage of
patients with peripheral neuropathy [22, 16] and with
autonomic neuropathy [7, 9].
An association with ischaemic heart disease was
found at the 10% level but no significant association
was found with the presence of intermittent claudica¬
tion. A prerequisite for normal erection is an ade¬
quate blood supply to the genital region as seen by
the occurrence of impotence in the Leriche syndrome
[15]. Rubin and Babbott [21] found an equal inci¬
dence of vascular disorders in their potent and impo¬
tent diabetics. In an unconfirmed angiographic study
in impotent diabetics Fournier and Huguet [12] have
claimed an absence of blood supply to the corpora
cavernosa of the penis. However, more extensive
investigations of penile blood supply have not been
carried out.
There are many variables therefore in the aetiol¬
ogy of diabetic impotence. Although it is possible to
identify the predominant cause in some patients,
detailed investigations of subgroups of impotent
patients will be necessary to clarify the problem
further.
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E/ffect of Alcohol Intake on Symptomatic
Peripheral Neuropathy in Diabetic Men
David k. Mcculloch, ian w. Campbell, robin j. prescott, and basil f. clarke
In a group of 541 white diabetic men aged 20-59 yr attending one clinic it was found that 91 (15%)
drank heavily, while a further 39 (7%) had frank alcoholism. The prevalence of symptomatic peripheral
neuropathy was much higher in the 120 men who drank excessively. It is considered important, there¬
fore, when treating diabetic patients with peripheral neuropathy not to assume that the diabetes itself is
the cause in all cases. The alcoholic intake of the patient should be ascertained and, if excessive, it
should be pointed out to the patient that this may well be the predominant factor causing symptoms.
diabetes care 3. 245-247, march-april 1980.
Most diabetic patients are advised to drink alco¬hol in moderation only and to restrict this todiabetic beer and lager or spirits without swee¬ened additives. Krall an Joslin1 urged com¬
plete abstention, and although others are more liberal in at¬
titude,2 most agree that regular ingestion of alcohol is not to
be encouraged among diabetic individuals, and that it may
lead to weight gain. Our own policy has been to accept a
moderate alcohol intake (up to 10 alcoholic drinks per week)
but to discourage any more alcohol than this.
Although diabetes and alcohol are well-known individual
factors causing peripheral neuropathy, little attention has
been paid to the effect of alcohol intake on peripheral neu¬
ropathy among diabetic individuals. This present study ex¬
amines the extent to which patients follow advice about al¬
cohol intake and whether this affects neurologic
complications in these patients.
PATIENTS AND METHODS
During a 9-mo period 541 men were interviewed, repre¬
senting 61% of the male clinic population aged between 20
and 59 yr (mean age 44 0 ± 11.6 yr). These comprised all
such men attending 134 routine clinics during this period
and included a random sample of 101 men. Male patients
only were selected because this study was part of a larger re¬
view of the male clinic population to ascertain the preva¬
lence of impotence.3 It was possible to check from the ran¬
dom sample that there was no important bias in the selection
of the other 440 patients. A questionnaire was completed at
the interview and a note made of the patient's weight, stan¬
dard weight (Metropolitan Life Insurance Company Tables,
1959), and diabetic treatment (diet alone, oral hypoglyce¬
mic agents, or insulin). The diet in nonobese non-insulin-
dependent diabetic patients, whether on oral agents or not,
was a simple carbohydrate-restricted diet (40% carbohy¬
drate, 45% fats, 15% protein), while obese non-insulin-de¬
pendent diabetic patients were on a calorie-restricted diet
(generally 500-1000 cal), often along with metformin.
Those on insulin received a carbohydrate exchange diet,
using 10-g carbohydrate exchanges, and on average took
240 g of carbohydrate daily. No patient was on any particu¬
lar vitamin supplement. Enquiry was made of any drugs the
patients were receiving that might contribute to the presence
of peripheral neuropathy.4
A history of alcohol intake was obtained and graded as:
grade 1 ("nondrinkers"), men who were nondrinkers or took
less than six alcoholic drinks throughout the year, usually
limited to special occasions; grade 2 ("social drinkers"),
those who consumed generally up to 10 alcoholic drinks per
week, usually on two or three nights plus occasional wine
with a meal; grade 3 ("heavy drinkers"), those taking up to
three to four drinks almost every night and often more at
weekends; and grade 4 ("alcoholic"), patients with drinking
habits frankly outside the social norm and those attending,
previously or at present, the alcoholic treatment center in
the city. Many of these patients drank half a bottle of spirits
or more per day.
Although there appears to be a gap between grades 2 and
3, this was not found to be the case. These four grades repre¬
sent distinct drinking patterns occurring in the Scottish pop¬
ulation under study. There is a clear cutoff between those
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TABLE 1
Effect of alcohol intake and duration of diabetes on prevalence of sympto¬
matic peripheral neuropathy
Duration of diabetes (yr)
Alcohol intake
Moderate Excessive
0-4 12/142* ( 8%) 18/57 (32%)
5-9 13/96 (14%) 11/25 (44%)
10-14 9/62 (15%) 7/18 (39%)
>14 27/121 (22%) 7/20 (34%)
Total 61/421 (14%) 43/120 (36%)
* Note: The figures represent the number of patients with symptomatic
peripheral neuropathy divided by the total number of patients who fell
within that alcohol intake grade and duration of diabetes. This fraction
is then represented by a percentage in parentheses.
whose intake was grades 3 and 4- For this reason much of the
subsequent analysis compares the moderate drinkers (grades
1 and 2) with the excessive drinkers (grades 3 and 4).
In all cases the patient's drinking pattern had been the
same for more than 5 yr. Note was taken of the type of alco¬
holic beverage preferred, whether beer, lager, wine, or spir¬
its.
Careful enquiry was made of symptoms suggestive of pe¬
ripheral neuropathy (numbness, parasthesiae, burning pains,
or limb weakness). These individual features were graded as
"mHd/moderate" or "severe." Objectively, those with mild/
moderate complaints usually had documented in their case
records absent ankle jerks, absent vibration sense at the
ankle, diminished sensation in the feet, and/or muscle wast¬
ing. Those with severe symptoms generally had more exten¬
sive sensory loss in the lower limbs, absent knee jerks, and
often had evidence of recent or old neuropathic ulceration.
The criteria for the presence of symptomatic peripheral neu¬
ropathy was one or more severe or two or more mild/moder-
ate symptoms along with objective evidence (as outlined
above) that these symptoms were due to neuropathy.
The recorded information was coded, punched, and veri¬
fied and the SPSS computer package used to produce tables.
The statistical tests of significance applied in this study are
for the most part standard (Student's t tests, \2 tests).
However, in Table 1, Woolf's test5 was first used to test
whether the relative risk of symptomatic peripheral neuropa¬
thy in patients with a high alcohol intake changed with the
duration of diabetes. The significance of the effect of alcohol
on symptomatic peripheral neuropathy was assessed using a
test described by Cox6 to combine the information from four
separate 2x2 contingencies corresponding to differing du¬
rations of diabetes, while the effect of duration itself was as¬
sessed by another test described by Cox.7
RESULTS
It was found that 421 subjects (78%) were moderate drinkers
(125 were grade 1 and 296 were grade 2) while 120 subjects
(22%) were excessive drinkers (81 were grade 3 and 39 were
grade 4).
Of the diabetic subjects on diet alone, the average weight
of the moderate drinkers was 183 ± 3 lb and of the excessive
drinkers 183 ± 5 lb. Moderate drinkers on oral hypoglyce¬
mic agents had an average weight of 163 ±2 lb, while those
who drank excessively had an average weight of 162 ± 3 lb.
Among the insulin-dependent diabetic subjects, the moder¬
ate drinkers had an average weight of 158 ± 1 lb, while the
excessive drinkers had an average weight of 156 ± 2 lb.
Overall, 23% of the moderate drinkers were greater than
10% above standard weight compared with 30% of those
who drank excessively. None of these results is statistically
significant.
None of the patients with symptomatic peripheral neurop¬
athy were found to be taking any drugs that would signifi¬
cantly contribute to their symptoms.
The effect of alcohol intake together with duration of dia¬
betes on the prevalence of symptomatic peripheral neuropa¬
thy is shown in Table 1. Both these factors affected neuro¬
pathic symptoms independently, with no evidence of
interaction (Woolf's test, P > 0.4). Neuropathic symptoms
become more common the longer the patients had had dia¬
betes (P < 0.001), and for any duration of diabetes the prev¬
alence of symptomatic peripheral ne.uropathy was increased
in those who drank excessively (P < 0.001). This increase
was most marked in patients with a short duration of diabe¬
tes. The prevalence of neuropathic symptoms in patients
who had had diabetes for less than 5 yr was increased fourfold
in those who drank excessively (8% among moderate
drinkers, rising to 32% among excessive drinkers). This dif¬
ference became less marked the longer the patients had had
diabetes. With a duration of 15 yr or more, the effect of ex¬
cessive alcohol intake only increased the prevalence of
neuropathic symptoms by IV2 times (22% among moderate
drinkers, rising to 34% in those who drank excessively).
DISCUSSION
The effect of diabetes together with alcohol on pe¬ripheral neuropathy has not been reported pre¬viously. The occurrence of peripheral neuropathyamong alcoholics is thought to be largely due to
associated deficiencies of B-group vitamins, which causes
damage to the axon itself.8 Diabetes, on the other hand,
causes damage to nerves primarily by a metabolic disturbance
resulting in segmental demylination and axonal degenera¬
tion.9 It may be that the combined insult to the neurons in
this way may have a cumulative effect, producing more severe
symptoms. That excessive alcohol seems to exert a greater
influence on neuropathic symptoms among recently diagnosed
diabetic persons may merely reflect the fact that, with the
passage of time, pure diabetic neuropathy becomes more
pronounced, such that the damaged nerves are less influenced
by the effect of excessive alcohol.
The authors believe that this study is important in the
assessment and treatment of symptomatic peripheral neurop-
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athy in diabetes. This is a very difficult area of treatment.
Various drugs, such as quinine, diphenylhydantoin, pro¬
cainamide, carbamazepine, asprin, and sulphinpyrazone,
are being tried empirically with no definite benefit being
shown from controlled clinical trials. The fact that diabetic
subjects with only moderate alcohol intake had far fewer
symptoms of peripheral neuropathy lends support to the view
that moderation should be advised to diabetic individuals as
a preventive measure in the development of peripheral neu¬
ropathy. It may simply be that asking a diabetic person who
drinks alcohol excessively to moderate intake could prevent
neuropathic symptoms from arising and hopefully may im¬
prove or reverse them when present.
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~he Clinical Features of Diabetic Impotence: A Preliminary Study
C. G. FAIRBURN, F. C. W. WU, D. K. McCULLOCH, D, Q. BORSEY, D. J. EWING,
B. F. CLARKE and J. H. J. BANCROFT
Summary: Twenty-seven diabetic men with erectile impotence were given
physical and psychosexual assessments. Physical assessment included vascular
and neurological evaluation. Psychosexual assessment was by means of a semi-
structured interview. Seven potent diabetic men formed a control group. Patients
with erectile failure had a varied clinical picture which differed from the stereo¬
type of diabetic impotence: morning erections were preserved in over a half (55
per cent), eight patients (30 per cent) had intact spontaneous erections, and
sexual interest was reduced in 12 patients (44 per cent). In 13 patients (48 per
cent) ejaculation was disturbed and a further four patients (15 per cent) des¬
cribed unusual disorders of sexual function.
Within the group there were no differences in clinical picture between those
with and without autonomic neuropathy, retinopathy or potential psychogenic
factors.
There are probably half a million known diabetics
l the United Kingdom and an equal or greater
umber of people with symptomless, undetected
iabetes (Jarrett and Keen, 1976). Surveys of diabetic
len using a variety of selection techniques indicate
tat between 35 and 60 per cent have erectile im-
otence (Rubin and Babbott, 1958; Ellenberg, 1971;
IcCulloch et al, 1980). Although these studies haye
icked control groups there is little doubt that this
revaience is significantly greater than that found
mong non-diabetic men in the general population
Frank et al, 1978;Gebhard and Johnson, 1979).
Two forms of diabetes-related impotence are recog-
ized. In the first, failure of erection occurs in the
ontext of poor diabetic control. Erectile failure and
ss of sexual interest accompany the general malaise,
nd these symptoms reverse once the patient's physical
ondition improves. This type of impotence is non-
pecific and is found in other debilitating conditions
jColodny et al, 1979). The second form of impotence
■.said to be characteristic of diabetes. It is thought to
« the result of a physical process and it is generally
escribed as progressive and irreversible. All erections
re affected, including those obtained spontaneously
nd on waking, and it is associated with no loss of
exual interest. 'Psychogenic' impotence, in contrast,
; characterized by erectile failure confined to certain
ircumstances (usually when with the sexual partner),
ometimes complicated by a loss of sexual interest
Cooper, 1972; Kolodny et at, 1974; Kockott et al,
980). The difference between the two clinical pictures
is widely used in the assessment of erectile failure in
diabetic men.
The validity of these clinical stereotypes has recently
been questioned (Fairburn, 1981) and it has been
suggested that many diabetic patients show 'inter¬
mediate' clinical features (Schiavi and Hogan, 1979).
Furthermore, there have been reports of the successful
use of sex therapy in the treatment of diabetic im¬
potence, a supposedly irreversible condition (Ren-
shaw, 1975,1979).
The aim of this study was to provide a comprehen¬
sive description of the sexual function of a group of
diabetic men with erectile failure and to relate this to
physical and psychological factors likely to be relevant
to the aetiology of their erectile disturbance.
Method
Subjects
Seventy-three diabetic men aged less than 55 years,
attending the diabetic out-patient department at the
Royal Infirmary, Edinburgh, were invited to join the
study. Each had described partial or complete erectile
failure of at least six months duration. Most subjects
had been identified in a prevalence study three years
earlier (McCulioch et al, 1980). Seven potent diabetic
men were selected from the same population for com¬
parison.
Thirty-four impotent subjects (47 per cent) did not
wish to take part in the study. Of the remaining 39
patients, 27 completed each aspect of the study. The
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mean age of the impotent group was 43.7 years (range
25-53 years; SD 8.0) and the mean duration of dia¬
betes was 13.1 years (range 1-33 years; SD 7.3). The
corresponding figures for the comparison group were
41.0 years (range 24-51 years; SD 9.3) and 12.4 years
(range 3-27 years; SD 9.2).
Investigations
(i) A full medical history and physical examination
were carried out.
(ii) Autonomic nerve function tests comprised five
simple tests of cardiovascular reflex function. These
were the Valsalva manoeuvre, lying-to-standing heart
rate response, a measure of R-R interval variation (all
assessing cardiac parasympathetic function), and the
blood pressure responses to sustained handgrip and
posture (assessing more widespread sympathetic
abnormalities). These tests have been described in
detail elsewhere (Ewing, 1978; Clarke el al, 1979;
Ewing el al, 1980).
(iii) Psychosexual assessment was conducted by a
psychiatrist experienced in the clinical management of
sexual problems (C.G.F.). A semi-structured inter¬
view was designed for the purpose. For each item a
standard initial probe question was used and followed
by further questioning sufficient to clarify the answer.
Replies were noted verbatim and coded during the
interview. The major areas examined were as follows:
the onset of sexual problem, present sexual function,
present life circumstances, past sexual function and
the effects of the sexual problem on the patient and his
partner.
Each investigation was performed independently by
different observers.
Statistical analysis
Where statistical comparisons were possible the
Fisher exact probability test was used.
Results
Onset of sexual problem
The impotent patients gave a history of sexual
difficulties lasting on average 4.4 years (range 1-8
years; SD 1.9) with a mean age at onset of 39.3 years
(range 20-52 years; SD 8.0). Twenty-three of the 27
patients had diabetes when their sexual difficulties
began, and two more were diagnosed as having
diabetes within the next six months.
The clinical picture at onset varied. In 24 subjects
the first symptom was a decline in either the strength
or the duration of erection. Seventeen reported that
both declined simultaneously; the remainder said they
obtained an erection of normal strength, but it failed
to last. Three patients described different modes of
onset. One developed premature ejaculation for the
first time when aged 44 years. This was in the conti
of a good marriage and stable social circumstanc
Four years later erectile failure supervened after
period of increased anxiety over sexual performan'
A second patient aged 42 years complained of sem
'trickling out' of his erect penis during foreplay. Ti
was a novel experience which was unaccompanied
the sensation of orgasm and occurred before t
patient was significantly aroused. Orgasm occurr
later, but in the absence of ejaculation. Erectile failu
developed after two months. The same pattern
disturbance was present on masturbation. A thi
patient aged 31 years complained of an increase in ti
ease with which he obtained an erection. He began
have numerous erections through the day, usually
the absence of sexual thoughts. These erections caus<
him embarrassment, particularly as he sometin)
ejaculated. Twelve months later he ceased to ejacula
with force; instead semen 'dribbled out' of his penis;
orgasm. Soon afterwards erectile failure developed.
By the end of the first six months, 26 of the I
patients had experienced a degree of erectile failui
and four had ceased to ejaculate despite continuing t
achieve orgasm. One patient had developed an abno
mality in the shape of his erect penis with it bendin
upwards mid-way along the shaft so that it resembled
smoker's pipe in profile. A second patient developed
similar abnormality three years after the onset c
erectile dysfunction.
Interest in sex remained intact throughout thi
initial six months period in 23 of the 27 patients. Tw<
patients (ages 25 and 26 years) had a reduced interes
in sex at the time of onset and in both these subject
concurrent marital difficulties were prominent; in th
two others (ages 38 and 52 years) interest in sex de
clined sharply once erectile failure developed. Boti
these patients had a history of premature ejaculatioi
and each described a resurgence of anxiety over sexua
performance.
Present sexual function
Table I summarises the symptomatology of th<
impotent and non-impotent groups at the time ol
interview. The clinical picture was varied. The classical
features of diabetic impotence, absent or reduced
morning erections and intact sexual interest, were not
present in a substantial proportion. Over half the
impotent men obtained full erections on waking and a
similar number had a reduced interest in sex. Most
subjects described fluctuations in their degree of
sexual interest.
Abnormalities of ejaculation were present in 13 of
the impotent patients. In nine subjects there was a loss
of the 'pumping sensation' associated with ejaculation.
Those patients who masturbated said that semen
C. G. FAIRBURN et al
Table I
Sexual symptomatology in the impotent and control groups
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Impotent group Control group
Significance
(Fisher test)ytual symptomatology (N = 27) (%> (N = 7) (%)
rectile failure 26* (96) 0 (0) —
npaired morning erections 12 (44) 1 (14) NS
npaired spontaneous erections 19 (70) 0 (0) P <0.05
jaculatory disturbance 13 (48) 0 (0) P <0.05
educed interest in sex 12 (44) 0 (0) P <0.05
One patient in the impotent group did not have erectile impotence at the time of assessment. He had experienced inter¬
mittent erectile failure in the past.
owed out' of their penis at orgasm. Four patients
ased to ejaculate at all, despite experiencing
-gasm. Only one of these patients described cloudy
?st-orgasmic urine suggestive of retrograde ejacu-
tion. A change in the nature of the ejaculate was
>ted by three patients with a decrease in its volume
id tendency to clot.
The degree of erectile failure was profound: only
■ur patients had a sufficiently firm erection to permit
tginal penetration and intercourse. Despite this,
ost patients insisted that they became sexually
oused under appropriate circumstances. Eight of the
ipotent patients were able to obtain erections on
asturbating or spontaneously, and these tended to be
mer than those obtained with their partner.
ist sexual function
None of the seven potent diabetic men had a
story of sexual dysfunction, whereas five of the
ipotent patients had previously sought help for
xual problems (Fisher exact probability test NS).
go of these patients had longstanding premature
iculation, one had a history of delayed ejaculation
id the remaining two had experienced an earlier
lisode of erectile failure. None of the patients des-
ibed having erectile failure at times of poor diabetic
tntrol.
iabetic complications and sexual symptomatology
(i) Retinopathy: When the impotent patients were
bdivided into those with (N = 16) and without (N =
) background, exudative or proliferative retinopathy
ie to their diabetes, no differences were found in the
xual symptomatology of the two groups (Fisher
act probability test NS).
(ii) Autonomic neuropathy: On the basis of cardio¬
vascular autonomic function tests, the patients were
divided into those with normal tests and those with
one or more abnormal results. The sexual symptom¬
atology of the two groups was similar (Fisher exact
probability test NS). No difference emerged when the
patients were further subdivided into those with car¬
diac parasympathetic abnormalities alone (N = 6) and
those with more widespread additional sympathetic
abnormalities (N = 5).
Psychological factors and sexual symptomatology
Two factors which might provide a psychological
component to the erectile failure were the presence of
previous sexual difficulties suggesting a vulnerability
to sexual dysfunction and the existence of active
marital dysharmony. One or both these factors was
present in nine of ffie impotent patients, whereas they
were absent from the potent group. (Fisher exact
probability test NS). There were no significant
differences in sexual symptomatology between those
impotent patients with and without psychological
problems (Fisher exact probability test NS).
Other factors liable to affect sexual function
Although the impotent patients were diagnosed as
having diabetic impotence, many other factors were
detected which might have been responsible for their
sexual difficulties. At the time of onset, six were
drinking heavily and two were still doing so at assess¬
ment (average consumption of at least 120 g of
ethanol daily). In two patients, erectile failure and
angina developed simultaneously following myo¬
cardial infarction. Seven patients had severely im¬
paired exercise tolerance sufficient to make it difficult
for them to climb two flights of stairs. One patient had
undergone a lumbar sympathectomy for intractable
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claudication. He described progressive erectile failure
and an inability to ejaculate; however, his sexual
interest and ability to become aroused and achieve
orgasm were unimpaired. Two other patients were
suspected of having multiple sclerosis. One patient had
experienced intermittent dysarthria and ataxia. His
sexual problems predated these symptoms by five
years. The second patient had retrobulbar neuritis and
a progressive weakness of both legs. He described
erectile failure which had started three years earlier
and this was accompanied by absent ejaculation, but
intact orgasm. Three patients were taking drugs at the
onset of their sexual problem which are known to
interfere with sexual function (imipramine, amitrip-
tyline and methyldopa) and at assessment one was
taking chlorpromazine. Of the seven control patients,
one had impaired exercise tolerance and another was
taking imipramine.
Reactions to the sexual problem
The reaction of the patient and his partner to the
onset of sexual difficulties was ascertained. Certain
patterns of response were discernible (see Fig). The
most common reaction (10 patients) was of increasing
anxiety over the decline of sexual performance leading
to a degree of sexual avoidance and reduced interest in
sex (pathway A). Four patients accepted the problem:
their attitude was that they should make the most of
their sexual capabilities. This attitude developed
gradually once the patient appreciated that such
difficulties were common among diabetics and could
be attributed to the disease; it was usually preceded by
a period of anxiety and loss of sexual interest (pathway
B). Two patients with a good knowledge of diabetes
and its complications had this attitude from the outset
(pathway C). In contrast, five patients accepted the
problem passively, stating that they were unconcerned
about the change in sexual function (pathway D)
While a degree of denial might have been present, al
five indicated that sex had never been of great import¬
ance to them. Two of these patients had experienced
erectile failure in the past.
In ten instances the patient's partner reacted
adversely to the sexual difficulty. Six of the wive
blamed themselves for the problem thinking that tbej
were no longer attractive to their partners, whereas is
four cases the reaction was of anger and resentment.
Both of these responses led to the avoidance of set-
Knowledge that the sexual problem might be secon¬
dary to the diabetes appeared to help resolve the
self-blame, but it did little to neutralize the other,
more hostile response.
Discussion
Unlike previous studies of diabetic impotence >
small number of patients have been examined in
detail, the number being limited by the intensive and
personal nature of the investigations. Most other
studies have examined large numbers of patients from
an epidemiological standpoint. The two approaches
complement one another.
The patient sample may have been biased, as almost
half of those invited did not wish to participate in the
study. However, this is unlikely to have affected the
principal conclusion that the clinical picture of dia¬
betic impotence is more varied than previously sug¬
gested. Marked differences were found between indi¬
viduals and within individuals over time, and certain
symptoms such as disturbed ejaculation were more






^ performance ^ avoidance of ^-A (n = 10)
sexual anxiety sex B (n = 4)
interest
Fig.—Reactions to the sexual problem.
* n = number of patients who clearly showed a particular reaction.
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Erectile failure was not necessarily the first symptom
of sexual dysfunction. One patient's problem started
with late onset premature ejaculation, another com¬
plained of an inconvenient increase in the ease with
which he obtained an erection, and a third noticed a
change in his ability to ejaculate. At the onset the
severity of sexual dysfunction varied from day to day,
but this variability declined with time.
Failure to obtain morning and spontaneous
erections is said to be characteristic of diabetic
impotence (Cooper, 1972; Kolodny et al, 1974). How¬
ever, in this study full morning erections were exper¬
ienced by over half the impotent patients and spon¬
taneous erections by almost a third. These results are
different from those predicted, but are not altogether
at variance with other reports: almost a half of the
patients studied by Rubin and Babbott (1958) and
Scott et a! (1980) had intact morning erections. The
alteration in the shape of erection reported by two
patients cannot be explained. There was no history of
penile trauma or evidence of Peyronie's disease on
palpation.
Ejaculatory disturbance was present in almost half
the patients. The form of disturbance varied. Retro¬
grade ejaculation as judged by the presence of cloudy
post-orgasmic urine was described by only one
patient. Three others had absent ejaculation, but un¬
remarkable post-orgasmic urine. In these subjects the
production of ejaculate may have ceased; alternatively,
emission may have been impaired. The most common
ejaculatory disorder, present in over a third of the
sample, was the absence of the pumping sensation that
normally accompanies ejaculation: 10 patients des¬
cribed semen seeping out of their erect or flaccid penis
at, or before orgasm. This phenomenon did not
resemble the emission experienced by patients with
severe premature ejaculation since it often occurred
prior to orgasm. It is also unlikely to have been due to
profuse secretion from the periurethral glands since all
the patients described it as a novel phenomenon.
Instead it is probable that this abnormality arose from
asubtle disruption of the ejaculatory process.
Sexual interest is considered to remain intact in
diabetic impotence (Cooper, 1972; Kolodny et al,
1974). In this sample, the majority of the sexual
difficulties developed in the context of intact interest in
sex, but in almost half the patients this subsequently
declined. It appeared that sexual interest was variably
affected and any decrease was not necessarily irre¬
versible. When sexual interest did decline, it seemed
that this represented a psychological response to the
sexual failure.
Although no associations were found between
retinopathy or autonomic neuropathy and the form of
sexual dysfunction, the numbers of patients in this
study are too small to permit firm conclusions. There
was also no clear association between the presence of
psychological factors and the pattern of sexual dys¬
function, although where such factors were present,
patients were more likely to have intact morning and
spontaneous erections and a reduced interest in sex.
These features are precisely those one would predict on
clinical grounds.
Since it is likely that the various aetiological factors
interact, it is not surprising that no simple asso¬
ciations emerged. It is probable that the erectile failure
of many diabetic men is in part the result of a pro¬
gressive physical disorder such as autonomic neuro¬
pathy. Superimposed upon this is the psychological
reaction of the patient and his partner which may
significantly worsen the problem. On the basis of the
present findings it seems that this reaction may take
various forms. It is likely to depend on the couple's
and each individual's prior experience of sexual
dysfunction, as well as their personalities, their
awareness of impotence as a complication of diabetes,
their evaluation of the importance of sex and potency,
and the quality of their relationship.
The concept of diabetic impotence is misleadingly
oversimplified. It is preferable to view diabetic men as
especially prone to physical factors liable to disturb
sexual function. These will interact with psychological
factors to produce a variety of clinical pictures. If
diabetic impotence is viewed in this way it may be
possible to improve the gloomy prognosis by using
appropriate counselling to minimize the psychological
reaction to sexual dysfunction.
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PAPERS AND SHORT REPORTS
Alcohol: another risk factor for diabetic retinopathy?
R J YOUNG, D K McCULLOCH, R J PRESCOTT, B F CLARKE
Abstract
In a five year prospective study clinical features
associated with the development and progress of retino¬
pathy were sought in 296 randomly selected diabetic
men aged 20-59. None had ophthalmoscopically detect¬
able retinopathy initially, but during follow up 66
developed the condition (47 background, 10 exudative,
9 proliferative). Linear logistic analyses (two tailed
tests) showed that the initial features independently
predictive of retinopathy were duration of diabetes,
poor glycaemic control, impotence, and—unexpectedly—
heavy alcohol consumption. Poor glycaemic control in
the interim and proteinuria at review were also as¬
sociated with the development of retinopathy. No relation
was found with smoking or obesity. Glycaemic control
and alcohol consumption were therefore the only aetio-
logically relevant associations identified. The develop¬
ment of severe retinopathy (exudative and proliferative)
showed a particular association with heavy alcohol
consumption, occurring in nine of the 70 heavy drinkers
(13%) compared with 10 (4-4%) of the rest.
Alcohol consumption may be an important inde¬
pendent factor associated predictively with sight
threatening diabetic retinopathy.
Introduction
Diabetic retinopathy remains a major cause of blindness.
Various factors have been suggested as associated with retino¬
pathy in cross sectional studies. A relation between duration of
diabetes and the development of retinopathy has long been
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recognised,1 and mean clinic blood glucose concentrations are
reported to be higher, particularly in severe retinopathy.2 3
Published data related to other factors such as cigarette
smoking,4"' obesity,2 8-11 blood pressure,8"18 and genetic
susceptibility19"21 have produced conflicting conclusions well
summarised by Dornan et al."
Only two studies have examined prospectively clinical
features predictive of retinopathy. Pirart confirmed the effect
of duration of diabetes and substantiated the importance of
glycaemic control, but a vast drop out rate limited the value
of his study.2 In Pima Indians, who have a high prevalence of
type II (non-insulin-dependent) diabetes, severity of disease, a
raised plasma glucose concentration, proteinuria, neuropathy,
and systolic blood pressure all had some predictive value.18
Much therefore remains uncertain about the factors respon¬
sible for the remarkable differences commonly observed between
individual diabetics with respect to both the presence and
severity of retinopathy. A prospective study of diabetic
impotence in a large number of diabetic men22 allowed us also
to consider clinical features which might be predictive of
diabetic retinopathy.
Patients and methods
At the outset 541 men aged 20-59 years were studied; 101 had been
selected at random from the total male clinic population of the same
age range and it was shown that the study group was fully representa¬
tive of the male diabetic clinic population.22 During the period of
follow up 36 patients left the area and a further 22 became untraceable.
In addition, six patients refused reinterview and 11 were unsuitable
(five severe psychiatric illness, three severe cerebrovascular disease,
one traumatic brain damage, two not diabetic). Of the remaining
466 men, 63 had died leaving 403 who were re-examined. The mean
interval between the first and second study examinations was 4 years
8 months (range 3 years 8 months to 6 years 2 months). The same
detailed questionnaire was completed at the initial and follow up
visits. Age, body weight, duration of diabetes, form of treatment,
other drug treatment, smoking (cigarettes a day), and alcohol intake
(measures a week) were recorded. In the analysis alcohol intake was
divided simply into none to moderate (<10 pints (5-7 1) of beer or
equivalent a week) and heavy (>10 pints of beer or equivalent a
week). Direct inquiry elicited past medical history, symptoms of
ischaemic heart disease, peripheral vascular disease, sexual function,
and diabetic peripheral and autonomic neuropathy. Initially the six
most recent clinic blood glucose values were averaged as an index of
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glycaemic control, and at review all of the values obtained during the
intervening period were averaged. Retinopathy was assessed by
direct ophthalmoscopy of both fundi through dilated pupils in a
dark cubicle; findings were recorded as normal (grade 1), micro¬
aneurysms with or without dot haemorrhages (grade 2), soft or hard
exudates (grade 3), and neovascularisation (grade 4). Proteinuria
(Albustix) was recorded as 0, ±, +, + + , or + + + .
Statistical analysis was principally by the application of linear
logistic models.®3 For binary responses (for example, retinopathy/no
retinopathy) these models are the equivalent of the more familiar
multiple regression models," which can be used only for continuous
response variables (for example, weight). Thus the linear logistic
model allows the simultaneous assessment of the possible influence
of several interrelated variables on the development of retinopathy.
Two tailed likelihood ratio tests were employed to determine the
significance of individual terms. The analysis had two stages. In the
first stage only variables relating to the initial examination were
the review period. The only significant features then were original
alcohol intake (p =0 02), original impotence (p =0 03), and proteinuria
at review (p<0 001). The estimated relative risk for heavy drinkers
of developing severe retinopathy was 3-5 but the 95% confidence
limits were wide (1-2 to 8-4) owing to small numbers.
No other features appeared in the fitted logistic model and, in
particular, the other potentially causal factors—smoking and body
mass index—did not show any evidence of association with retinopathy
even when considered separately.
Discussion
The prevalence of diabetic retinopathy is about 80% after
25 years of diabetes in otherwise unselected diabetics, but only
a small proportion (roughly 15%) will have developed prolifera-
TABLE II—Development of retinopathy over 5 years (mean 4 years 8 months; range 3 years 8 months to 6 years 2 months) in
296 diabetic men originally free of retinopathy; significantly associated features. (Percentages given in parentheses)
Grade of retinopathy at review
Total: all groups Significance*
Initial features






<4 137 (91) 9 (6) 2 (1) 3 (2) 151
5-9 59(71) 14 (17) 5 (6) 5 (6) 83
^10 34 (55) 24 (39) 3 (5) 1 (2) 62
<9 107 (87) 12 (10) 3 (3) 0 116
9-14 88 (73) 21 (17) 6 (5) 6 (5) 121
>14 41 (69) 14 (24) 1 (2) 3 (5) 59
Potent 185 (83) 28 (13) 7 (3) 3 (1) 223
Impotent 45 (62) 19 (26) 3 (4) 6 (8) 73
<10 181 (80) 35 (15) 5 (2) 5 (2) 226
>10 49 (70) 12 (17) 5 (7) 4 (6) 70
Features at review
<9 61 (87) 5 (7) 3 (4) 1 (1) 70
9-14 127 (80) 21 (13) 5 (3) 5 (3) 158
>14 25 (57) 14 (32) 2 (5) 3 (7) 44
Nil or intermittent 224(81) 41 (15) 6 (2) 5 (2) 276
Persistent 6(30) 6(30) 4(20) 4(20) 20
p<00001
j. p = 0-02
j- p< 0-001
} P = 002
| pCO-OOl
j- p<0 001
•Based on likelihood ratio tests from linear logistic model.
tValues are means of clinic blood glucose concentrations as detailed in text; 24 records missing at review.
Conversion: SI to traditional units—Glucose: 1 mmol/l~ 18 mg/100 ml.
included in the model. In the second stage the significant variables
from the first stage were retained in the model and the additional
effect of variables relating to the follow up period were assessed.
TABLE I—Progression of retinopathy over 5 years (mean
4 years 8 months; range 3 years 8 months to 6 years
2 months) in 403 diabetic men
Grade* at review
Initial grade* No of patients
1 2 3 4
1 296 230 47 10 9
2 66 16 31 6 13
3 23 3 7 13
4 18 18
Total 403 246 81 23 53
* 1 = No retinopathy. 2 =Microaneurysms ± haemorrhages.
3 = Exudates. 4 = Neovascularisation.
Results
Table I shows the fundoscopic findings initially and at review in
the 403 men who were followed up. Initially no retinopathy was seen
in 296, of whom 66 subsequently developed retinal changes. Table II
lists the features significantly associated with the development of
retinopathy in this group. From the logistic model the estimated
relative risk of developing retinopathy of any grade in "heavy"
compared with "none to moderate" drinkers was 2-25 with 95%
confidence limits of 115 to 4 42. Table II also suggests that heavy
drinkers were more likely to develop severe retinopathy. This was
confirmed when the data were analysed to extract features associated
with progression of retinopathy from grade 1 to grade 3 or 4 during
tive retinopathy or maculopathy." In clinical practice it is
noticeable that in apparently similar patients retinopathy
develops to greatly varying degrees. Thus, although sight
threatening retinopathy will usually not develop unless there is
hyperglycaemia of substantial duration, glycaemic control and
duration of diabetes often seem insufficient in themselves to
account for the variations observed. Numerous studies have
therefore sought aetiopathogenic factors other than glycaemic
control, including genetic susceptibility, body mass index,
blood pressure, and smoking, for all of which the evidence is
conflicting. We have investigated the influence of some of these
factors and additionally, for the first time, the effect of alcohol.
Before discussing the results further it is important to
consider the following. Unlike cross sectional studies, prospective
studies such as ours may identify predictive as well as co¬
existent features with respect to a dependent variable such as
retinopathy. They cannot, however, determine whether such
associations are causal. Nevertheless, based on what we know
about the disease the statistically significant and non-significant
features in the analysis may be divided into those such as
glycaemic control and alcohol consumption which might have
an aetiological role in retinopathy and those such as impotence
and proteinuria which are probably just other manifestations of
generalised microangiopathy. It is the former with which this
study was concerned particularly, and the statistical analysis
ensured that inclusion of the latter in the model did not obscure
or create any significant associations with the former. Finally,
almost all prospective studies have the inevitable shortcoming
that follow up is incomplete. In our series 14% of the original
cohort were "lost" and 12% died. We have no evidence that
those who moved away or became untraceable differed ap-
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preciably from the group reviewed. With respect to death it
might be argued that risk factors for retinopathy may be
obscured if they also increase the risk of early death. Features
at the outset significantly associated with death during the re¬
view period were proteinuria, previous myocardial infarction,
symptomatic autonomic neuropathy, and retinopathy.22 There
was therefore an underrepresentation of initially retinopathy free
men among those who died, but none of the features predictive
of death are probable aetiological factors for retinopathy, and so
it is unlikely that this would influence the results.
Apart from duration of diabetes our prospective study in men
initially clinically free of retinopathy showed significant relations
between the development of retinopathy of any grade and two
features of potential aetiological relevance—glycaemic control
and alcohol intake. Body mass index and smoking were in¬
cluded in the analysis but no relation was found; this 3grees
with other studies.2 1 ' 10 21 We did not look for a genetic
influence or an association with blood pressure.
The importance of the degree of glycaemic control in the
development and progression of diabetic retinopathy remains
controversial. There are very few prospective data from which
the role of glycaemic control in the development of retinopathy
may be deduced, but both Pirart's study and the six year
prospective study of Pima Indians found positive associations.2 ld
Retrospective studies have found a relation between the mean of
many clinic blood glucose estimations and the degree of result¬
ing retinopathy.2 21 On the other hand, in intervention studies
data relating the degree of glycaemic control to the progression
of established retinopathy have produced contradictory
results.26 25 Our prospective data on clinical retinopathy arising
as a new complication support the contention that glycaemic
control is an important determinant of the development of
retinopathy despite the poor index of glycaemic control used.
Thus both initially and during follow up there were significant
associations of the degrees of glycaemic control with the
development of retinopathy of any grade. Inspection of the
data also suggests that severe retinopathy was more likely to
develop if glycaemic control was poor during follow up. This
was not, however, statistically significant.
The surprising finding was the relation between alcohol intake
initially and the subsequent development of retinopathy. So far
as we know no such relation has been reported. It is clearly
a relatively small effect, but none the less significant, and the
particular association with the more severe degrees of retino¬
pathy is noteworthy. If this were a causal relation it might
account, in a few diabetics, for otherwise inexplicably rapid
progression to sight threatening retinopathy. If we speculate
further, potential causal mechanisms might operate via syner¬
gistic glucose and alcohol mediated metabolic tissue damage or
through the intermediary of hypertension. Alternatively, high
alcohol intake might just be a marker for some other habit—
possibly poor diet—which is the true causal association.
Whatever the explanation we have shown prospectively the
association of two potentially aetiologically explanatory variables
—glycaemic control and alcohol intake—with both the develop¬
ment and the progress of diabetic retinopathy. Further primary
intervention studies are required to determine the precise
degrees of influence and mechanisms of action of these factors.
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the teeth, and their medicines—If you will keep your teeth from
rotting, or aching, wash your mouth continually every morning with
juice of Lemons, and afterwards rub your teeth either with a Sage-leaf,
or else with a little Nutmeg in powder; also wash your mouth with a
little fair water after meats; for the only way to keep teeth sound,
and free from pain, is to keep them clean. To keep Teeth white—Dip a
little piece of white cloth in Vinegar of Quinces, and rub your gums
with it, for it is of a gallant binding quality, and not only makes the
teeth white, but also strengthens the gums, fastens the teeth, and
also causeth a sweet breath. To fasten the Teeth—Seethe the roots of
Vervain in old Wine, and wash your teeth often with them, and it
will fasten them. For the Tooth-ache—Take the inner rind of an
Elder-tree, and bruise it, and put thereto a little Pepper, and make it
into balls, and hold them between the teeth that ache. (Nicholas
Culpeper (1616-54) The Complete Herbal, 1850.)
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